BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R;  Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900-20; quiz 1943. [PMID: 16928254 DOI: 10.1111/j.1572-0241.2006.00630.x] [Cited by in Crossref: 2128] [Cited by in F6Publishing: 1700] [Article Influence: 141.9] [Reference Citation Analysis]
Number Citing Articles
1 Holtmann G, Bigard MA, Malfertheiner P, Pounder R. Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD. Int J Clin Pharm. 2011;33:493-500. [PMID: 21472476 DOI: 10.1007/s11096-011-9489-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
2 Wilder-Smith CH, Materna A, Martig L, Lussi A. Longitudinal study of gastroesophageal reflux and erosive tooth wear. BMC Gastroenterol 2017;17:113. [PMID: 29070010 DOI: 10.1186/s12876-017-0670-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
3 Marshall-webb M, Peters MD, Bright T, Watson DI. Effectiveness of Nissen fundoplication versus anterior and posterior partial fundoplications for treatment of gastro-esophageal reflux disease: a systematic review protocol. JBI Database of Systematic Reviews and Implementation Reports 2018;16:1095-102. [DOI: 10.11124/jbisrir-2017-003484] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Kariri AM, Darraj MA, Wassly A, Arishi HA, Lughbi M, Kariri A, Madkhali AM, Ezzi MI, Khawaji B. Prevalence and Risk Factors of Gastroesophageal Reflux Disease in Southwestern Saudi Arabia. Cureus 2020;12:e6626. [PMID: 31966942 DOI: 10.7759/cureus.6626] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Fukuda N, Ishimura N, Okada M, Izumi D, Mikami H, Okimoto E, Aimi M, Mishiro T, Oshima N, Ishihara S, Kinoshita Y. Mucosal breaks show same circumferential distribution in majority of patients with recurrent reflux esophagitis. Endosc Int Open 2017;5:E214-21. [PMID: 28317018 DOI: 10.1055/s-0043-102401] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Frazzoni M, Bertani H, Manta R, Mirante VG, Frazzoni L, Conigliaro R, Melotti G. Impairment of chemical clearance is relevant to the pathogenesis of refractory reflux oesophagitis. Dig Liver Dis 2014;46:596-602. [PMID: 24709005 DOI: 10.1016/j.dld.2014.03.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
7 Nocca D, Skalli EM, Boulay E, Nedelcu M, Michel Fabre J, Loureiro M. Nissen Sleeve (N-Sleeve) operation: preliminary results of a pilot study. Surg Obes Relat Dis 2016;12:1832-7. [PMID: 27234340 DOI: 10.1016/j.soard.2016.02.010] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 8.8] [Reference Citation Analysis]
8 Tolia V, Gilger MA, Barker PN, Illueca M. Healing of erosive esophagitis and improvement of symptoms of gastroesophageal reflux disease after esomeprazole treatment in children 12 to 36 months old. J Pediatr Gastroenterol Nutr 2010;51:593-8. [PMID: 20706150 DOI: 10.1097/MPG.0b013e3181ddcf11] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Arul P, Vinoth B, Alexander T, Phansalkar M, Padhi S. Correlation of narrow band imaging endoscopy and histopathology in the diagnosis of nonerosive reflux disease. Saudi J Gastroenterol 2015;21:330-6. [PMID: 26458862 DOI: 10.4103/1319-3767.164205] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
10 Chen L, Chen Y, Li B. The efficacy and safety of proton-pump inhibitors in treating patients with non-erosive reflux disease: a network meta-analysis. Sci Rep 2016;6:32126. [PMID: 27581096 DOI: 10.1038/srep32126] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
11 Mizuno H, Matsuhashi N, Sakaguchi M, Inoue S, Nakada K, Higuchi K, Haruma K, Joh T. Recent effectiveness of proton pump inhibitors for severe reflux esophagitis: the first multicenter prospective study in Japan. J Clin Biochem Nutr. 2015;57:233-238. [PMID: 26566310 DOI: 10.3164/jcbn.14-144] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
12 Minatsuki C, Yamamichi N, Shimamoto T, Kakimoto H, Takahashi Y, Fujishiro M, Sakaguchi Y, Nakayama C, Konno-Shimizu M, Matsuda R, Mochizuki S, Asada-Hirayama I, Tsuji Y, Kodashima S, Ono S, Niimi K, Mitsushima T, Koike K. Background factors of reflux esophagitis and non-erosive reflux disease: a cross-sectional study of 10,837 subjects in Japan. PLoS One. 2013;8:e69891. [PMID: 23922844 DOI: 10.1371/journal.pone.0069891] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 6.5] [Reference Citation Analysis]
13 Lin C, Wang Y, Wang K, Lien H, Liang M, Yen T, Wang J, Liu S, Wang C. Association of Heartburn and Laryngopharyngeal Symptoms with Endoscopic Reflux Esophagitis, Smoking, and Drinking. Otolaryngol Head Neck Surg 2009;141:264-71. [DOI: 10.1016/j.otohns.2009.05.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
14 Molina-infante J, Rivas MD, Hernandez-alonso M, Vinagre-rodríguez G, Mateos-rodríguez JM, Dueñas-sadornil C, Perez-gallardo B, Ferrando-lamana L, Fernandez-gonzalez N, Bañares R, Zamorano J. Proton pump inhibitor-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2 cytokines overexpression. Aliment Pharmacol Ther 2014;40:955-65. [DOI: 10.1111/apt.12914] [Cited by in Crossref: 94] [Cited by in F6Publishing: 79] [Article Influence: 13.4] [Reference Citation Analysis]
15 Galli G, Carabotti M, Pilozzi E, Lahner E, Annibale B, Conti L. Relationship between Persistent Gastrointestinal Symptoms and Duodenal Histological Findings after Adequate Gluten-Free Diet: A Gray Area of Celiac Disease Management in Adult Patients. Nutrients 2021;13:600. [PMID: 33673062 DOI: 10.3390/nu13020600] [Reference Citation Analysis]
16 Lee SP, Sung I, Kim JH, Lee S, Park HS, Shim CS. The Clinical Features and Predisposing Factors of Asymptomatic Erosive Esophagitis. Dig Dis Sci 2016;61:3522-9. [DOI: 10.1007/s10620-016-4341-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
17 Pace F, Casini V, Pallotta S. Heterogeneity of endoscopy negative heartburn: Epidemiology and natural history. World J Gastroenterol 2008; 14(34): 5233-5236 [PMID: 18785272 DOI: 10.3748/wjg.14.5233] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
18 Kleiman DA, Sporn MJ, Beninato T, Metz Y, Crawford C, Fahey TJ, Zarnegar R. Early referral for 24-h esophageal pH monitoring may prevent unnecessary treatment with acid-reducing medications. Surg Endosc. 2013;27:1302-1309. [PMID: 23232999 DOI: 10.1007/s00464-012-2602-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
19 Fuchs KH, DeMeester TR, Otte F, Broderick RC, Breithaupt W, Varga G, Musial F. Severity of GERD and disease progression. Dis Esophagus 2021:doab006. [PMID: 33575739 DOI: 10.1093/dote/doab006] [Reference Citation Analysis]
20 Li ZT, Ji F, Han XW, Gu LX, Wang L, Yue YQ, Wang ZG. Contribution of hiatal hernia to asthma in patients with gastroesophageal reflux disease. Clin Respir J 2018;12:1858-64. [PMID: 29193785 DOI: 10.1111/crj.12748] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
21 Jones R, Rubin G, de Wit N, Seifert B, Agreus L. Gastro-oesophageal reflux disease redefined: Implications for primary care. European Journal of General Practice 2009;13:214-5. [DOI: 10.1080/13814780701855757] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
22 Talley NJ, Zand Irani M. Optimal management of severe symptomatic gastroesophageal reflux disease. J Intern Med 2021;289:162-78. [PMID: 32691466 DOI: 10.1111/joim.13148] [Reference Citation Analysis]
23 Zhang M, Hou ZK, Huang ZB, Chen XL, Liu FB. Dietary and Lifestyle Factors Related to Gastroesophageal Reflux Disease: A Systematic Review. Ther Clin Risk Manag 2021;17:305-23. [PMID: 33883899 DOI: 10.2147/TCRM.S296680] [Reference Citation Analysis]
24 Chen CH, Lin CL, Kao CH. Association between gastroesophageal reflux disease and coronary heart disease: A nationwide population-based analysis. Medicine (Baltimore) 2016;95:e4089. [PMID: 27399102 DOI: 10.1097/MD.0000000000004089] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 2.8] [Reference Citation Analysis]
25 Krznaric Z, Ljubas Kelecic D, Rustemovic N, Vranesic Bender D, Ostojic R, Markos P, Scarpignato C. Pharmaceutical principles of acid inhibitors: unmet needs. Dig Dis 2011;29:469-75. [PMID: 22095012 DOI: 10.1159/000331515] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
26 e Souza MÂN, Nobre RA, Bezerra PC, dos Santos AA, Sifrim D. Anatomical and functional deficiencies of the crural diaphragm in patients with esophagitis. Neurogastroenterol Motil 2017;29:e12899. [DOI: 10.1111/nmo.12899] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
27 Gatta L, Vaira D, Sorrenti G, Zucchini S, Sama C, Vakil N. Meta-analysis: the efficacy of proton pump inhibitors for laryngeal symptoms attributed to gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2007;25:385-92. [PMID: 17269993 DOI: 10.1111/j.1365-2036.2006.03213.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 60] [Article Influence: 5.3] [Reference Citation Analysis]
28 [DOI: 10.1101/811737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Nobre e Souza MÂ, Lima MJ, Martins GB, Nobre RA, Souza MH, de Oliveira RB, dos Santos AA. Inspiratory muscle training improves antireflux barrier in GERD patients. Am J Physiol Gastrointest Liver Physiol 2013;305:G862-7. [PMID: 24113771 DOI: 10.1152/ajpgi.00054.2013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
30 Scholten T. Long-term management of gastroesophageal reflux disease with pantoprazole. Ther Clin Risk Manag 2007;3:231-43. [PMID: 18360632 DOI: 10.2147/tcrm.2007.3.2.231] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
31 Modlin I, Hunt R, Malfertheiner P, Moayyedi P, Quigley E, Tytgat G, Tack J, Heading R, Holtman G, Moss S. Diagnosis and Management of Non-Erosive Reflux Disease – The Vevey NERD Consensus Group. Digestion 2009;80:74-88. [DOI: 10.1159/000219365] [Cited by in Crossref: 87] [Cited by in F6Publishing: 78] [Article Influence: 7.3] [Reference Citation Analysis]
32 Li Y, Fang M, Niu L, Fan Y, Liu Y, Long Y, Liu X, Tay FR, Chen J. Associations among gastroesophageal reflux disease, mental disorders, sleep and chronic temporomandibular disorder: a case-control study. CMAJ 2019;191:E909-15. [PMID: 31427355 DOI: 10.1503/cmaj.181535] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
33 Rusu RI, Fox MR, Tucker E, Zeki S, Dunn JM, Jafari J, Warburton F, Wong T. Validation of the Lyon classification for GORD diagnosis: acid exposure time assessed by prolonged wireless pH monitoring in healthy controls and patients with erosive oesophagitis. Gut 2021:gutjnl-2020-323798. [PMID: 33579789 DOI: 10.1136/gutjnl-2020-323798] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Kawaguchi S, Takeuchi T, Inoue Y, Takahashi Y, Ozaki H, Ota K, Harada S, Edogawa S, Kojima Y, Yamashita H, Fukuchi T, Ashida K, Higuchi K. Exploratory Research on Latent Esophageal Motility Disorders in Dysphagia Patients. Digestion 2017;95:269-74. [DOI: 10.1159/000470901] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
35 Vailati C, Mazzoleni G, Testoni PA, Passaretti S. pH-Impedance Findings and Proton Pump Inhibitors-Responsiveness in Patients With Typical Gastroesophageal Reflux Disease Symptoms in a Large Single-Center Italian Series. Journal of Clinical Gastroenterology 2014;48:613-9. [DOI: 10.1097/mcg.0000000000000051] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
36 Lee SW, Lien HC, Lin CC, Wen MC, Chang CS. Low Expression of Transforming Growth Factor β in the Epithelium of Barrett's Esophagus. Gastroenterology Res 2018;11:189-94. [PMID: 29915628 DOI: 10.14740/gr1009w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
37 Mehta RS, Song M, Staller K, Chan AT. Association Between Beverage Intake and Incidence of Gastroesophageal Reflux Symptoms. Clinical Gastroenterology and Hepatology 2020;18:2226-2233.e4. [DOI: 10.1016/j.cgh.2019.11.040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
38 Lv J, Liu J, Guo L, Zhang J, Cheng Y, Chen C, Zhao H, Wang J. Bioinformatic analyses of microRNA-targeted genes and microarray-identified genes correlated with Barrett's esophagus. Cell Cycle 2018;17:792-800. [PMID: 29417867 DOI: 10.1080/15384101.2018.1431597] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
39 Sacco O, Mattioli G, Girosi D, Battistini E, Jasonni V, Rossi GA. Gastroesophageal reflux and its clinical manifestation at gastroenteric and respiratory levels in childhood: physiology, signs and symptoms, diagnosis and treatment. Expert Review of Respiratory Medicine 2014;1:391-401. [DOI: 10.1586/17476348.1.3.391] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
40 Hsu CK, Lai CC, Wang K, Chen L. Risk of lung cancer in patients with gastro-esophageal reflux disease: a population-based cohort study. PeerJ 2016;4:e2753. [PMID: 28028458 DOI: 10.7717/peerj.2753] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
41 Forcelini CM, Tomiozzo JC Jr, Farré R, Van Oudenhove L, Callegari-Jacques SM, Ribeiro M, Madalosso BH, Fornari F. Effect of nortriptyline on brain responses to painful esophageal acid infusion in patients with non-erosive reflux disease. Neurogastroenterol Motil 2014;26:187-95. [PMID: 24188252 DOI: 10.1111/nmo.12251] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
42 Ghisa M, Marinelli C, Savarino V, Savarino E. Idiopathic pulmonary fibrosis and GERD: links and risks. Ther Clin Risk Manag 2019;15:1081-93. [PMID: 31564886 DOI: 10.2147/TCRM.S184291] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 4.5] [Reference Citation Analysis]
43 Kwon OJ, Kim MY, Shin SH, Lee AR, Lee JY, Seo BI, Shin MR, Choi HG, Kim JA, Min BS. Antioxidant and Anti-Inflammatory Effects of Rhei Rhizoma and Coptidis Rhizoma Mixture on Reflux Esophagitis in Rats. Evid Based Complement Alternat Med. 2016;2016:2052180. [PMID: 27239206 DOI: 10.1155/2016/2052180] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
44 Rutegård M, Nordenstedt H, Lu Y, Lagergren J, Lagergren P. Sex-specific exposure prevalence of established risk factors for oesophageal adenocarcinoma. Br J Cancer 2010;103:735-40. [PMID: 20700121 DOI: 10.1038/sj.bjc.6605804] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
45 Jiang JX, Liu Q, Mao XY, Zhang HH, Zhang GX, Xu SF. Downward trend in the prevalence of Helicobacter pylori infections and corresponding frequent upper gastrointestinal diseases profile changes in Southeastern China between 2003 and 2012. Springerplus 2016;5:1601. [PMID: 27652174 DOI: 10.1186/s40064-016-3185-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
46 Pacheco A, Faro V, Cobeta I, Royuela A. Chronic Cough With Limited Response to Treatment and Incidence of Gastroesophageal Reflux. Archivos de Bronconeumología (English Edition) 2012;48:197-201. [DOI: 10.1016/j.arbr.2012.03.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
47 Meuret AE, Tunnell N, Roque A. Anxiety Disorders and Medical Comorbidity: Treatment Implications. Adv Exp Med Biol 2020;1191:237-61. [PMID: 32002933 DOI: 10.1007/978-981-32-9705-0_15] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
48 Sinn DH, Kim JH, Kim S, Son HJ, Kim JJ, Rhee JC, Rhee P. Response rate and predictors of response in a short-term empirical trial of high-dose rabeprazole in patients with globus: HIGH-DOSE RABEPARAZOLE IN PATIENTS WITH GLOBUS. Alimentary Pharmacology & Therapeutics 2008;27:1275-81. [DOI: 10.1111/j.1365-2036.2008.03659.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
49 Bresadola V, Adani GL, Londero F, Leo CA, Cherchi V, Lorenzin D, Rossetto A, Vit G, Baccarani U, Terrosu G, Anna DD. Non-erosive and uncomplicated erosive reflux diseases: Difference in physiopathological and symptom pattern. World J Gastrointest Pathophysiol 2011; 2(3): 42-48 [PMID: 21860835 DOI: 10.4291/wjgp.v2.i3.42] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
50 Kseneva SI, Borodulina EV, Udut VV, Fisenko VP. Mechanism Underlying the Formation of a Cluster of Metabolic Syndrome. Endocr Metab Immune Disord Drug Targets 2020;20:564-9. [PMID: 31589129 DOI: 10.2174/1871530319666191007115214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Mello M, Gyawali CP. Esophageal Manometry in Gastroesophageal Reflux Disease. Gastroenterology Clinics of North America 2014;43:69-87. [DOI: 10.1016/j.gtc.2013.11.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
52 Müller DT, Schulte E, Babic B, Knepper L, Fuchs C, Schröder W, Bruns CJ, Leers JM, Fuchs HF. Software improvement for evaluation of laryngopharyngeal pH testing (Restech) – a comparison between DataView 3 and 4. World J Gastrointest Surg 2020; 12(5): 236-246 [PMID: 32551029 DOI: 10.4240/wjgs.v12.i5.236] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Witteman BP, Strijkers R, de Vries E, Toemen L, Conchillo JM, Hameeteman W, Dagnelie PC, Koek GH, Bouvy ND. Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice. Surg Endosc. 2012;26:3307-3315. [PMID: 22648098 DOI: 10.1007/s00464-012-2324-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
54 Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108:308-28; quiz 329. [PMID: 23419381 DOI: 10.1038/ajg.2012.444] [Cited by in Crossref: 940] [Cited by in F6Publishing: 680] [Article Influence: 117.5] [Reference Citation Analysis]
55 Kandulski A, Weigt J, Caro C, Jechorek D, Wex T, Malfertheiner P. Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn. Clin Gastroenterol Hepatol 2015;13:1075-81. [PMID: 25496815 DOI: 10.1016/j.cgh.2014.11.033] [Cited by in Crossref: 79] [Cited by in F6Publishing: 63] [Article Influence: 11.3] [Reference Citation Analysis]
56 Weijenborg PW, Bredenoord AJ. How reflux causes symptoms: Reflux perception in gastroesophageal reflux disease. Best Practice & Research Clinical Gastroenterology 2013;27:353-64. [DOI: 10.1016/j.bpg.2013.06.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
57 Lie TM, Bomme M, Hveem K, Hansen JM, Ness-Jensen E. Snus and risk of gastroesophageal reflux. A population-based case-control study: the HUNT study. Scand J Gastroenterol 2017;52:193-8. [PMID: 27797289 DOI: 10.1080/00365521.2016.1245775] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
58 Elsheaita A, El-Bially MA, Shamseya MM, Ahmed SS, Madkour MA, Shamseya AM, Nouh HH. Seattle protocol vs narrow band imaging guided biopsy in screening of Barrett's esophagus in gastroesophageal reflux disease patients. Medicine (Baltimore) 2020;99:e19261. [PMID: 32080134 DOI: 10.1097/MD.0000000000019261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Tolia V, Vandenplas Y. Systematic review: the extra-oesophageal symptoms of gastro-oesophageal reflux disease in children. Aliment Pharmacol Ther 2009;29:258-72. [PMID: 19143046 DOI: 10.1111/j.1365-2036.2008.03879.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 45] [Article Influence: 6.1] [Reference Citation Analysis]
60 Stein E, Sloan J, Sonu I, Kathpalia P, Jodorkovsky D. GERD for the nongastroenterologist: successful evaluation, management, and lifestyle-based symptom control. Ann N Y Acad Sci 2020;1482:106-12. [PMID: 32944973 DOI: 10.1111/nyas.14496] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Zhang Z, Curran G, Altinok Dindar D, Wu Y, Wu H, Sharpton T, Zhao L, Lieberman D, Otaki F. Insights Into the Oral Microbiome and Barrett's Esophagus Early Detection: A Narrative Review. Clin Transl Gastroenterol 2021;12:e00390. [PMID: 34446641 DOI: 10.14309/ctg.0000000000000390] [Reference Citation Analysis]
62 Xiao Y, Zhang S, Dai N, Fei G, Goh KL, Chun HJ, Sheu BS, Chong CF, Funao N, Zhou W, Chen M. Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis. Gut 2020;69:224-30. [PMID: 31409606 DOI: 10.1136/gutjnl-2019-318365] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
63 Lin HC, Xirasagar S, Lee CZ, Huang CC, Chen CH. The association between gastro-oesophageal reflux disease and subsequent rheumatoid arthritis occurrence: a nested case-control study from Taiwan. BMJ Open 2017;7:e016667. [PMID: 29151046 DOI: 10.1136/bmjopen-2017-016667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
64 Kim SY, Park B, Lim H, Kim M, Kong IG, Choi HG. Gastroesophageal reflux disease increases the risk of chronic rhinosinusitis: a nested case-control study using a national sample cohort. Int Forum Allergy Rhinol 2019;9:357-62. [PMID: 30548214 DOI: 10.1002/alr.22259] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
65 Richter JE, Pandolfino JE, Vela MF, Kahrilas PJ, Lacy BE, Ganz R, Dengler W, Oelschlager BK, Peters J, DeVault KR, Fass R, Gyawali CP, Conklin J, DeMeester T;  Esophageal Diagnostic Working Group. Utilization of wireless pH monitoring technologies: a summary of the proceedings from the esophageal diagnostic working group. Dis Esophagus. 2013;26:755-765. [PMID: 22882487 DOI: 10.1111/j.1442-2050.2012.01384.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.2] [Reference Citation Analysis]
66 Yadlapati R, Pandolfino JE, Greytak M, Cahoon J, Clarke M, Clary M, Fink D, Menard-Katcher P, Vahabzadeh-Hagh AM, Weissbrod P, Gupta S, Kaizer A, Wani S. Upper Esophageal Sphincter Compression Device as an Adjunct to Proton Pump Inhibition for Laryngopharyngeal Reflux. Dig Dis Sci 2021. [PMID: 34275061 DOI: 10.1007/s10620-021-07172-2] [Reference Citation Analysis]
67 Roman S, Gyawali CP, Savarino E, Yadlapati R, Zerbib F, Wu J, Vela M, Tutuian R, Tatum R, Sifrim D, Keller J, Fox M, Pandolfino JE, Bredenoord AJ; GERD consensus group. Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group. Neurogastroenterol Motil 2017;29:1-15. [PMID: 28370768 DOI: 10.1111/nmo.13067] [Cited by in Crossref: 158] [Cited by in F6Publishing: 119] [Article Influence: 39.5] [Reference Citation Analysis]
68 Herbella FAM, Patti MG. Gastroesophageal Reflux Disease and Idiopathic Lung Fibrosis. From Heartburn to Lung Transplant, and Beyond. Am Surg 2021;:3134821998686. [PMID: 33629881 DOI: 10.1177/0003134821998686] [Reference Citation Analysis]
69 Xi L, Zhu J, Zhang H, Muktiali M, Li Y, Wu A. The treatment efficacy of adding prokinetics to PPIs for gastroesophageal reflux disease: a meta-analysis. Esophagus 2021;18:144-51. [PMID: 32519226 DOI: 10.1007/s10388-020-00753-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
70 Bai P, Bano S, Kumar S, Sachdev P, Ali A, Dembra P, Bachani P, Shahid S, Jamil A, Rizwan A. Gastroesophageal Reflux Disease in the Young Population and Its Correlation With Anxiety and Depression. Cureus 2021;13:e15289. [PMID: 34194886 DOI: 10.7759/cureus.15289] [Reference Citation Analysis]
71 Farré R, Vicario M. Abnormal Barrier Function in Gastrointestinal Disorders. Handb Exp Pharmacol 2017;239:193-217. [PMID: 27995392 DOI: 10.1007/164_2016_107] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
72 Hunt RH, Tytgat GH, Malfertheiner P, Fock KM, Heading RC, Katelaris PH, McCarthy DM, McColl KE, Moss SF, Sachs G, Sontag SJ, Thomson AB, Modlin IM. Whistler summary: "the slow rate of rapid progress". J Clin Gastroenterol 2007;41:539-45. [PMID: 17577108 DOI: 10.1097/MCG.0b013e31803d0fd8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
73 Choi JM, Yang JI, Kang SJ, Han YM, Lee J, Lee C, Chung SJ, Yoon DH, Park B, Kim YS. Association Between Anxiety and Depression and Gastroesophageal Reflux Disease: Results From a Large Cross-sectional Study. J Neurogastroenterol Motil 2018;24:593-602. [PMID: 30347938 DOI: 10.5056/jnm18069] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
74 Rugge M, Meggio A, Cataudella G, Parente P, Salvagnini G, de Pretis G, Zaninotto G. Barrett's esophagus: still much to learn, but "Yes, we can!". Am J Gastroenterol 2008;103:2944-6; author reply 2946-7. [PMID: 19032478 DOI: 10.1111/j.1572-0241.2008.02094_9.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
75 Daum C, Sweis R, Kaufman E, Fuellemann A, Anggiansah A, Fried M, Fox M. Failure to respond to physiologic challenge characterizes esophageal motility in erosive gastro-esophageal reflux disease. Neurogastroenterol Motil. 2011;23:517-e200. [PMID: 21272162 DOI: 10.1111/j.1365-2982.2011.01669.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 7.2] [Reference Citation Analysis]
76 Chandran S, Raman R, Kishor M, Nandeesh HP. The effectiveness of mindfulness meditation in relief of symptoms of depression and quality of life in patients with gastroesophageal reflux disease. Indian J Gastroenterol 2019;38:29-38. [PMID: 30864012 DOI: 10.1007/s12664-019-00940-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
77 Cho JH, Yoon H, Shin CM, Park YS, Kim N, Lee DH. Efficacy of DA-5204 (Stillen 2X) for patients with gastroesophageal reflux disease: A randomized, double-blind, placebo-controlled pilot study. Medicine (Baltimore) 2020;99:e22729. [PMID: 33126310 DOI: 10.1097/MD.0000000000022729] [Reference Citation Analysis]
78 Wex T, Mönkemüller K, Kuester D, Fry L, Kandulski A, Malfertheiner P. Zonulin is not increased in the cardiac and esophageal mucosa of patients with gastroesophageal reflux disease. Peptides 2009;30:1082-7. [PMID: 19463740 DOI: 10.1016/j.peptides.2009.03.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
79 Neumann H, Mönkemüller K, Fry LC, Dombrowski F, Kuester D, Beyer M, Malfertheiner P. Intercellular space volume is mainly increased in the basal layer of esophageal squamous epithelium in patients with GERD. Dig Dis Sci. 2011;56:1404-1411. [PMID: 21053078 DOI: 10.1007/s10620-010-1458-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
80 Manabe N, Haruma K, Imamura H, Kamada T, Kusunoki H, Inoue K, Shiotani A, Hata J. Does short-segment columnar-lined esophagus elongate during a mean follow-up period of 5.7 years? Dig Endosc. 2011;23:166-172. [PMID: 21429023 DOI: 10.1111/j.1443-1661.2010.01073.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
81 Niimi A. Gastroesophageal reflux disease: An important consideration for respiratory disorders. Respiratory Investigation 2017;55:291-2. [DOI: 10.1016/j.resinv.2017.08.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
82 Neumann H, Neurath MF, Vieth M, Lever FM, Meijer GJ, Lips IM, Mcmahon BP, Ruurda J, van Hillegersberg R, Siersema P, Levine MS, Scharitzer M, Pokieser P, Zerbib F, Savarino V, Zentilin P, Savarino E, Chan WW. Innovative techniques in evaluating the esophagus; imaging of esophageal morphology and function; and drugs for esophageal disease: Innovative techniques in evaluating the esophagus. Ann N Y Acad Sci 2013;1300:11-28. [DOI: 10.1111/nyas.12233] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
83 Das D, Ishaq S, Harrison R, Kosuri K, Harper E, Decaestecker J, Sampliner R, Attwood S, Barr H, Watson P. Management of Barrett's esophagus in the UK: overtreated and underbiopsied but improved by the introduction of a national randomized trial. Am J Gastroenterol. 2008;103:1079-1089. [PMID: 18445097 DOI: 10.1111/j.1572-0241.2008.01790.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 57] [Article Influence: 5.5] [Reference Citation Analysis]
84 Garrigues V, Ponce J. Aspectos menos conocidos de la enfermedad por reflujo gastroesofágico: pirosis funcional y reflujo no ácido. Gastroenterología y Hepatología 2008;31:522-9. [DOI: 10.1157/13127096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
85 Stanghellini V, Barbara G, Cogliandro R, Salvioli B, Cremon C, De Giorgio R, Corinaldesi R. Overlap Between GERD and IBS: Irrefutable But Subtle. Journal of Clinical Gastroenterology 2007;41:S114-7. [DOI: 10.1097/mcg.0b013e31803d0f94] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
86 Weijenborg PW, Rohof WO, Akkermans LM, Verheij J, Smout AJ, Bredenoord AJ. Electrical tissue impedance spectroscopy: a novel device to measure esophageal mucosal integrity changes during endoscopy. Neurogastroenterol Motil 2013;25:574-8, e457-8. [PMID: 23607721 DOI: 10.1111/nmo.12106] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
87 Finocchio E, Locatelli F, Sanna F, Vesentini R, Marchetti P, Spiteri G, Antonicelli L, Battaglia S, Bono R, Corsico AG, Ferrari M, Murgia N, Pirina P, Olivieri M, Verlato G. Gastritis and gastroesophageal reflux disease are strongly associated with non-allergic nasal disorders. BMC Pulm Med 2021;21:53. [PMID: 33557802 DOI: 10.1186/s12890-020-01364-8] [Reference Citation Analysis]
88 Spechler SJ. Evaluation and Treatment of Patients with Persistent Reflux Symptoms Despite Proton Pump Inhibitor Treatment. Gastroenterol Clin North Am 2020;49:437-50. [PMID: 32718563 DOI: 10.1016/j.gtc.2020.04.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
89 Ponce J, Garrigues V, Agréus L, Tabaglio E, Gschwantler M, Güallar E, Tafalla M, Nuevo J, Hatlebakk JG. Structured management strategy versus usual care for gastroesophageal reflux disease: rationale for pooled analysis of five European cluster-randomized trials. Therap Adv Gastroenterol 2011;4:11-26. [PMID: 21317991 DOI: 10.1177/1756283X10387060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
90 Guiddir T, Saint-Pierre P, Purenne-Denis E, Lambert N, Laoudi Y, Couderc R, Gouvis-Echraghi R, Amat F, Just J. Neutrophilic Steroid-Refractory Recurrent Wheeze and Eosinophilic Steroid-Refractory Asthma in Children. J Allergy Clin Immunol Pract 2017;5:1351-1361.e2. [PMID: 28363401 DOI: 10.1016/j.jaip.2017.02.003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
91 Zerbib F, Bredenoord AJ, Fass R, Kahrilas PJ, Roman S, Savarino E, Sifrim D, Vaezi M, Yadlapati R, Gyawali C. ESNM/ANMS consensus paper: Diagnosis and management of refractory gastro‐esophageal reflux disease. Neurogastroenterology & Motility 2021;33. [DOI: 10.1111/nmo.14075] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
92 Takenaka R, Okada H, Kawano S, Komazawa Y, Yoshinaga F, Nagata S, Inoue M, Komatsu H, Onogawa S, Kushiyama Y, Mukai S, Todo H, Okanobu H, Manabe N, Tanaka S, Haruma K, Kinoshita Y. Randomized study of lafutidine vs lansoprazole in patients with mild gastroesophageal reflux disease. World J Gastroenterol 2016; 22(23): 5430-5435 [PMID: 27340360 DOI: 10.3748/wjg.v22.i23.5430] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
93 Wex T, Mönkemüller K, Stahr A, Kuester D, Fry LC, Völkel S, Kandulski A, Roessner A, Malfertheiner P. Gastro-oesophageal reflux disease is associated with up-regulation of desmosomal components in oesophageal mucosa. Histopathology 2012;60:405-15. [PMID: 22276604 DOI: 10.1111/j.1365-2559.2011.04123.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
94 Tolboom R, Broeders I, Draaisma W. Robot-assisted laparoscopic hiatal hernia and antireflux surgery: Robot-assisted antireflux surgery. J Surg Oncol 2015;112:266-70. [DOI: 10.1002/jso.23912] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
95 Li M, Lu B, Chu L, Zhou H, Chen MY. Prevalence and characteristics of dyspepsia among college students in Zhejiang Province. World J Gastroenterol 2014; 20(13): 3649-3654 [PMID: 24707150 DOI: 10.3748/wjg.v20.i13.3649] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
96 Monino L, Gonzalez JM, Vitton V, Barthet M. Antireflux mucosectomy band in treatment of refractory gastroesophageal reflux disease: a pilot study for safety, feasibility and symptom control. Endosc Int Open 2020;8:E147-54. [PMID: 32010747 DOI: 10.1055/a-1038-4012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
97 Ocak E, Kubat G, Yorulmaz İ. Immunoserologic pepsin detection in the saliva as a non-invasive rapid diagnostic test for laryngopharyngeal reflux. Balkan Med J 2015;32:46-50. [PMID: 25759771 DOI: 10.5152/balkanmedj.2015.15824] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
98 Savarino V, Marabotto E, Zentilin P, Demarzo MG, de Bortoli N, Savarino E. Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art. Drug Des Devel Ther 2021;15:1609-21. [PMID: 33907381 DOI: 10.2147/DDDT.S306371] [Reference Citation Analysis]
99 Krawczyk M, ścierski W, Ryszkiel I, Namysłowski G, Grzegorzek S, Misiołek M. Endoscopic evidence of reflux disease in the larynx. Acta Oto-Laryngologica 2014;134:831-7. [DOI: 10.3109/00016489.2014.890738] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
100 de Bortoli N, Martinucci I, Bellini M, Savarino E, Savarino V, Blandizzi C, Marchi S. Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome. World J Gastroenterol 2013; 19(35): 5787-5797 [PMID: 24124323 DOI: 10.3748/wjg.v19.i35.5787] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
101 Kahrilas PJ. Clinical practice. Gastroesophageal reflux disease. N Engl J Med. 2008;359:1700-1707. [PMID: 18923172 DOI: 359/16/1700] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
102 Fock KM, Talley NJ, Fass R, Goh KL, Katelaris P, Hunt R, Hongo M, Ang TL, Holtmann G, Nandurkar S. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol. 2008;23:8-22. [PMID: 18171339 DOI: 10.1111/j.1440-1746.2007.05249.x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 102] [Article Influence: 8.8] [Reference Citation Analysis]
103 Fiocca R, Mastracci L, Engström C, Attwood S, Ell C, Galmiche JP, Hatlebakk J, Junghard O, Lind T, Lundell L. Long-term outcome of microscopic esophagitis in chronic GERD patients treated with esomeprazole or laparoscopic antireflux surgery in the LOTUS trial. Am J Gastroenterol. 2010;105:1015-1023. [PMID: 19904246 DOI: 10.1038/ajg.2009.631] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
104 Pauwels A, Boecxstaens V, Broers C, Tack JF. Severely impaired gastric accommodation is a hallmark of post-Nissen functional dyspepsia symptoms. Neurogastroenterol Motil 2017;29:e13063. [DOI: 10.1111/nmo.13063] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
105 Goldani HA, Nunes DL, Ferreira CT. Managing gastroesophageal reflux disease in children: The role of endoscopy. World J Gastrointest Endosc 2012; 4(8): 339-346 [PMID: 22912907 DOI: 10.4253/wjge.v4.i8.339] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
106 Bennett C, Vakil N, Bergman J, Harrison R, Odze R, Vieth M, Sanders S, Gay L, Pech O, Longcroft-Wheaton G, Romero Y, Inadomi J, Tack J, Corley DA, Manner H, Green S, Al Dulaimi D, Ali H, Allum B, Anderson M, Curtis H, Falk G, Fennerty MB, Fullarton G, Krishnadath K, Meltzer SJ, Armstrong D, Ganz R, Cengia G, Going JJ, Goldblum J, Gordon C, Grabsch H, Haigh C, Hongo M, Johnston D, Forbes-Young R, Kay E, Kaye P, Lerut T, Lovat LB, Lundell L, Mairs P, Shimoda T, Spechler S, Sontag S, Malfertheiner P, Murray I, Nanji M, Poller D, Ragunath K, Regula J, Cestari R, Shepherd N, Singh R, Stein HJ, Talley NJ, Galmiche JP, Tham TC, Watson P, Yerian L, Rugge M, Rice TW, Hart J, Gittens S, Hewin D, Hochberger J, Kahrilas P, Preston S, Sampliner R, Sharma P, Stuart R, Wang K, Waxman I, Abley C, Loft D, Penman I, Shaheen NJ, Chak A, Davies G, Dunn L, Falck-Ytter Y, Decaestecker J, Bhandari P, Ell C, Griffin SM, Attwood S, Barr H, Allen J, Ferguson MK, Moayyedi P, Jankowski JA. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology. 2012;143:336-346. [PMID: 22537613 DOI: 10.1053/j.gastro.2012.04.032] [Cited by in Crossref: 263] [Cited by in F6Publishing: 225] [Article Influence: 29.2] [Reference Citation Analysis]
107 Săraru ER, Enciu V, Peagu R, Fierbinţeanu-Braticevici C. Advances in the diagnosis of GERD. Rom J Intern Med 2021;59:3-9. [PMID: 33010143 DOI: 10.2478/rjim-2020-0027] [Reference Citation Analysis]
108 Shaheen NJ, Richter JE. Barrett’s oesophagus. Lancet. 2009;373:850-861. [PMID: 19269522 DOI: 10.1016/s0140-6736(09)60487-6] [Cited by in Crossref: 209] [Cited by in F6Publishing: 94] [Article Influence: 17.4] [Reference Citation Analysis]
109 Richter JE, Rubenstein JH. Presentation and Epidemiology of Gastroesophageal Reflux Disease. Gastroenterology. 2018;154:267-276. [PMID: 28780072 DOI: 10.1053/j.gastro.2017.07.045] [Cited by in Crossref: 125] [Cited by in F6Publishing: 82] [Article Influence: 31.3] [Reference Citation Analysis]
110 Kandulski A, Wex T, Kuester D, Mönkemüller K, Peitz U, Roessner A, Malfertheiner P. Chronic mucosal inflammation of the gastric cardia in gastroesophageal reflux disease is not regulated by FOXP3-expressing T cells. Dig Dis Sci. 2009;54:1940-1946. [PMID: 19242793 DOI: 10.1007/s10620-009-0746-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
111 Ahn B, Lee DH, Lee CM, Hwang JJ, Yoon H, Shin CM, Park YS, Kim N. Effect of Proton Pump Inhibitors in Bronchiectatic Patients with Gastroesophageal Reflux Disease. Korean J Gastroenterol 2016;68:10. [DOI: 10.4166/kjg.2016.68.1.10] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
112 Scheiman JM, Herlitz J, Veldhuyzen van Zanten SJ, Lanas A, Agewall S, Nauclér EC, Svedberg L, Nagy P. Esomeprazole for Prevention and Resolution of Upper Gastrointestinal Symptoms in Patients Treated With Low-dose Acetylsalicylic Acid for Cardiovascular Protection: The OBERON Trial. Journal of Cardiovascular Pharmacology 2013;61:250-7. [DOI: 10.1097/fjc.0b013e31827cb626] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
113 Filiberti RA, Fontana V, De Ceglie A, Blanchi S, Lacchin T, De Matthaeis M, Ignomirelli O, Cappiello R, Rosa A, D'Onofrio V, Iaquinto G, Conio M. Dietary Habits and Risk of Esophagitis and Barrett's Esophagus: A Multicenter Italian Case-Control Study. Dig Dis Sci 2021;66:3448-60. [PMID: 33073332 DOI: 10.1007/s10620-020-06658-9] [Reference Citation Analysis]
114 Craven MR, Kia L, O'Dwyer LC, Stern E, Taft TH, Keefer L. Systematic review: methodological flaws in racial/ethnic reporting for gastroesophageal reflux disease. Dis Esophagus 2018;31. [PMID: 29444213 DOI: 10.1093/dote/dox154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
115 Li S, Shi S, Chen F, Lin J. The effects of baclofen for the treatment of gastroesophageal reflux disease: a meta-analysis of randomized controlled trials. Gastroenterol Res Pract. 2014;2014:307805. [PMID: 25389436 DOI: 10.1155/2014/307805] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
116 Promberger R, Spitzer A, Ott J, Lenglinger J, Eilenberg W, Gadenstätter M, Neumayer C. Quality of life in type 2 diabetics with gastroesophageal reflux disease: a case control study. Eur Surg 2013;45:194-9. [DOI: 10.1007/s10353-013-0219-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
117 Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev. 2007;CD001216. [PMID: 17253456 DOI: 10.1002/14651858] [Cited by in Crossref: 2625] [Cited by in F6Publishing: 769] [Article Influence: 187.5] [Reference Citation Analysis]
118 Shi S, Klotz U. Proton pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol. 2008;64:935-951. [PMID: 18679668 DOI: 10.1007/s00228-008-0538-y] [Cited by in Crossref: 204] [Cited by in F6Publishing: 188] [Article Influence: 15.7] [Reference Citation Analysis]
119 Gerson LB, Kahrilas PJ, Fass R. Insights into gastroesophageal reflux disease-associated dyspeptic symptoms. Clin Gastroenterol Hepatol 2011;9:824-33. [PMID: 21699806 DOI: 10.1016/j.cgh.2011.05.015] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
120 Burton L, Joffe D, Mackey DW, Van der Wall H, Falk GL. A transformational change in scintigraphic gastroesophageal reflux studies: A comparison with historic techniques. Clin Physiol Funct Imaging 2021;41:136-45. [PMID: 33155748 DOI: 10.1111/cpf.12677] [Reference Citation Analysis]
121 Lin YH, Chang TS, Yao YC, Li YC. Increased Risk of Chronic Sinusitis in Adults With Gastroesophgeal Reflux Disease: A Nationwide Population-Based Cohort Study. Medicine (Baltimore) 2015;94:e1642. [PMID: 26426655 DOI: 10.1097/MD.0000000000001642] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 4.2] [Reference Citation Analysis]
122 Dolder M, Tutuian R. Laboratory based investigations for diagnosing gastroesophageal reflux disease. Best Pract Res Clin Gastroenterol. 2010;24:787-798. [PMID: 21126694 DOI: 10.1016/j.bpg.2010.10.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
123 Rogers BD, Valdovinos LR, Crowell MD, Bell R, Vela MF, Gyawali CP. Number of reflux episodes on pH-impedance monitoring associates with improved symptom outcome and treatment satisfaction in gastro-oesophageal reflux disease (GERD) patients with regurgitation. Gut 2021;70:450-5. [PMID: 32467089 DOI: 10.1136/gutjnl-2020-321395] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
124 Siddiqui MRS, Abdulaal Y, Nisar A, Ali H, Hasan F. A meta-analysis of outcomes after open and laparoscopic Nissen's fundoplication in the treatment for gastro-oesophageal reflux disease. Eur Surg 2012;44:138-49. [DOI: 10.1007/s10353-011-0003-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
125 Ierardi E, Rosania R, Zotti M, Principe S, Laonigro G, Giorgio F, de Francesco V, Panella C. Metabolic syndrome and gastro-esophageal reflux: A link towards a growing interest in developed countries. World J Gastrointest Pathophysiol. 2010;1:91-96. [PMID: 21607146 DOI: 10.4291/wjgp.v1.i3.91.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Hunt R, Armstrong D, Katelaris P, Afihene M, Bane A, Bhatia S, Chen MH, Choi MG, Melo AC, Fock KM, Ford A, Hongo M, Khan A, Lazebnik L, Lindberg G, Lizarzabal M, Myint T, Moraes-Filho JP, Salis G, Lin JT, Vaidya R, Abdo A, LeMair A; Review Team:. World Gastroenterology Organisation Global Guidelines: GERD Global Perspective on Gastroesophageal Reflux Disease. J Clin Gastroenterol. 2017;51:467-478. [PMID: 28591069 DOI: 10.1097/mcg.0000000000000854] [Cited by in Crossref: 56] [Cited by in F6Publishing: 25] [Article Influence: 28.0] [Reference Citation Analysis]
127 Picos A, Vulturar R, Picos A, Chis A, Chiorean I, Piciu A, Petrachescu N, Dumitrascu DL. Interleukin-1A and interleukin-1B gene polymorphisms in gastroesophageal reflux disease. Exp Ther Med 2020;20:3394-8. [PMID: 32904982 DOI: 10.3892/etm.2020.9030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Chronopoulos V, Maroulakos G, Tsoutis K, Stathopoulou P, Nagy WW. Complete mouth rehabilitation and gastroesophageal reflux disease: Conventional and contemporary treatment approaches. The Journal of Prosthetic Dentistry 2017;117:1-7. [DOI: 10.1016/j.prosdent.2016.05.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
129 Neto RML, Herbella FAM, Schlottmann F, Patti MG. Does DeMeester score still define GERD? Dis Esophagus. 2019;32. [PMID: 30561585 DOI: 10.1093/dote/doy118] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
130 Lee AL, Goldstein RS. Gastroesophageal reflux disease in COPD: links and risks. Int J Chron Obstruct Pulmon Dis 2015;10:1935-49. [PMID: 26392769 DOI: 10.2147/COPD.S77562] [Cited by in Crossref: 40] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
131 Kahrilas PJ, Shaheen NJ, Vaezi MF, Hiltz SW, Black E, Modlin IM, Johnson SP, Allen J, Brill JV; American Gastroenterological Association. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology 2008;135:1383-91, 1391.e1-5. [PMID: 18789939 DOI: 10.1053/j.gastro.2008.08.045] [Cited by in Crossref: 409] [Cited by in F6Publishing: 310] [Article Influence: 31.5] [Reference Citation Analysis]
132 Mine S, Tanaka Y. Lansoprazole-induced improvement of esophageal submucosal injury. J Clin Biochem Nutr 2007;41:92-6. [PMID: 18193102 DOI: 10.3164/jcbn.2007013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
133 Zerbib F, Omari T. Oesophageal dysphagia: manifestations and diagnosis. Nat Rev Gastroenterol Hepatol 2015;12:322-31. [PMID: 25404278 DOI: 10.1038/nrgastro.2014.195] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
134 Dettmar PW, Hampson FC, Taubel J, Lorch U, Johnstone LM, Sykes J, Berry PJ. The suppression of gastro-oesophageal reflux by alginates. Int J Clin Pract. 2007;61:1654-1662. [PMID: 17681004 DOI: 10.1111/j.1742-1241.2007.01524.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
135 Ummarino D, Vandermeulen L, Roosens B, Urbain D, Hauser B, Vandenplas Y. Gastroesophageal reflux evaluation in patients affected by chronic cough: Restech versus multichannel intraluminal impedance/pH metry: Restech Versus MII/pH Metry. The Laryngoscope 2013;123:980-4. [DOI: 10.1002/lary.23738] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
136 Lien HC, Wang CC, Lee SW, Hsu JY, Yeh HZ, Ko CW, Chang CS, Liang WM. Responder Definition of a Patient-Reported Outcome Instrument for Laryngopharyngeal Reflux Based on the US FDA Guidance. Value Health. 2015;18:396-403. [PMID: 26091593 DOI: 10.1016/j.jval.2015.01.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
137 Argyrou A, Legaki E, Koutserimpas C, Gazouli M, Papaconstantinou I, Gkiokas G, Karamanolis G. Polymorphisms of the BARX1 and ADAMTS17 Locus Genes in Individuals With Gastroesophageal Reflux Disease. J Neurogastroenterol Motil 2019;25:436-41. [PMID: 31048564 DOI: 10.5056/jnm18183] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
138 Nwokediuko SC, Adekanle O, Akere A, Olokoba A, Anyanechi C, Umar SM, Maiyaki A, Ijoma U, Obienu O, Uhunmwangho A, Ndububa D. Gastroesophageal reflux disease in a typical African population: a symptom-based multicenter study. BMC Gastroenterol 2020;20:107. [PMID: 32293291 DOI: 10.1186/s12876-020-01261-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Kinoshita Y, Ishihara S. Causes of, and therapeutic approaches for, proton pump inhibitor-resistant gastroesophageal reflux disease in Asia. Therap Adv Gastroenterol 2008;1:191-9. [PMID: 21180528 DOI: 10.1177/1756283X08098181] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
140 van Zanten SV. Chronic GERD and risk of esophageal adenocarcinoma: Should we screen with gastroscopy? CMAJ 2020;192:E781-2. [PMID: 32631910 DOI: 10.1503/cmaj.200697] [Reference Citation Analysis]
141 Bayerdörffer E, Bigard MA, Weiss W, Mearin F, Rodrigo L, Dominguez Muñoz JE, Grundling H, Persson T, Svedberg LE, Keeling N. Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease. BMC Gastroenterol. 2016;16:48. [PMID: 27080034 DOI: 10.1186/s12876-016-0448-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
142 Yamashita H, Kanamori A, Kano C, Hashimura H, Matsumoto K, Tsujimae M, Yoshizaki T, Momose K, Obata D, Eguchi T, Fujita M, Okada A. The Effects of Switching to Vonoprazan, a Novel Potassium-Competitive Acid Blocker, on Gastric Acidity and Reflux Patterns in Patients with Erosive Esophagitis Refractory to Proton Pump Inhibitors. Digestion 2017;96:52-9. [PMID: 28662503 DOI: 10.1159/000478255] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
143 Tack J, Becher A, Mulligan C, Johnson DA. Systematic review: the burden of disruptive gastro-oesophageal reflux disease on health-related quality of life. Aliment Pharmacol Ther. 2012;35:1257-1266. [PMID: 22486579 DOI: 10.1111/j.1365-2036.2012.05086.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 55] [Article Influence: 8.4] [Reference Citation Analysis]
144 Schneider SL, Clary MS, Fink DS, Wang SX, Chowdhury FN, Yadlapati R, Jetté ME, Courey MS. Voice therapy associated with a decrease in the reflux symptoms index in patients with voice complaints. Laryngoscope 2019;129:1169-73. [PMID: 30444264 DOI: 10.1002/lary.27583] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
145 Fass OZ, Mashimo H. The Effect of Bariatric Surgery and Endoscopic Procedures on Gastroesophageal Reflux Disease. J Neurogastroenterol Motil 2021;27:35-45. [PMID: 33380553 DOI: 10.5056/jnm20169] [Reference Citation Analysis]
146 Lee SW, Chang CS. Impact of Overlapping Functional Gastrointestinal Disorders on the Quality of Life in Patients With Gastroesophageal Reflux Disease. J Neurogastroenterol Motil 2021;27:176-84. [PMID: 33795540 DOI: 10.5056/jnm19006] [Reference Citation Analysis]
147 Tang RS, Wu JC. Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients--focus on esomeprazole. Clin Interv Aging 2013;8:1433-43. [PMID: 24187492 DOI: 10.2147/CIA.S41350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
148 Wahlqvist P, Brook RA, Campbell SM, Wallander MA, Alexander AM, Smeeding JE, Kleinman NL. Objective measurement of work absence and on-the-job productivity: a case-control study of US employees with and without gastroesophageal reflux disease. J Occup Environ Med 2008;50:25-31. [PMID: 18188078 DOI: 10.1097/JOM.0b013e31815dba5a] [Cited by in Crossref: 24] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
149 Rayner-Hartley E, Takach O, Galorport C, Enns RA. Diagnosis and Management of Barrett's Esophagus: A Retrospective Study Comparing the Endoscopic Assessment of Early Esophageal Lesions in the Community versus a Specialized Center. Can J Gastroenterol Hepatol 2016;2016:5749573. [PMID: 27446850 DOI: 10.1155/2016/5749573] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
150 Hunter JG, Kahrilas PJ, Bell RC, Wilson EB, Trad KS, Dolan JP, Perry KA, Oelschlager BK, Soper NJ, Snyder BE, Burch MA, Melvin WS, Reavis KM, Turgeon DG, Hungness ES, Diggs BS. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology. 2015;148:324-333.e5. [PMID: 25448925 DOI: 10.1053/j.gastro.2014.10.009] [Cited by in Crossref: 102] [Cited by in F6Publishing: 72] [Article Influence: 14.6] [Reference Citation Analysis]
151 Aydin MF, Aydin MA. Quality and reliability of information available on YouTube and Google pertaining gastroesophageal reflux disease. Int J Med Inform 2020;137:104107. [PMID: 32146372 DOI: 10.1016/j.ijmedinf.2020.104107] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
152 Modlin IM, Moss SF. Symptom evaluation in gastroesophageal reflux disease. J Clin Gastroenterol. 2008;42:558-563. [PMID: 18364584 DOI: 10.1097/mcg.0b013e31816207cb] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
153 Fornari F, Callegari-Jacques SM, Dantas RO, Scarsi AL, Ruas LO, de Barros SG. Obese patients have stronger peristalsis and increased acid exposure in the esophagus. Dig Dis Sci. 2011;56:1420-1426. [PMID: 20972851 DOI: 10.1007/s10620-010-1454-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
154 Benjamin T, Zackria S, Lopez R, Richter J, Thota PN. Upper esophageal sphincter abnormalities and high-resolution esophageal manometry findings in patients with laryngopharyngeal reflux. Scand J Gastroenterol. 2017;52:816-821. [PMID: 28471304 DOI: 10.1080/00365521.2017.1322139] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
155 Lottrup C, Olesen SS, Drewes AM. The pain system in oesophageal disorders: mechanisms, clinical characteristics, and treatment. Gastroenterol Res Pract 2011;2011:910420. [PMID: 21826137 DOI: 10.1155/2011/910420] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
156 Vakil N, Wernersson B, Ohlsson L, Dent J. Prevalence of gastro-oesophageal reflux disease with upper gastrointestinal symptoms without heartburn and regurgitation. United European Gastroenterol J 2014;2:173-8. [PMID: 25360300 DOI: 10.1177/2050640614532458] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
157 Chandrasoma P, Demeester T. A New Pathologic Assessment of Gastroesophageal Reflux Disease: The Squamo-Oxyntic Gap. In: Jansen M, Wright NA, editors. Stem Cells, Pre-neoplasia, and Early Cancer of the Upper Gastrointestinal Tract. Cham: Springer International Publishing; 2016. pp. 41-78. [DOI: 10.1007/978-3-319-41388-4_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
158 Kindt S, Vos R, Blondeau K, Tack J. Influence of intra-oesophageal capsaicin instillation on heartburn induction and oesophageal sensitivity in man. Neurogastroenterol Motil 2009;21:1032-e82. [PMID: 19566590 DOI: 10.1111/j.1365-2982.2009.01332.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
159 Lagergren J. Any role for endoscopy screening or surveillance for esophageal adenocarcinoma among persons with GERD? Gastrointest Endosc 2008;68:856-8. [PMID: 18984099 DOI: 10.1016/j.gie.2008.04.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
160 Meira ATDS, Tanajura D, Viana IDS. CLINICAL AND ENDOSCOPIC EVALUATION IN PATIENTS WITH GASTROESOPHAGEAL SYMPTOMS. Arq Gastroenterol 2019;56:51-4. [PMID: 31141065 DOI: 10.1590/S0004-2803.201900000-16] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
161 Ates F, Yuksel ES, Higginbotham T, Slaughter JC, Mabary J, Kavitt RT, Garrett CG, Francis D, Vaezi MF. Mucosal impedance discriminates GERD from non-GERD conditions. Gastroenterology 2015;148:334-43. [PMID: 25448923 DOI: 10.1053/j.gastro.2014.10.010] [Cited by in Crossref: 102] [Cited by in F6Publishing: 76] [Article Influence: 14.6] [Reference Citation Analysis]
162 Patel A, Hasak S, Nix BD, Sayuk GS, Newberry RD, Gyawali CP. Genetic risk factors for perception of symptoms in GERD: an observational cohort study. Aliment Pharmacol Ther 2018;47:289-97. [PMID: 29148080 DOI: 10.1111/apt.14414] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
163 Ljungdalh JS, Rubin KH, Durup J, Houlind KC. Treatment of newly-diagnosed gastroesophageal reflux disease: a nationwide register-based cohort study. Scand J Gastroenterol 2019;54:830-7. [PMID: 31280616 DOI: 10.1080/00365521.2019.1635202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
164 Jain M, Srinivas M, Bawane P, Venkataraman J. Basal lower esophageal sphincter pressure in gastroesophageal reflux disease: An ignored metric in high-resolution esophageal manometry. Indian J Gastroenterol 2018;37:446-51. [DOI: 10.1007/s12664-018-0898-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
165 Molyneux ID, Morice AH. Airway reflux, cough and respiratory disease. Ther Adv Chronic Dis 2011;2:237-48. [PMID: 23251752 DOI: 10.1177/2040622311406464] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
166 Trad KS, Barnes WE, Prevou ER, Simoni G, Steffen JA, Shughoury AB, Raza M, Heise JA, Fox MA, Mavrelis PG. The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective. Surg Innov. 2018;25:149-157. [PMID: 29405886 DOI: 10.1177/1553350618755214] [Cited by in Crossref: 52] [Cited by in F6Publishing: 35] [Article Influence: 17.3] [Reference Citation Analysis]
167 Zhong C, Liu K, Wang K, Liu H, Su H, Wu J, Duan L. Developing a diagnostic understanding of GERD phenotypes through the analysis of levels of mucosal injury, immune activation, and psychological comorbidity. Dis Esophagus. 2018;31. [PMID: 29757356 DOI: 10.1093/dote/doy039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
168 Herbella FA, Patti MG. Gastroesophageal reflux disease: From pathophysiology to treatment. World J Gastroenterol 2010; 16(30): 3745-3749 [PMID: 20698035 DOI: 10.3748/wjg.v16.i30.3745] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 44] [Article Influence: 4.7] [Reference Citation Analysis]
169 Ahmed S, Kreft A, Chowdhury EH, Hossain SM, Galle PR, Neumann H. Molecular endoscopic imaging for the detection of Barrett's metaplasia using biodegradable inorganic nanoparticles: An ex-vivo pilot study on human tissue. PLoS One 2020;15:e0239814. [PMID: 33002048 DOI: 10.1371/journal.pone.0239814] [Reference Citation Analysis]
170 Kang HS, Hong SN, Kim YS, Park HS, Kim BK, Lee JH, Kim SI, Lee TY, Kim JH, Lee SY. The efficacy of i-SCAN for detecting reflux esophagitis: a prospective randomized controlled trial. Dis Esophagus. 2013;26:204-211. [PMID: 23009249 DOI: 10.1111/j.1442-2050.2012.01427.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
171 Mastracci L, Spaggiari P, Grillo F, Zentilin P, Dulbecco P, Ceppa P, Baccini P, Mansi C, Savarino V, Fiocca R. Microscopic esophagitis in gastro-esophageal reflux disease: individual lesions, biopsy sampling, and clinical correlations. Virchows Arch. 2009;454:31-39. [PMID: 19048292 DOI: 10.1007/s00428-008-0704-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
172 Abdallah J, George N, Yamasaki T, Ganocy S, Fass R. Most Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Also Have Functional Esophageal Disorders. Clin Gastroenterol Hepatol 2019;17:1073-1080.e1. [PMID: 29913281 DOI: 10.1016/j.cgh.2018.06.018] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 7.7] [Reference Citation Analysis]
173 Kim SY, Jung HK, Lim J, Kim TO, Choe AR, Tae CH, Shim KN, Moon CM, Kim SE, Jung SA. Gender Specific Differences in Prevalence and Risk Factors for Gastro-Esophageal Reflux Disease. J Korean Med Sci 2019;34:e158. [PMID: 31144481 DOI: 10.3346/jkms.2019.34.e158] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
174 Mastracci L, Piol N, Molinaro L, Pitto F, Tinelli C, De Silvestri A, Fiocca R, Grillo F; ABRAM Study Group. Interobserver reproducibility in pathologist interpretation of columnar-lined esophagus. Virchows Arch. 2016;468:159-167. [PMID: 26563401 DOI: 10.1007/s00428-015-1878-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
175 O'Brien NF, Reuter-Rice K, Wainwright MS, Kaplan SL, Appavu B, Erklauer JC, Ghosh S, Kirschen M, Kozak B, Lidsky K, Lovett ME, Mehollin-Ray AR, Miles DK, Press CA, Simon DW, Tasker RC, LaRovere KL. Practice Recommendations for Transcranial Doppler Ultrasonography in Critically Ill Children in the Pediatric Intensive Care Unit: A Multidisciplinary Expert Consensus Statement. J Pediatr Intensive Care 2021;10:133-42. [PMID: 33884214 DOI: 10.1055/s-0040-1715128] [Reference Citation Analysis]
176 Peat CM, Huang L, Thornton LM, Von Holle AF, Trace SE, Lichtenstein P, Pedersen NL, Overby DW, Bulik CM. Binge eating, body mass index, and gastrointestinal symptoms. J Psychosom Res 2013;75:456-61. [PMID: 24182635 DOI: 10.1016/j.jpsychores.2013.08.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
177 Kawano T, Ogiya K, Nakajima Y, Nishikage T, Nagai K. Prevalence of Barrett's esophagus in Japan. Esophagus 2006;3:155-64. [DOI: 10.1007/s10388-006-0095-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
178 Ong JS, An J, Han X, Law MH, Nandakumar P, Schumacher J, Gockel I, Bohmer A, Jankowski J, Palles C, Olsen CM, Neale RE, Fitzgerald R, Thrift AP, Vaughan TL, Buas MF, Hinds DA, Gharahkhani P, Kendall BJ, MacGregor S; 23andMe Research team., Esophageal cancer consortium. Multitrait genetic association analysis identifies 50 new risk loci for gastro-oesophageal reflux, seven new loci for Barrett's oesophagus and provides insights into clinical heterogeneity in reflux diagnosis. Gut 2021:gutjnl-2020-323906. [PMID: 34187846 DOI: 10.1136/gutjnl-2020-323906] [Reference Citation Analysis]
179 Lagergren P, Johar AM, Lagergren J. Validation of the reflux scale in the European Organisation for Research and Treatment of Cancer QLQ-OES18. European Journal of Cancer 2013;49:1097-103. [DOI: 10.1016/j.ejca.2012.09.037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
180 Norder Grusell E, Mjörnheim A, Finizia C, Ruth M, Bergquist H. The diagnostic value of GerdQ in subjects with atypical symptoms of gastro-esophageal reflux disease. Scandinavian Journal of Gastroenterology 2018;53:1165-70. [DOI: 10.1080/00365521.2018.1503708] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
181 Su KY, Thomas AD, Chang JC, Leung JH, Lee SM, Holzknecht ZE, Everett ML, Foster WM, Kraft M, Parker W, Davis RD, Lin SS. Chronic aspiration shifts the immune response from adaptive immunity to innate immunity in a murine model of asthma. Inflamm Res 2012;61:863-73. [PMID: 22565668 DOI: 10.1007/s00011-012-0479-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
182 Taylor F, Reasner DS, Carson RT, Deal LS, Foley C, Iovin R, Lundy JJ, Pompilus F, Shields AL, Silberg DG. Development of a Symptom-Based Patient-Reported Outcome Instrument for Functional Dyspepsia: A Preliminary Conceptual Model and an Evaluation of the Adequacy of Existing Instruments. Patient 2016;9:409-18. [PMID: 27020447 DOI: 10.1007/s40271-016-0164-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
183 Lee SJ, Jung MK, Kim SK, Jang BI, Lee SH, Kim KO, Kim ES, Cho KB, Park KS, Kim EY, Jung JT, Kwon JG, Lee JH, Yang CH, Park CK, Seo HE, Jeon SW. [Clinical characteristics of gastroesophageal reflux disease with esophageal injury in korean: focusing on risk factors]. Korean J Gastroenterol 2011;57:281-7. [PMID: 21623136 DOI: 10.4166/kjg.2011.57.5.281] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
184 Chang CS, Chen HJ, Liao CH. Patients with Cerebral Stroke Have an Increased Risk of Gastroesophageal Reflux Disease: A Population-Based Cohort Study. J Stroke Cerebrovasc Dis 2018;27:1267-74. [PMID: 29325919 DOI: 10.1016/j.jstrokecerebrovasdis.2017.12.001] [Reference Citation Analysis]
185 Rehfeldt KH, Renew JR, Subramanian A, Pulido JN, Mauermann WJ. The Safety and Feasibility of Transesophageal Echocardiography in Patients With Esophageal Stricture. Journal of Cardiothoracic and Vascular Anesthesia 2020;34:1846-52. [DOI: 10.1053/j.jvca.2019.11.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
186 Labenz J, Labenz G, Stephan D, Willeke F; LOPA-Studiengruppe. [Insufficient symptom control under long-term treatment with PPI in GERD - fact or fiction? MMW Fortschr Med. 2016;158 Suppl 4:7-11. [PMID: 27221555 DOI: 10.1007/s15006-016-8303-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
187 Kaya H, Barutçu S. Gastroesophageal reflux disease is associated with abnormal ventricular repolarization indices. Turk J Gastroenterol 2019;30:1021-4. [PMID: 31854306 DOI: 10.5152/tjg.2019.181008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
188 Manolakis AC, Broers C, Geysen H, Goelen N, Van Houtte B, Rommel N, Vanuytsel T, Tack J, Pauwels A. Effect of citalopram on esophageal motility in healthy subjects—Implications for reflux episodes, dysphagia, and globus. Neurogastroenterology & Motility 2019;31. [DOI: 10.1111/nmo.13632] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
189 Khan DZ, Khan MS, Kotter MR, Davies BM. Tackling Research Inefficiency in Degenerative Cervical Myelopathy: Illustrative Review. JMIR Res Protoc 2020;9:e15922. [PMID: 32525490 DOI: 10.2196/15922] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
190 Fass OZ, Fass R. Overlap Between GERD and Functional Esophageal Disorders—a Pivotal Mechanism for Treatment Failure. Curr Treat Options Gastro 2019;17:161-4. [DOI: 10.1007/s11938-019-00224-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
191 Lavorini F, Fontana GA, Chellini E, Magni C, Pistolesi M, Widdicombe J. Respiratory Expulsive Efforts Evoked by Maximal Lung Emptying. Chest 2011;140:690-6. [DOI: 10.1378/chest.10-1084] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
192 Ang D, Lee Y, Clarke JO, Lynch K, Guillaume A, Onyimba F, Kamal A, Gyawali CP. Diagnosis of gastroesophageal reflux: an update on current and emerging modalities. Ann N Y Acad Sci 2020;1481:154-69. [DOI: 10.1111/nyas.14369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
193 Kandulski A, Malfertheiner P. Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation. Nat Rev Gastroenterol Hepatol. 2012;9:15-22. [PMID: 22105108 DOI: 10.1038/nrgastro.2011.210] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
194 Ventura TMDS, Cassiano LPS, Souza E Silva CM, Taira EA, Leite AL, Rios D, Buzalaf MAR. The proteomic profile of the acquired enamel pellicle according to its location in the dental arches. Arch Oral Biol 2017;79:20-9. [PMID: 28282514 DOI: 10.1016/j.archoralbio.2017.03.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 11.0] [Reference Citation Analysis]
195 Enomoto S, Oka M, Ohata H, Mukoubayashi C, Watanabe M, Moribata K, Muraki Y, Shingaki N, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Yanaoka K, Tamai H, Fujishiro M, Mohara O, Ichinose M. Assessment of gastroesophageal reflux disease by serodiagnosis of Helicobacter pylori-related chronic gastritis stage. World J Gastrointest Endosc 2011; 3(4): 71-77 [PMID: 21603035 DOI: 10.4253/wjge.v3.i4.71] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
196 Löfdahl HE, Lu Y, Lagergren J. Sex-specific risk factor profile in oesophageal adenocarcinoma. Br J Cancer. 2008;99:1506-1510. [PMID: 18841152 DOI: 10.1038/sj.bjc.6604701] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
197 Miwa H, Takeshima T, Iwasaki K, Hiroi S. Medical cost, incidence rate, and treatment status of gastroesophageal reflux disease in Japan: analysis of claims data. J Med Econ 2016;19:1049-55. [PMID: 27207316 DOI: 10.1080/13696998.2016.1192551] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
198 Sato T, Kato Y, Matsuura M, Gagner M. Significance of Palisading Longitudinal Esophagus Vessels: Identification of the True Esophagogastric Junction Has Histopathological and Oncological Considerations. Dig Dis Sci 2010;55:3095-101. [DOI: 10.1007/s10620-010-1132-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
199 Snyder B, Wilson E, Wilson T, Mehta S, Bajwa K, Klein C. A randomized trial comparing reflux symptoms in sleeve gastrectomy patients with or without hiatal hernia repair. Surgery for Obesity and Related Diseases 2016;12:1681-8. [DOI: 10.1016/j.soard.2016.09.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 4.4] [Reference Citation Analysis]
200 Núñez-rodríguez MH, Miranda Sivelo A. Psychological Factors in Gastroesophageal Reflux Disease Measured by SCL-90-R Questionnaire. Dig Dis Sci 2008;53:3071-5. [DOI: 10.1007/s10620-008-0276-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
201 Boltin D, Boaz M, Aizic S, Sperber A, Fass R, Niv Y, Dickman R. Psychological distress is not associated with treatment failure in patients with gastroesophageal reflux disease. J Psychosom Res 2013;75:462-6. [PMID: 24182636 DOI: 10.1016/j.jpsychores.2013.08.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
202 Luo X, Guo XX, Wang WF, Peng LH, Yang YS, Uedo N. Autofluorescence imaging endoscopy can distinguish non-erosive reflux disease from functional heartburn: A pilot study. World J Gastroenterol 2016; 22(14): 3845-3851 [PMID: 27076770 DOI: 10.3748/wjg.v22.i14.3845] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
203 Lv J, Guo L, Wang JH, Yan YZ, Zhang J, Wang YY, Yu Y, Huang YF, Zhao HP. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett’s esophagus. World J Gastroenterol 2019; 25(2): 233-244 [PMID: 30670912 DOI: 10.3748/wjg.v25.i2.233] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
204 Morozov S, Isakov V, Konovalova M. Fiber-enriched diet helps to control symptoms and improves esophageal motility in patients with non-erosive gastroesophageal reflux disease. World J Gastroenterol 2018; 24(21): 2291-2299 [PMID: 29881238 DOI: 10.3748/wjg.v24.i21.2291] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 19] [Article Influence: 8.7] [Reference Citation Analysis]
205 Jang SH, Ryu HS, Choi SC, Lee SY. Psychological factors influence the gastroesophageal reflux disease (GERD) and their effect on quality of life among firefighters in South Korea. Int J Occup Environ Health 2016;22:315-20. [PMID: 27691373 DOI: 10.1080/10773525.2016.1235675] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
206 Guimarães EV, Guerra PV, Penna FJ. Management of gastroesophageal reflux disease and erosive esophagitis in pediatric patients: focus on delayed-release esomeprazole. Ther Clin Risk Manag 2010;6:531-7. [PMID: 21063463 DOI: 10.2147/TCRM.S14425] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
207 Lin S, Li H, Fang X. Esophageal Motor Dysfunctions in Gastroesophageal Reflux Disease and Therapeutic Perspectives. J Neurogastroenterol Motil 2019;25:499-507. [PMID: 31587540 DOI: 10.5056/jnm19081] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
208 Ramirez FC, Akins R, Shaukat M. Screening of Barrett's esophagus with string-capsule endoscopy: a prospective blinded study of 100 consecutive patients using histology as the criterion standard. Gastrointest Endosc. 2008;68:25-31. [PMID: 18499107 DOI: 10.1016/j.gie.2007.10.040] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
209 Eckley CA, Sardinha LR, Rizzo LV. Salivary Concentration of Epidermal Growth Factor in Adults with Reflux Laryngitis before and after Treatment. Ann Otol Rhinol Laryngol 2013;122:440-4. [DOI: 10.1177/000348941312200705] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
210 Melo AM, Mylod E, Fitzgerald V, Donlon NE, Murphy DM, Foley EK, Bhardwaj A, Reynolds JV, Doherty DG, Lysaght J, Dunne MR, Conroy MJ. Tissue distribution of γδ T cell subsets in oesophageal adenocarcinoma. Clin Immunol 2021;229:108797. [PMID: 34273585 DOI: 10.1016/j.clim.2021.108797] [Reference Citation Analysis]
211 Borg W, Cassar G, Camilleri L, Attard N, Camilleri J. Surface Microstructural Changes and Release of Ions from Dental Metal Alloy Removable Prostheses in Patients Suffering from Acid Reflux: Dental Base Metal Alloys and Acid Reflux. Journal of Prosthodontics 2018;27:115-9. [DOI: 10.1111/jopr.12470] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
212 Kang SG, Hwang HJ, Kim Y, Lee J, Oh JH, Kim J, Lim CH, Youn SB, Jung SH. Reflux Esophagitis and Fatigue: Are They Related? J Clin Med 2021;10:1588. [PMID: 33918665 DOI: 10.3390/jcm10081588] [Reference Citation Analysis]
213 Quigley EM, Keohane J. Dyspepsia. Curr Opin Gastroenterol. 2008;24:692-697. [PMID: 19122517 DOI: 10.1097/mog.0b013e328313b983] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
214 Dowgiałło-Wnukiewicz N, Frask A, Lech P, Michalik M. Study of the prevalence of gastroesophageal reflux symptoms and the role of each in relation to the GERD Impact Scale, based on a population of patients admitted for laparoscopic surgery compared to a control group. Wideochir Inne Tech Maloinwazyjne 2018;13:199-211. [PMID: 30002752 DOI: 10.5114/wiitm.2018.75909] [Reference Citation Analysis]
215 Ierardi E, Rosania R, Zotti M, Principe S, Laonigro G, Giorgio F, Francesco V, Panella C. Metabolic syndrome and gastro-esophageal reflux: A link towards a growing interest in developed countries. World J Gastrointest Pathophysiol 2010; 1(3): 91-96 [PMID: 21607146 DOI: 10.4291/wjgp.v1.i3.91] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
216 Woodland P, Shen Ooi JL, Grassi F, Nikaki K, Lee C, Evans JA, Koukias N, Triantos C, Mcdonald SA, Peiris M, Aktar R, Blackshaw LA, Sifrim D. Superficial Esophageal Mucosal Afferent Nerves May Contribute to Reflux Hypersensitivity in Nonerosive Reflux Disease. Gastroenterology 2017;153:1230-9. [DOI: 10.1053/j.gastro.2017.07.017] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 9.8] [Reference Citation Analysis]
217 Suzuki H, Matsuzaki J, Masaoka T, Inadomi JM. Greater loss of productivity among Japanese workers with gastro-esophageal reflux disease (GERD) symptoms that persist vs resolve on medical therapy. Neurogastroenterol Motil 2014;26:764-71. [DOI: 10.1111/nmo.12319] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
218 Ke MY. How to differentiate non-erosive reflux disease from functional heartburn. J Dig Dis. 2012;13:605-608. [PMID: 23134478 DOI: 10.1111/j.1751-2980.2012.00637.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
219 Mun E, Kim D, Lee Y, Lee W, Park S. Association between Shift Work and Reflux Esophagitis: The Kangbuk Samsung Health Study. Int J Environ Res Public Health 2021;18:6189. [PMID: 34201073 DOI: 10.3390/ijerph18126189] [Reference Citation Analysis]
220 Trad KS, Fox MA, Simoni G, Shughoury AB, Mavrelis PG, Raza M, Heise JA, Barnes WE. Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm. Surg Endosc. 2017;31:2498-2508. [PMID: 27655380 DOI: 10.1007/s00464-016-5252-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
221 Edriss H, El-Bakush A, Nugent K. Esophgeal Perforation and Bilateral Empyema Following Endoscopic EsophyX Transoral Incisionless Fundoplication. Clin Endosc 2014;47:560-3. [PMID: 25505723 DOI: 10.5946/ce.2014.47.6.560] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
222 van der Schaaf M, Johar A, Lagergren P, Rouvelas I, Gossage J, Mason R, Lagergren J. Surgical Prevention of Reflux after Esophagectomy for Cancer. Ann Surg Oncol 2013;20:3655-61. [DOI: 10.1245/s10434-013-3041-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
223 Connor MJ, Springford LR, Kapetanakis VV, Giuliani S. Esophageal atresia and transitional care--step 1: a systematic review and meta-analysis of the literature to define the prevalence of chronic long-term problems. Am J Surg. 2015;209:747-759. [PMID: 25605033 DOI: 10.1016/j.amjsurg.2014.09.019] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
224 Pacheco A, de Diego A, Domingo C, Lamas A, Gutierrez R, Naberan K, Garrigues V, López Vime R. Tos crónica. Archivos de Bronconeumología 2015;51:579-89. [DOI: 10.1016/j.arbres.2015.03.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
225 Scarpignato C, Gatta L, Zullo A, Blandizzi C; SIF-AIGO-FIMMG Group; Italian Society of Pharmacology, the Italian Association of Hospital Gastroenterologists, and the Italian Federation of General Practitioners. Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression. BMC Med. 2016;14:179. [PMID: 27825371 DOI: 10.1186/s12916-016-0718-z] [Cited by in Crossref: 148] [Cited by in F6Publishing: 123] [Article Influence: 29.6] [Reference Citation Analysis]
226 de Bortoli N, Martinucci I, Savarino EV, Frazzoni M, Tutuian R, Tolone S, Piaggi P, Furnari M, Russo S, Bertani L, Macchia L, Savarino V, Marchi S. Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring. Dig Liver Dis 2015;47:1027-32. [PMID: 26362613 DOI: 10.1016/j.dld.2015.08.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
227 Rodríguez L, Rodriguez P, Gómez B, Ayala JC, Oxenberg D, Perez-Castilla A, Netto MG, Soffer E, Boscardin WJ, Crowell MD. Two-year results of intermittent electrical stimulation of the lower esophageal sphincter treatment of gastroesophageal reflux disease. Surgery. 2015;157:556-567. [PMID: 25726315 DOI: 10.1016/j.surg.2014.10.012] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 6.3] [Reference Citation Analysis]
228 Jansson C, Nordenstedt H, Wallander MA, Johansson S, Johnsen R, Hveem K, Lagergren J. A population-based study showing an association between gastroesophageal reflux disease and sleep problems. Clin Gastroenterol Hepatol. 2009;7:960-965. [PMID: 19286481 DOI: 10.1016/j.cgh.2009.03.007] [Cited by in Crossref: 59] [Cited by in F6Publishing: 46] [Article Influence: 4.9] [Reference Citation Analysis]
229 Newberry C, Lynch K. The role of diet in the development and management of gastroesophageal reflux disease: why we feel the burn. J Thorac Dis 2019;11:S1594-601. [PMID: 31489226 DOI: 10.21037/jtd.2019.06.42] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
230 Salimian KJ, Birkness-Gartman J, Waters KM. The path(ology) from reflux oesophagitis to Barrett oesophagus to oesophageal adenocarcinoma. Pathology 2021:S0031-3025(21)00482-7. [PMID: 34711413 DOI: 10.1016/j.pathol.2021.08.006] [Reference Citation Analysis]
231 Kahrilas P, Yadlapati R, Roman S. Emerging dilemmas in the diagnosis and management of gastroesophageal reflux disease. F1000Res 2017;6:1748. [PMID: 29034088 DOI: 10.12688/f1000research.11918.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
232 Winter HS, Illueca M, Henderson C, Vaezi M. Review of the persistence of gastroesophageal reflux disease in children, adolescents and adults: does gastroesophageal reflux disease in adults sometimes begin in childhood? Scand J Gastroenterol 2011;46:1157-68. [PMID: 21675820 DOI: 10.3109/00365521.2011.591425] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
233 Bajbouj M. [Diagnosis and therapy of atypical reflux symptoms when PPI therapy fails]. HNO 2012;60:193-9. [PMID: 22402899 DOI: 10.1007/s00106-011-2430-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
234 Khoma O, Falk SE, Burton L, Van der Wall H, Falk GL. Gastro-Oesophageal Reflux and Aspiration: Does Laparoscopic Fundoplication Significantly Decrease Pulmonary Aspiration? Lung 2018;196:491-6. [PMID: 29804143 DOI: 10.1007/s00408-018-0128-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
235 Ribolsi M, Cicala M, Zentilin P, Neri M, Mauro A, Efthymakis K, Petitti T, Savarino V, Penagini R. Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease. Aliment Pharmacol Ther 2018;48:1074-81. [PMID: 30294924 DOI: 10.1111/apt.14986] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
236 Lee KJ, Son BK, Kim GH, Jung HK, Jung HY, Chung IK, Sung IK, Kim JI, Kim JH, Lee JS, Kwon JG, Park JH, Huh KC, Park KS, Park MI, Kim N, Lee OY, Jee SR, Lee SK, Youn SJ, Kim SK, Lee ST, Hong SJ, Choi SC, Kim TN, Youn YH, Park HJ, Kang MJ, Park CH, Kim BT, Youn S, Song GS, Rhee PL. Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis. Aliment Pharmacol Ther 2019;49:864-72. [PMID: 30843245 DOI: 10.1111/apt.15185] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
237 Contreras-Omaña R, Sánchez-Reyes O, Ángeles-Granados E. Comparison of the Carlsson-Dent and GERD-Q questionnaires for gastroesophageal reflux disease symptom detection in a general population. Rev Gastroenterol Mex 2017;82:19-25. [PMID: 27865578 DOI: 10.1016/j.rgmx.2016.05.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
238 Adamko DJ, Majaesic CM, Skappak C, Jones AB. A pilot trial on the treatment of gastroesophageal reflux-related cough in infants. Transl Pediatr 2012;1:23-34. [PMID: 26835260 DOI: 10.3978/j.issn.2224-4336.2012.03.03] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
239 Bhat S, Varghese C, Carson DA, Hayes TCL, Gharibans AA, Andrews CN, O'Grady G. Gastric dysrhythmia in gastroesophageal reflux disease: a systematic review and meta-analysis. Esophagus 2021;18:425-35. [PMID: 33594598 DOI: 10.1007/s10388-021-00820-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
240 Puchkov KV, Khabarova EV, Tishchenko ES. [Two-stage treatment of Barrett's esophagus]. Khirurgiia (Mosk) 2019;:18-24. [PMID: 31532162 DOI: 10.17116/hirurgia201909118] [Reference Citation Analysis]
241 Olmi S, Cesana G, D'Angiolella L, Bonaldi M, Uccelli M, Mantovani L. Sleeve gastrectomy with tailored 360° fundoplication according to Rossetti in patients affected by obesity and gastroesophageal reflux: a prospective observational study. Surg Obes Relat Dis 2021;17:1057-65. [PMID: 33622604 DOI: 10.1016/j.soard.2021.01.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
242 Lee KS, Kim ES, Kim DY, Song IS, Ahn KH. Association of Gastroesophageal Reflux Disease with Preterm Birth: Machine Learning Analysis. J Korean Med Sci 2021;36:e282. [PMID: 34751010 DOI: 10.3346/jkms.2021.36.e282] [Reference Citation Analysis]
243 Kung Y, Hsu W, Wu M, Wang J, Liu C, Su Y, Kuo C, Kuo F, Wu D, Wang Y. Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease. Dig Dis Sci 2017;62:3298-316. [DOI: 10.1007/s10620-017-4830-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
244 Pyun JE, Choi DM, Lee JH, Yoo KH, Shim JO. Achalasia Previously Diagnosed as Gastroesophageal Reflux Disease by Relying on Esophageal Impedance-pH Monitoring: Use of High-Resolution Esophageal Manometry in Children. Pediatr Gastroenterol Hepatol Nutr 2015;18:55-9. [PMID: 25866734 DOI: 10.5223/pghn.2015.18.1.55] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
245 Wu TC, Lu CN, Hu WL, Wu KL, Chiang JY, Sheen JM, Hung YC. Tongue diagnosis indices for gastroesophageal reflux disease: A cross-sectional, case-controlled observational study. Medicine (Baltimore) 2020;99:e20471. [PMID: 32702810 DOI: 10.1097/MD.0000000000020471] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
246 Yoo JH, Kwon C, Yoo K, Yoon H, Kim WH, Ko KH, Hong SP, Park PW. Effect of Proton Pump Inhibitor in Patients with Acute Pancreatitis - Pilot Study. Korean J Gastroenterol 2012;60:362. [DOI: 10.4166/kjg.2012.60.6.362] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
247 Bonfiglio F, Hysi PG, Ek W, Karhunen V, Rivera NV, Männikkö M, Nordenstedt H, Zucchelli M, Bresso F, Williams F, Tornblom H, Magnusson PK, Pedersen NL, Ronkainen J, Schmidt PT, D'Amato M. A meta-analysis of reflux genome-wide association studies in 6750 Northern Europeans from the general population. Neurogastroenterol Motil 2017;29. [PMID: 27485664 DOI: 10.1111/nmo.12923] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
248 Park CH, Lee SK. [Gastroesophageal Reflux Disease]. Korean J Gastroenterol 2019;73:70-6. [PMID: 30845382 DOI: 10.4166/kjg.2019.73.2.70] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
249 Spechler SJ, Fitzgerald RC, Prasad GA, Wang KK. History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterology. 2010;138:854-869. [PMID: 20080098 DOI: 10.1053/j.gastro.2010.01.002] [Cited by in Crossref: 142] [Cited by in F6Publishing: 112] [Article Influence: 12.9] [Reference Citation Analysis]
250 Zhang L, Tu L, Chen J, Song J, Bai T, Xiang XL, Wang RY, Hou XH. Health-related quality of life in gastroesophageal reflux patients with noncardiac chest pain: Emphasis on the role of psychological distress. World J Gastroenterol 2017; 23(1): 127-134 [PMID: 28104988 DOI: 10.3748/wjg.v23.i1.127] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
251 Jiang Y, Jiang L, Ye B, Lin L. Value of adjunctive evidence from MII-pH monitoring and high-resolution manometry in inconclusive GERD patients with AET 4-6. Therap Adv Gastroenterol 2021;14:17562848211013484. [PMID: 34104208 DOI: 10.1177/17562848211013484] [Reference Citation Analysis]
252 Jansson C, Nordenstedt H, Wallander MA, Johansson S, Johnsen R, Hveem K, Lagergren J. Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based study. Aliment Pharmacol Ther. 2007;26:683-691. [PMID: 17697202 DOI: 10.1111/j.1365-2036.2007.03411.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 5.6] [Reference Citation Analysis]
253 Gyawali CP, Carlson DA, Chen JW, Patel A, Wong RJ, Yadlapati RH. ACG Clinical Guidelines: Clinical Use of Esophageal Physiologic Testing. Am J Gastroenterol 2020;115:1412-28. [PMID: 32769426 DOI: 10.14309/ajg.0000000000000734] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 22.0] [Reference Citation Analysis]
254 Wu J, Liu D, Feng C, Luo Y, Nian Y, Wang X, Zhang J. The Characteristics of Postprandial Proximal Gastric Acid Pocket in Gastroesophageal Reflux Disease. Med Sci Monit 2018;24:170-6. [PMID: 29309401 DOI: 10.12659/msm.904964] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
255 Fan-hsu J. Evidence Linking Gastroesophageal Reflux Disease and Dental Erosion Is Not Strong. The Journal of the American Dental Association 2009;140:1401-2. [DOI: 10.14219/jada.archive.2009.0077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
256 Hart AM. Evidence-based recommendations for GERD treatment. Nurse Pract. 2013;38:26-34; quiz 34. [PMID: 23812348 DOI: 10.1097/01.npr.0000431881.25363.84] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
257 Noguchi Y, Katsuno H, Ueno A, Otsubo M, Yoshida A, Kanematsu Y, Sugita I, Esaki H, Tachi T, Tsuchiya T, Teramachi H. Signals of gastroesophageal reflux disease caused by incretin-based drugs: a disproportionality analysis using the Japanese adverse drug event report database. J Pharm Health Care Sci 2018;4:15. [PMID: 29946474 DOI: 10.1186/s40780-018-0109-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
258 Singhal V, Khaitan L. Preoperative Evaluation of Gastroesophageal Reflux Disease. Surgical Clinics of North America 2015;95:615-27. [DOI: 10.1016/j.suc.2015.02.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
259 Zhong C, Duan L, Wang K, Xu Z, Ge Y, Yang C, Han Y. Esophageal intraluminal baseline impedance is associated with severity of acid reflux and epithelial structural abnormalities in patients with gastroesophageal reflux disease. J Gastroenterol 2013;48:601-10. [PMID: 23076541 DOI: 10.1007/s00535-012-0689-6] [Cited by in Crossref: 76] [Cited by in F6Publishing: 65] [Article Influence: 8.4] [Reference Citation Analysis]
260 Wang G, Qu C, Wang L, Liu H, Han H, Xu B, Zhou Y, Li B, Zhang Y, Sun Z, Gong J, Li L, Wu W. Utility of 24-hour pharyngeal pH monitoring and clinical feature in laryngopharyngeal reflux disease. Acta Otolaryngol 2019;139:299-303. [PMID: 31056040 DOI: 10.1080/00016489.2019.1571280] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
261 Manabe N, Haruma K, Hata J, Kamada T, Kusunoki H. Differences in recognition of heartburn symptoms between Japanese patients with gastroesophageal reflux, physicians, nurses, and healthy lay subjects. Scand J Gastroenterol 2008;43:398-402. [PMID: 18365903 DOI: 10.1080/00365520701815074] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
262 Chang C, Liao C, Muo C, Kao C. Increased risk of concurrent gastroesophageal reflux disease among patients with Sjögren's syndrome: A nationwide population-based study. European Journal of Internal Medicine 2016;31:73-8. [DOI: 10.1016/j.ejim.2016.01.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
263 Liang CM, Kuo MT, Hsu PI, Kuo CH, Tai WC, Yang SC, Wu KL, Wang HM, Yao CC, Tsai CE, Wang YK, Wang JW, Huang CF, Wu DC, Chuah SK, Taiwan Acid-Related Disease Study Group. First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease. World J Gastroenterol 2017; 23(47): 8395-8404 [PMID: 29307999 DOI: 10.3748/wjg.v23.i47.8395] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
264 Yadlapati R, Adkins C, Jaiyeola DM, Lidder AK, Gawron AJ, Tan BK, Shabeeb N, Price CP, Agrawal N, Ellenbogen M, Smith SS, Bove M, Pandolfino JE. Abilities of Oropharyngeal pH Tests and Salivary Pepsin Analysis to Discriminate Between Asymptomatic Volunteers and Subjects With Symptoms of Laryngeal Irritation. Clin Gastroenterol Hepatol 2016; 14: 535-542. e2. [PMID: 26689899 DOI: 10.1016/j.cgh.2015.11.017] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
265 Reimer C, Lødrup AB, Smith G, Wilkinson J, Bytzer P. Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add-on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor. Aliment Pharmacol Ther 2016;43:899-909. [DOI: 10.1111/apt.13567] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 9.4] [Reference Citation Analysis]
266 Qureshi F, Asad H, Patel PS, Ramprasad A, Singh SP, Suman S, Cheng AL, Salzman G. Gastroesophageal Reflux Disease-Associated Chronic Cough: A Population-Based Analysis of Patient Presentations in the United States. Cureus 2021;13:e17512. [PMID: 34595079 DOI: 10.7759/cureus.17512] [Reference Citation Analysis]
267 Jung HK. Epidemiology of gastroesophageal reflux disease in Asia: a systematic review. J Neurogastroenterol Motil. 2011;17:14-27. [PMID: 21369488 DOI: 10.5056/jnm.2011.17.1.14] [Cited by in Crossref: 135] [Cited by in F6Publishing: 113] [Article Influence: 13.5] [Reference Citation Analysis]
268 Menezes MA, Herbella FAM. Pathophysiology of Gastroesophageal Reflux Disease. World J Surg. 2017;41:1666-1671. [PMID: 28258452 DOI: 10.1007/s00268-017-3952-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 9.3] [Reference Citation Analysis]
269 Argyrou A, Legaki E, Koutserimpas C, Gazouli M, Papaconstantinou I, Gkiokas G, Karamanolis G. Risk factors for gastroesophageal reflux disease and analysis of genetic contributors. World J Clin Cases 2018; 6(8): 176-182 [PMID: 30148145 DOI: 10.12998/wjcc.v6.i8.176] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
270 Arivan R, Deepanjali S. Prevalence and risk factors of gastro-esophageal reflux disease among undergraduate medical students from a southern Indian medical school: a cross-sectional study. BMC Res Notes 2018;11:448. [PMID: 29986748 DOI: 10.1186/s13104-018-3569-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
271 Tsukanov VV, Kasparov EV, Onuchina EV, Vasyutin AV, Butorin NN, Amelchugova OS, Tonkikh YL. [The frequency and clinical aspects of extraesophageal syndromes in elderly patients with gastroesophageal reflux disease]. Ter Arkh 2016;88:28-32. [PMID: 27030180 DOI: 10.17116/terarkh201688228-32] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
272 de Bortoli N, Tolone S, Frazzoni M, Martinucci I, Sgherri G, Albano E, Ceccarelli L, Stasi C, Bellini M, Savarino V, Savarino EV, Marchi S. Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders. Ann Gastroenterol 2018;31:639-48. [PMID: 30386113 DOI: 10.20524/aog.2018.0314] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
273 Song Q, Liu H, Wang J, Jia Y, Liu Y, Wang N, Tan B, Guan S, An D, Cheng Y. Dinner-to-bed time and post-dinner walk: new potential independent factors in esophageal cancer development. J Cancer Res Clin Oncol 2014;140:817-21. [PMID: 24531974 DOI: 10.1007/s00432-014-1613-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
274 Wang C, Hunt RH. Medical management of gastroesophageal reflux disease. Gastroenterol Clin North Am. 2008;37:879-899, ix. [PMID: 19028323 DOI: 10.1016/j.gtc.2008.09.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
275 Katona BW, Falk GW. Barrett’s esophagus surveillance: When, how often, does it work? Gastrointest Endosc Clin N Am. 2011;21:9-24. [PMID: 21112494 DOI: 10.1016/j.giec.2010.09.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
276 Lei WY, Yu HC, Wen SH, Liu TT, Yi CH, Wang CC, Hsu CS, Chen CH, Chen CL, Pace F. Predictive factors of silent reflux in subjects with erosive esophagitis. Dig Liver Dis. 2015;47:24-29. [PMID: 25308612 DOI: 10.1016/j.dld.2014.09.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
277 Wu CP, Liang WM, Wang CC, Chang CS, Yeh HZ, Hsu JY, Ko CW, Lee SW, Chang SC, Sung FC, Lien HC. The suitability of the GERDyzer instrument in pH-test-proven laryngopharyngeal reflux patients. Medicine (Baltimore) 2016;95:e4439. [PMID: 27495070 DOI: 10.1097/MD.0000000000004439] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
278 Peura DA, Traxler B, Kocun C, Lind T. Esomeprazole treatment of frequent heartburn: two randomized, double-blind, placebo-controlled trials. Postgrad Med 2014;126:33-41. [PMID: 25141241 DOI: 10.3810/pgm.2014.07.2781] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
279 Lee J, Wong SK, Liu SY, Ng EK. Is Preoperative Upper Gastrointestinal Endoscopy in Obese Patients Undergoing Bariatric Surgery Mandatory? An Asian Perspective. Obes Surg 2017;27:44-50. [PMID: 27233898 DOI: 10.1007/s11695-016-2243-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
280 Dorval E, Rey JF, Soufflet C, Halling K, Barthélemy P. Perspectives on gastroesophageal reflux disease in primary care: the REFLEX study of patient-physician agreement. BMC Gastroenterol 2011;11:25. [PMID: 21435198 DOI: 10.1186/1471-230X-11-25] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
281 Holmberg D, Santoni G, Xie S, Lagergren J. Gastric bypass surgery in the treatment of gastro-oesophageal reflux symptoms. Aliment Pharmacol Ther 2019;50:159-66. [DOI: 10.1111/apt.15274] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
282 Sobrino-Cossío S, Soto-Pérez JC, Coss-Adame E, Mateos-Pérez G, Teramoto Matsubara O, Tawil J, Vallejo-Soto M, Sáez-Ríos A, Vargas-Romero JA, Zárate-Guzmán AM, Galvis-García ES, Morales-Arámbula M, Quiroz-Castro O, Carrasco-Rojas A, Remes-Troche JM. Post-fundoplication symptoms and complications: Diagnostic approach and treatment. Rev Gastroenterol Mex 2017;82:234-47. [PMID: 28065591 DOI: 10.1016/j.rgmx.2016.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
283 Chang CY, Lee YC, Lee CT, Tu CH, Hwang JC, Chiang H, Tai CM, Chiang TH, Wu MS, Lin JT. The application of Prague C and M criteria in the diagnosis of Barrett's esophagus in an ethnic Chinese population. Am J Gastroenterol. 2009;104:13-20. [PMID: 19098843 DOI: 10.1038/ajg.2008.43] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
284 McMahon BP, Jobe BA, Pandolfino JE, Gregersen H. Do we really understand the role of the oesophagogastric junction in disease? World J Gastroenterol 2009; 15(2): 144-150 [PMID: 19132763 DOI: 10.3748/wjg.15.144] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
285 Lu CL. Silent gastroesophageal reflux disease. J Neurogastroenterol Motil 2012;18:236-8. [PMID: 22837870 DOI: 10.5056/jnm.2012.18.3.236] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
286 Djärv T, Wikman A, Nordenstedt H, Johar A, Lagergren J, Lagergren P. Physical activity, obesity and gastroesophageal reflux disease in the general population. World J Gastroenterol. 2012;18:3710-3714. [PMID: 22851863 DOI: 10.3748/wjg.v18.i28.371] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
287 Orenstein SR. Infant GERD: symptoms, reflux episodes & amp; reflux disease, acid & amp; non-acid refllux--implications for treatment with PPIs. Curr Gastroenterol Rep. 2013;15:353. [PMID: 24197743 DOI: 10.1007/s11894-013-0353-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
288 Kim HY. Association Between Erosive Esophagitis and the Anthropometric Index in the General Korean Population. Balkan Med J 2019;36:169-73. [PMID: 30539623 DOI: 10.4274/balkanmedj.galenos.2018.2018.0523] [Reference Citation Analysis]
289 Etemadi A, Gandomkar A, Freedman ND, Moghadami M, Fattahi MR, Poustchi H, Islami F, Boffetta P, Dawsey SM, Abnet CC, Malekzadeh R. The association between waterpipe smoking and gastroesophageal reflux disease. Int J Epidemiol 2017;46:1968-77. [PMID: 29025018 DOI: 10.1093/ije/dyx158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
290 Zhao J, Mcmahon B, Fox M, Gregersen H. The esophagiome: integrated anatomical, mechanical, and physiological analysis of the esophago-gastric segment: The esophagiome. Ann N Y Acad Sci 2018;1434:5-20. [DOI: 10.1111/nyas.13869] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
291 Matsuzaki J, Suzuki H, Iwasaki E, Yokoyama H, Sugino Y, Hibi T. Serum lipid levels are positively associated with non-erosive reflux disease, but not with functional heartburn. Neurogastroenterol Motil. 2010;22:965-70, e251. [PMID: 20482701 DOI: 10.1111/j.1365-2982.2010.01518.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
292 Kahrilas PJ, Shaheen NJ, Vaezi MF; American Gastroenterological Association Institute; Clinical Practice and Quality Management Committee. American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135:1392-1413, 1413.e1-1413.e5. [PMID: 18801365 DOI: 10.1053/j.gastro.2008.08.044] [Cited by in Crossref: 264] [Cited by in F6Publishing: 203] [Article Influence: 20.3] [Reference Citation Analysis]
293 Kandulski A, Jechorek D, Caro C, Weigt J, Wex T, Mönkemüller K, Malfertheiner P. Histomorphological differentiation of non-erosive reflux disease and functional heartburn in patients with PPI-refractory heartburn. Aliment Pharmacol Ther 2013;38:643-51. [PMID: 23895770 DOI: 10.1111/apt.12428] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
294 Wang W, Uedo N, Yang Y, Peng L, Bai D, Lu Z, Fan K, Wang J, Wang X, Zhao Y. Autofluorescence imaging endoscopy for predicting acid reflux in patients with gastroesophageal reflux disease. J Gastroenterol Hepatol. 2014;29:1442-1448. [PMID: 25587615 DOI: 10.1111/jgh.12566] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
295 Holmberg D, Santoni G, von Euler-Chelpin MC, Färkkilä M, Kauppila JH, Maret-Ouda J, Ness-Jensen E, Lagergren J. Incidence and Mortality in Upper Gastrointestinal Cancer After Negative Endoscopy for Gastroesophageal Reflux Disease. Gastroenterology 2021:S0016-5085(21)03617-9. [PMID: 34627859 DOI: 10.1053/j.gastro.2021.10.003] [Reference Citation Analysis]
296 Kaindlstorfer A, Koch OO, Antoniou SA, Asche KU, Granderath FA, Pointner R. A randomized trial on endoscopic full-thickness gastroplication versus laparoscopic antireflux surgery in GERD patients without hiatal hernias. Surg Laparosc Endosc Percutan Tech 2013;23:212-22. [PMID: 23579521 DOI: 10.1097/SLE.0b013e3182827f79] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
297 Choi JY, Jung HK, Song EM, Shim KN, Jung SA. Determinants of symptoms in gastroesophageal reflux disease: nonerosive reflux disease, symptomatic, and silent erosive reflux disease. Eur J Gastroenterol Hepatol. 2013;25:764-771. [PMID: 23459104 DOI: 10.1097/MEG.0b013e32835f594c] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 3.1] [Reference Citation Analysis]
298 Friedlander EA, Pallentino J, Miller SK, Vanbeuge SS. The evolution of proton pump inhibitors for the treatment of gastroesophageal reflux disease: Evolution of proton pump inhibitors for GERD treatment. Journal of the American Academy of Nurse Practitioners 2010;22:674-83. [DOI: 10.1111/j.1745-7599.2010.00578.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
299 Lupu VV, Burlea M, Nistor N, Streanga V, Starcea MI, Paduraru G, Ghica DC, Mitrofan EC, Moscalu M, Ignat A. Correlation between esophageal pH-metry and esophagitis in gastroesophageal reflux disease in children. Medicine (Baltimore) 2018;97:e12042. [PMID: 30212934 DOI: 10.1097/MD.0000000000012042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
300 Trachalaki A, Irfan M, Wells AU. Pharmacological management of Idiopathic Pulmonary Fibrosis: current and emerging options. Expert Opin Pharmacother 2021;22:191-204. [PMID: 32993388 DOI: 10.1080/14656566.2020.1822326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
301 Tomita T, Iijima H, Kim Y, Oshima T, Hori K, Nishiguchi S, Matsumoto T, Miwa H. Abdominal ultrasonography as a new modality for the diagnosis of gastroesophageal reflux disease. J Gastroenterol Hepatol 2010;25 Suppl 1:S45-8. [PMID: 20586865 DOI: 10.1111/j.1440-1746.2010.06226.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
302 Reid BJ, Li X, Galipeau PC, Vaughan TL. Barrett’s oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer. 2010;10:87-101. [PMID: 20094044 DOI: 10.1038/nrc2773] [Cited by in Crossref: 282] [Cited by in F6Publishing: 254] [Article Influence: 25.6] [Reference Citation Analysis]
303 Hoffman I, De Greef T, Haesendonck N, Tack J. Esophageal Motility in Children With Suspected Gastroesophageal Reflux Disease. Journal of Pediatric Gastroenterology & Nutrition 2010;50:601-8. [DOI: 10.1097/mpg.0b013e3181c1f596] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 2.1] [Reference Citation Analysis]
304 Hongo M, Kinoshita Y, Shimozuma K, Kumagai Y, Sawada M, Nii M. Psychometric validation of the Japanese translation of the Quality of Life in Reflux and Dyspepsia questionnaire in patients with heartburn. J Gastroenterol 2007;42:807-15. [DOI: 10.1007/s00535-007-2098-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
305 Yadlapati R, Kaizer A, Greytak M, Ezekewe E, Simon V, Wani S. Diagnostic performance of salivary pepsin for gastroesophageal reflux disease. Dis Esophagus 2021;34:doaa117. [PMID: 33180095 DOI: 10.1093/dote/doaa117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
306 Mastracci L, Bruzzone M, Pacella E, Tinelli C, Zentilin P, Savarino E, De Silvestri A, Fiocca R, Grillo F. The contribution of intraepithelial inflammatory cells to the histological diagnosis of microscopic esophagitis. Esophagus 2016;13:80-7. [DOI: 10.1007/s10388-015-0501-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
307 de Bortoli N, Nacci A, Savarino E, Martinucci I, Bellini M, Fattori B, Ceccarelli L, Costa F, Mumolo MG, Ricchiuti A, Savarino V, Berrettini S, Marchi S. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? World J Gastroenterol 2012; 18(32): 4363-4370 [PMID: 22969200 DOI: 10.3748/wjg.v18.i32.4363] [Cited by in CrossRef: 85] [Cited by in F6Publishing: 67] [Article Influence: 9.4] [Reference Citation Analysis]
308 Lee KJ, Kim JI, Park JS, Moon BS, Kim SG, Chun JH, Jung HY, Choi CH, Chun SW, Song GA, Choi MG, Chun HJ. Practice pattern of gastroenterologists for the management of GERD under the minimal influence of the insurance reimbursement guideline: a multicenter prospective observational study. J Korean Med Sci 2011;26:1613-8. [PMID: 22147999 DOI: 10.3346/jkms.2011.26.12.1613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
309 Junghard O, Wiklund IK. Effect of baseline symptom severity on patient-reported outcomes in gastroesophageal reflux disease: . European Journal of Gastroenterology & Hepatology 2007;19:555-60. [DOI: 10.1097/meg.0b013e328133f2d1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
310 Mulder DJ, Hurlbut DJ, Noble AJ, Justinich CJ. Clinical features distinguish eosinophilic and reflux-induced esophagitis. J Pediatr Gastroenterol Nutr 2013;56:263-70. [PMID: 23085895 DOI: 10.1097/MPG.0b013e3182794466] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
311 Sakin YS, Vardar R, Sezgin B, Cetin ZE, Alev Y, Yildirim E, Kirazli T, Bor S. The diagnostic value of 24-hour ambulatory intraesophageal pH-impedance in patients with laryngopharyngeal reflux symptoms comparable with typical symptoms. United European Gastroenterol J 2017;5:632-40. [PMID: 28815026 DOI: 10.1177/2050640616675040] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
312 Francis D, Badillo R. Gastroesophageal Reflux Disease. In: Lacy BE, Crowell MD, Dibaise JK, editors. Functional and Motility Disorders of the Gastrointestinal Tract. New York: Springer; 2015. pp. 37-47. [DOI: 10.1007/978-1-4939-1498-2_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
313 Chatila AT, Nguyen MTT, Krill T, Roark R, Bilal M, Reep G. Natural history, pathophysiology and evaluation of gastroesophageal reflux disease. Dis Mon 2020;66:100848. [PMID: 30803725 DOI: 10.1016/j.disamonth.2019.02.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
314 Zhang C, Wu J, Hu Z, Yan C, Gao X, Liang W, Liu D, Li F, Wang Z. Diagnosis and Anti-Reflux Therapy for GERD with Respiratory Symptoms: A Study Using Multichannel Intraluminal Impedance-pH Monitoring. PLoS One. 2016;11:e0160139. [PMID: 27532103 DOI: 10.1371/journal.pone.0160139] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
315 Ribolsi M, Gyawali CP, Savarino E, Rogers B, Rengarajan A, Della Coletta M, Ghisa M, Cicala M. Correlation between reflux burden, peristaltic function, and mucosal integrity in GERD patients. Neurogastroenterol Motil 2020;32:e13752. [PMID: 31670453 DOI: 10.1111/nmo.13752] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
316 Dabholkar AH, Han C, Paris MM, Perez MC, Atkinson SN, Peura DA. The 12-month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro-oesophageal reflux disease: Twelve-month safety of dexlansoprazole MR in patients with GERD. Alimentary Pharmacology & Therapeutics 2011;33:366-77. [DOI: 10.1111/j.1365-2036.2010.04519.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
317 Cheng CL, Lin CH, Liu NJ, Tang JH, Kuo YL, Tsui YN. Endoscopic diagnosis of cervical esophageal heterotopic gastric mucosa with conventional and narrow-band images. World J Gastroenterol 2014; 20(1): 242-249 [PMID: 24415878 DOI: 10.3748/wjg.v20.i1.242] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
318 Sifrim D, Barnes N. GERD-related chronic cough: how to identify patients who will respond to antireflux therapy? J Clin Gastroenterol. 2010;44:234-236. [PMID: 20104183 DOI: 10.1097/MCG.0b013e3181d06b2f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
319 Akst LM, Haque OJ, Clarke JO, Hillel AT, Best SR, Altman KW. The Changing Impact of Gastroesophageal Reflux Disease in Clinical Practice: An Updated Study. Ann Otol Rhinol Laryngol 2017;126:229-35. [DOI: 10.1177/0003489416686586] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
320 Masuda T, Yano F, Omura N, Tsuboi K, Hoshino M, Yamamoto SR, Akimoto S, Kashiwagi H, Yanaga K. Effect of Low-Dose Aspirin on Chronic Acid Reflux Esophagitis in Rats. Dig Dis Sci 2018;63:72-80. [PMID: 29143196 DOI: 10.1007/s10620-017-4840-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
321 Almadi MA, Almousa MA, Althwainy AF, Altamimi AM, Alamoudi HO, Alshamrani HS, Alharbi OR, Azzam NA, Sadaf N, Aljebreen AM. Prevalence of symptoms of gastroesopahgeal reflux in a cohort of Saudi Arabians: a study of 1265 subjects. Saudi J Gastroenterol 2014;20:248-54. [PMID: 25038211 DOI: 10.4103/1319-3767.136982] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
322 Ali T, Miner PB. New developments in gastroesophageal reflux disease diagnosis and therapy: . Current Opinion in Gastroenterology 2008;24:502-8. [DOI: 10.1097/mog.0b013e3283025c6d] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
323 Li CH, Hsieh TC, Hsiao TH, Wang PC, Tseng TC, Lin HH, Wang CC. Different risk factors between reflux symptoms and mucosal injury in gastroesophageal reflux disease. Kaohsiung J Med Sci. 2015;31:320-327. [PMID: 26043412 DOI: 10.1016/j.kjms.2015.02.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
324 Griffiths TL, Nassar M, Soubani AO. Pulmonary manifestations of gastroesophageal reflux disease. Expert Rev Respir Med 2020;14:767-75. [PMID: 32308062 DOI: 10.1080/17476348.2020.1758068] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
325 Fuchs HF, Müller DT, Berlth F, Maus MK, Fuchs C, Dübbers M, Schröder W, Bruns CJ, Leers JM. Simultaneous laryngopharyngeal pH monitoring (Restech) and conventional esophageal pH monitoring-correlation using a large patient cohort of more than 100 patients with suspected gastroesophageal reflux disease. Dis Esophagus 2018;31. [PMID: 29534167 DOI: 10.1093/dote/doy018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
326 Lu J, Shi L, Huang D, Fan W, Li X, Zhu L, Wei J, Fang X. Depression and Structural Factors Are Associated With Symptoms in Patients of Irritable Bowel Syndrome With Diarrhea. J Neurogastroenterol Motil 2020;26:505-13. [PMID: 32675388 DOI: 10.5056/jnm19166] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
327 Grechenig M, Gruber R, Weitzendorfer M, von Rahden BHA, Widmann B, Emmanuel K, Koch O. [Reflux Symptoms - No Difference in Severity and Intensity in Patients with and without Functional Verified Gastroesophageal Reflux Disease]. Zentralbl Chir 2021;146:170-5. [PMID: 33556980 DOI: 10.1055/a-1333-3910] [Reference Citation Analysis]
328 Chang CY, Cook MB, Lee YC, Lin JT, Ando T, Bhatia S, Chow WH, El-Omar EM, Goto H, Li YQ, McColl K, Reddy N, Rhee PL, Sharma P, Sung JJ, Ghoshal U, Wong JY, Wu JC, Zhang J, Ho KY;  Asian Barrett's Consortium. Current status of Barrett's esophagus research in Asia. J Gastroenterol Hepatol. 2011;26:240-246. [PMID: 21155883 DOI: 10.1111/j.1440-1746.2010.06529.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
329 Tanaka Y, Ihara E, Hirano K, Takahashi S, Hirano M, Nakamura K, Akiho H, Oda Y, Takayanagi R. Trypsin-induced biphasic regulation of tone in the porcine lower esophageal sphincter. European Journal of Pharmacology 2015;752:97-105. [DOI: 10.1016/j.ejphar.2015.02.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
330 Jansson C, Wiberg M, Alexanderson K. Sickness absence due to gastroesophageal reflux diagnoses: a nationwide Swedish population-based study. Scand J Gastroenterol 2013;48:17-26. [PMID: 23181538 DOI: 10.3109/00365521.2012.737359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
331 Kandulski A, Moleda L, Müller-Schilling M. Diagnostic Investigations of Gastroesophageal Reflux Disease: Who and When to Refer and for What Test? Visc Med 2018;34:97-100. [PMID: 29888237 DOI: 10.1159/000488184] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
332 Martinucci I, Bortoli N, Giacchino M, Bodini G, Marabotto E, Marchi S, Savarino V, Savarino E. Esophageal motility abnormalities in gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther 2014; 5(2): 86-96 [PMID: 24868489 DOI: 10.4292/wjgpt.v5.i2.86] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
333 Vaezi MF. Reflux monitoring: on or off therapy? Am J Gastroenterol 2011;106:183-5. [PMID: 21301447 DOI: 10.1038/ajg.2010.318] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
334 Burton L, Falk GL, Parsons S, Cusi M, Van Der Wall H. Benchmarking of a Simple Scintigraphic Test for Gastro-oesophageal Reflux Disease That Assesses Oesophageal Disease and Its Pulmonary Complications. Mol Imaging Radionucl Ther 2018;27:113-20. [PMID: 30317833 DOI: 10.4274/mirt.10438] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
335 Wang GR, Zhang H, Wang ZG, Jiang GS, Guo CH. Relationship between dental erosion and respiratory symptoms in patients with gastro-oesophageal reflux disease. J Dent 2010;38:892-8. [PMID: 20696201 DOI: 10.1016/j.jdent.2010.08.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
336 Xiao YL, Zhou LY, Hou XH, Li YQ, Zou DW, Chen MH; Chinese Society of Gastroenterology. Chinese expert consensus on gastroesophageal reflux disease in 2020. J Dig Dis 2021;22:376-89. [PMID: 34105263 DOI: 10.1111/1751-2980.13028] [Reference Citation Analysis]
337 Hatlebakk JG. Endoscopy in gastro-oesophageal reflux disease. Best Practice & Research Clinical Gastroenterology 2010;24:775-86. [DOI: 10.1016/j.bpg.2010.09.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
338 Hatlebakk JG, Zerbib F, Bruley des Varannes S, Attwood SE, Ell C, Fiocca R, Galmiche JP, Eklund S, Långström G, Lind T, Lundell LR; LOTUS Study Group. Gastroesophageal Acid Reflux Control 5 Years After Antireflux Surgery, Compared With Long-term Esomeprazole Therapy. Clin Gastroenterol Hepatol 2016;14:678-85.e3. [PMID: 26226096 DOI: 10.1016/j.cgh.2015.07.025] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
339 Diamond IR, Grant RC, Feldman BM, Pencharz PB, Ling SC, Moore AM, Wales PW. Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies. Journal of Clinical Epidemiology 2014;67:401-9. [DOI: 10.1016/j.jclinepi.2013.12.002] [Cited by in Crossref: 691] [Cited by in F6Publishing: 559] [Article Influence: 98.7] [Reference Citation Analysis]
340 Nagahara A, Hojo M, Asaoka D, Watanabe S. Maintenance therapy of gastroesophageal reflux disease. Clin J Gastroenterol 2010;3:61-8. [PMID: 26189996 DOI: 10.1007/s12328-010-0139-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
341 Komatsu-Tanaka M, Iwakiri R, Fujimoto K, Fujiwara Y, Inamori M, Tanaka J, Shimatani T, Akiyama J, Ando T, Manabe N, Kinjo F, Deguchi R, Kusano M. Clinical symptoms of FSSG in gastroesophageal reflux disease are critical for PPI treatment: Japanese multi-centers with 185 patients. Dig Endosc 2012;24:407-11. [PMID: 23078431 DOI: 10.1111/j.1443-1661.2012.01301.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
342 Potamitis GS, Axon AT. Helicobacter pylori and Nonmalignant Diseases. Helicobacter. 2015;20 Suppl 1:26-29. [PMID: 26372821 DOI: 10.1111/hel.12253] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
343 Smits MJ, Loots CM, van Wijk MP, Bredenoord AJ, Benninga MA, Smout AJ. An expert panel-based study on recognition of gastro-esophageal reflux in difficult esophageal pH-impedance tracings. Neurogastroenterol Motil. 2015;27:637-645. [PMID: 25756933 DOI: 10.1111/nmo.12536] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
344 Singendonk MM, Rexwinkel R, Steutel NF, Gottrand F, Mccall L, Orsagh-yentis DK, Rosen R, Strisciuglio C, Thapar N, Vandenplas Y, Benninga MA, Tabbers MM. Development of a Core Outcome Set for Infant Gastroesophageal Reflux Disease. Journal of Pediatric Gastroenterology & Nutrition 2019;68:655-61. [DOI: 10.1097/mpg.0000000000002245] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
345 Richter JE. Gastrooesophageal reflux disease. Best Pract Res Clin Gastroenterol. 2007;21:609-631. [PMID: 17643904 DOI: 10.1016/j.bpg.2007.03.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
346 Hunt RH, Scarpignato C. Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease? Clin Transl Gastroenterol 2015;6:e119. [PMID: 26513137 DOI: 10.1038/ctg.2015.39] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 5.7] [Reference Citation Analysis]
347 Kellerman R, Kintanar T. Gastroesophageal Reflux Disease. Prim Care. 2017;44:561-573. [PMID: 29132520 DOI: 10.1016/j.pop.2017.07.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
348 Warsi I, Ahmed J, Younus A, Rasheed A, Akhtar TS, Ain QU, Khurshid Z. Risk factors associated with oral manifestations and oral health impact of gastro-oesophageal reflux disease: a multicentre, cross-sectional study in Pakistan. BMJ Open 2019;9:e021458. [PMID: 30928919 DOI: 10.1136/bmjopen-2017-021458] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
349 Chait MM. Gastroesophageal reflux disease: Important considerations for the older patients. World J Gastrointest Endosc 2010; 2(12): 388-396 [PMID: 21191512 DOI: 10.4253/wjge.v2.i12.388] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
350 Wilkinson J, Wade A, Thomas SJ, Jenner B, Hodgkinson V, Coyle C. Randomized clinical trial: a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate–antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease. European Journal of Gastroenterology & Hepatology 2019;31:86-93. [DOI: 10.1097/meg.0000000000001258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
351 Kahrilas PJ, Smith JA, Dicpinigaitis PV. A causal relationship between cough and gastroesophageal reflux disease (GERD) has been established: a pro/con debate. Lung. 2014;192:39-46. [PMID: 24221340 DOI: 10.1007/s00408-013-9528-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
352 Soffer E, Rodríguez L, Rodriguez P, Gómez B, Neto MG, Crowell MD. Effect of electrical stimulation of the lower esophageal sphincter in gastroesophageal reflux disease patients refractory to proton pump inhibitors. World J Gastrointest Pharmacol Ther 2016; 7(1): 145-155 [PMID: 26855821 DOI: 10.4292/wjgpt.v7.i1.145] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
353 Al-Zahrani MS, Zawawi KH, Austah ON, Al-Ghamdi HS. Self reported halitosis in relation to glycated hemoglobin level in diabetic patients. Open Dent J 2011;5:154-7. [PMID: 21966334 DOI: 10.2174/1874210601105010154] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
354 Gorczyca R, Pardak P, Pękala A, Filip R. Impact of gastroesophageal reflux disease on the quality of life of Polish patients. World J Clin Cases 2019; 7(12): 1421-1429 [PMID: 31363470 DOI: 10.12998/wjcc.v7.i12.1421] [Cited by in CrossRef: 4] [Article Influence: 2.0] [Reference Citation Analysis]
355 Hoogendoorn RJ, Groeneveld L, Kwee JA. Patient Satisfaction with Switching to Esomeprazole from Existing Proton Pump Inhibitor Therapy for Gastro-Oesophageal Reflux Disease: An Observational, Multicentre Study. Clinical Drug Investigation 2009;29:803-10. [DOI: 10.2165/11530810-000000000-00000] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
356 Coste T, Nedelcu M, Ferrandis C, Loureiro M, Souche R, Nedelcu A, Nocca D. Revised Sleeve Gastrectomy: Our Experience. Journal of Laparoendoscopic & Advanced Surgical Techniques 2021;31:161-5. [DOI: 10.1089/lap.2020.0724] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
357 Becher A, Dent J. Systematic review: Ageing and gastro-oesophageal reflux disease symptoms, oesophageal function and reflux oesophagitis. Aliment Pharmacol Ther. 2011;33:442-454. [PMID: 21138458 DOI: 10.1111/j.1365-2036.2010.04542.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
358 Lechien JR, Chiesa-Estomba CM, Calvo Henriquez C, Mouawad F, Ristagno C, Barillari MR, Schindler A, Nacci A, Bouland C, Laino L, Saussez S. Laryngopharyngeal reflux, gastroesophageal reflux and dental disorders: A systematic review. PLoS One 2020;15:e0237581. [PMID: 32797062 DOI: 10.1371/journal.pone.0237581] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
359 Patel D, Fass R, Vaezi M. Untangling Nonerosive Reflux Disease From Functional Heartburn. Clin Gastroenterol Hepatol 2021;19:1314-26. [PMID: 32246998 DOI: 10.1016/j.cgh.2020.03.057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
360 Engels LG, Klinkenberg-Knol EC, Carlsson J, Halling K. Psychometric validation of the Dutch translation of the quality of life in reflux and dyspepsia (QOLRAD) questionnaire in patients with gastroesophageal reflux disease. Health Qual Life Outcomes 2010;8:85. [PMID: 20716328 DOI: 10.1186/1477-7525-8-85] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
361 Ates F, Vaezi MF. Approach to the patient with presumed extraoesophageal GERD. Best Pract Res Clin Gastroenterol. 2013;27:415-431. [PMID: 23998979 DOI: 10.1016/j.bpg.2013.06.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
362 Leiman DA, Riff BP, Morgan S, Metz DC, Falk GW, French B, Umscheid CA, Lewis JD. Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis. Dis Esophagus 2017;30:1-9. [PMID: 28375448 DOI: 10.1093/dote/dow020] [Cited by in Crossref: 55] [Cited by in F6Publishing: 35] [Article Influence: 13.8] [Reference Citation Analysis]
363 Saino G, Bonavina L, Lipham JC, Dunn D, Ganz RA. Magnetic Sphincter Augmentation for Gastroesophageal Reflux at 5 Years: Final Results of a Pilot Study Show Long-Term Acid Reduction and Symptom Improvement. J Laparoendosc Adv Surg Tech A. 2015;25:787-792. [PMID: 26437027 DOI: 10.1089/lap.2015.0394] [Cited by in Crossref: 58] [Cited by in F6Publishing: 43] [Article Influence: 9.7] [Reference Citation Analysis]
364 Mouly S, Charlemagne A, Le jeunne P, Fagnani F. Étude pharmaco-économique sur la prise en charge du reflux gastro-œsophagien en France en 2005 en médecine générale. La Presse Médicale 2008;37:1397-406. [DOI: 10.1016/j.lpm.2007.11.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
365 He J, Ma X, Zhao Y, Wang R, Yan X, Yan H, Yin P, Kang X, Fang J, Hao Y. A population-based survey of the epidemiology of symptom-defined gastroesophageal reflux disease: the Systematic Investigation of Gastrointestinal Diseases in China. BMC Gastroenterol. 2010;10:94. [PMID: 20707933 DOI: 10.1186/1471-230x-10-94] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
366 Akinola MA, Oyedele TA, Akande KO, Oluyemi OY, Salami OF, Adesina AM, Adebajo AD. Gastroesophageal reflux disease: prevalence and Extraesophageal manifestations among undergraduate students in South West Nigeria. BMC Gastroenterol 2020;20:160. [PMID: 32456613 DOI: 10.1186/s12876-020-01292-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
367 Kusano M, Hosaka H, Kawamura O, Kawada A, Kuribayashi S, Shimoyama Y, Yasuoka H, Mizuide M, Tomizawa T, Sagawa T, Sato K, Yamada M. More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy. J Gastroenterol 2015;50:298-304. [PMID: 24919745 DOI: 10.1007/s00535-014-0972-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
368 Savarino E, Gemignani L, Pohl D, Zentilin P, Dulbecco P, Assandri L, Marabotto E, Bonfanti D, Inferrera S, Fazio V. Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2011;34:476-486. [PMID: 21671968 DOI: 10.1111/j.1365-2036.2011.04742.x] [Cited by in Crossref: 122] [Cited by in F6Publishing: 99] [Article Influence: 12.2] [Reference Citation Analysis]
369 Ronkainen J, Aro P, Walker MM, Agréus L, Johansson S, Jones M, Talley NJ. Duodenal eosinophilia is associated with functional dyspepsia and new onset gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2019;50:24-32. [DOI: 10.1111/apt.15308] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
370 Vakil N, Niklasson A, Denison H, Rydén A. Symptom profile in partial responders to a proton pump inhibitor compared with treatment-naïve patients with gastroesophageal reflux disease: a post hoc analysis of two study populations. BMC Gastroenterol 2014;14:177. [PMID: 25304129 DOI: 10.1186/1471-230X-14-177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
371 Naik RD, Vaezi MF. Extra-esophageal gastroesophageal reflux disease and asthma: understanding this interplay. Expert Rev Gastroenterol Hepatol. 2015;9:969-982. [PMID: 26067887 DOI: 10.1586/17474124.2015.1042861] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
372 Boulkedid R, Sibony O, Goffinet F, Fauconnier A, Branger B, Alberti C. Quality indicators for continuous monitoring to improve maternal and infant health in maternity departments: a modified Delphi survey of an international multidisciplinary panel. PLoS One 2013;8:e60663. [PMID: 23577143 DOI: 10.1371/journal.pone.0060663] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
373 Conrado LM, Gurski RR, da Rosa AR, Simic AP, Callegari-Jacques SM. Is there an association between hiatal hernia and ineffective esophageal motility in patients with gastroesophageal reflux disease? J Gastrointest Surg. 2011;15:1756-1761. [PMID: 21830151 DOI: 10.1007/s11605-011-1619- 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
374 Jonasson C, Moum B, Bang C, Andersen KR, Hatlebakk JG. Randomised clinical trial: a comparison between a GerdQ-based algorithm and an endoscopy-based approach for the diagnosis and initial treatment of GERD. Aliment Pharmacol Ther. 2012;35:1290-1300. [PMID: 22510027 DOI: 10.1111/j.1365-2036.2012.05092.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
375 Xu X, Yang Z, Chen Q, Yu L, Liang S, Lü H, Qiu Z. Comparison of clinical characteristics of chronic cough due to non-acid and acid gastroesophageal reflux. Clin Respir J 2015;9:196-202. [PMID: 24898575 DOI: 10.1111/crj.12124] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
376 Chang CH, Wu CP, Wang JD, Lee SW, Chang CS, Yeh HZ, Ko CW, Lien HC. Alcohol and tea consumption are associated with asymptomatic erosive esophagitis in Taiwanese men. PLoS One. 2017;12:e0173230. [PMID: 28264069 DOI: 10.1371/journal.pone.0173230] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
377 Peng S, Xiong LS, Xiao YL, Lin JK, Wang AJ, Zhang N, Hu PJ, Chen MH. Prompt upper endoscopy is an appropriate initial management in uninvestigated chinese patients with typical reflux symptoms. Am J Gastroenterol 2010;105:1947-52. [PMID: 20354508 DOI: 10.1038/ajg.2010.121] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
378 Shimazu R, Yamamoto M, Minesaki A, Kuratomi Y. Dental and oropharyngeal lesions in rats with chronic acid reflux esophagitis. Auris Nasus Larynx 2018;45:522-6. [PMID: 28882408 DOI: 10.1016/j.anl.2017.08.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
379 Schiöler L, Ruth M, Jõgi R, Gislason T, Storaas T, Janson C, Forsberg B, Sigsgaard T, Torén K, Hellgren J. Nocturnal GERD - a risk factor for rhinitis/rhinosinusitis: the RHINE study. Allergy 2015;70:697-702. [PMID: 25808429 DOI: 10.1111/all.12615] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
380 Takeuchi T, Takahashi Y, Kawaguchi S, Ota K, Harada S, Kojima Y, Sakamoto H, Kuramoto T, Kojima K, Sanomura M, Hoshimoto M, Higashino T, Itabashi T, Takada K, Sakaguchi M, Tominaga K, Kusano M, Higuchi K. Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor. J Gastroenterol Hepatol 2018;33:623-30. [PMID: 28865098 DOI: 10.1111/jgh.13970] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
381 Satibi S, Rokhman MR, Aditama H. Developing Consensus Indicators to Assess Pharmacy Service Quality at Primary Health Centres in Yogyakarta, Indonesia. Malays J Med Sci 2019;26:110-21. [PMID: 31496900 DOI: 10.21315/mjms2019.26.4.13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
382 Boeckxstaens GE, Rydholm H, Lei A, Adler J, Ruth M. Effect of lesogaberan, a novel GABA(B)-receptor agonist, on transient lower oesophageal sphincter relaxations in male subjects. Aliment Pharmacol Ther. 2010;31:1208-1217. [PMID: 20222915 DOI: 10.1111/j.1365-2036.2010.04283.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
383 Chan Y, Ching JY, Cheung CM, Tsoi KK, Polder-Verkiel S, Pang SH, Quan WL, Kee KM, Chan FK, Sung JJ. Development and validation of a disease-specific quality of life questionnaire for gastro-oesophageal reflux disease: the GERD-QOL questionnaire. Aliment Pharmacol Ther. 2010;31:452-460. [PMID: 19878152 DOI: 10.1111/j.1365-2036.2009.04187.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
384 Quiding-Järbrink M, Bove M, Dahlén G. Infections of the esophagus and the stomach. Periodontol 2000 2009;49:166-78. [PMID: 19152533 DOI: 10.1111/j.1600-0757.2008.00280.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
385 Miura Y, Fukuda K, Maeda T, Kurosaka M. Gastroesophageal reflux disease in patients with rheumatoid arthritis. Modern Rheumatology 2014;24:291-5. [DOI: 10.3109/14397595.2013.843749] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
386 Havemann BD, Henderson CA, El-Serag HB. The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut. 2007;56:1654-1664. [PMID: 17682001 DOI: 10.1136/gut.2007.122465] [Cited by in Crossref: 162] [Cited by in F6Publishing: 130] [Article Influence: 11.6] [Reference Citation Analysis]
387 Allaix ME, Fisichella PM, Noth I, Mendez BM, Patti MG. The Pulmonary Side of Reflux Disease: from Heartburn to Lung Fibrosis. J Gastrointest Surg 2013;17:1526-35. [DOI: 10.1007/s11605-013-2208-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
388 Wu JC. Gastroesophageal reflux disease: an Asian perspective. J Gastroenterol Hepatol. 2008;23:1785-1793. [PMID: 19120871 DOI: 10.1111/j.1440-1746.2008.05684.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 5.3] [Reference Citation Analysis]
389 Keppler S, Mannara G, Marra F, Bornhorst GM. Characterization of raft-forming alginate suspensions formed in HCl or model food systems at varying pH levels to better simulate gastric postprandial conditions. Drug Dev Ind Pharm 2021;:1-11. [PMID: 34254865 DOI: 10.1080/03639045.2021.1954940] [Reference Citation Analysis]
390 Martinucci I, Natilli M, Lorenzoni V, Pappalardo L, Monreale A, Turchetti G, Pedreschi D, Marchi S, Barale R, de Bortoli N. Gastroesophageal reflux symptoms among Italian university students: epidemiology and dietary correlates using automatically recorded transactions. BMC Gastroenterol 2018;18:116. [PMID: 30016938 DOI: 10.1186/s12876-018-0832-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
391 Rasmussen S, Søndergaard J, Larsen PV, Balasubramaniam K, Elnegaard S, Svendsen RP, Andersen RS, Pedersen AF, Vedsted P, Jarbøl DE. The Danish Symptom Cohort: Questionnaire and Feasibility in the Nationwide Study on Symptom Experience and Healthcare-Seeking among 100 000 Individuals. Int J Family Med 2014;2014:187280. [PMID: 25147736 DOI: 10.1155/2014/187280] [Cited by in Crossref: 17] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
392 Geysen H, Michielsen S, Rommel N, Vanuytsel T, Tack J, Pauwels A. The gastro-sphincteric pressure gradient: A new parameter to diagnose a rumination episode. Neurogastroenterol Motil 2021;33:e14068. [PMID: 33350555 DOI: 10.1111/nmo.14068] [Reference Citation Analysis]
393 Sadiku E, Hasani E, Këlliçi I, Mone I, Kraja F, Kraja B, Burazeri G. Extra-esophageal symptoms in individuals with and without erosive esophagitis: a case-control study in Albania. BMC Gastroenterol 2021;21:76. [PMID: 33593300 DOI: 10.1186/s12876-021-01658-z] [Reference Citation Analysis]
394 Vakil N, Björck K, Denison H, Halling K, Karlsson M, Paty J, Silberg DG, Rydén A. Validation of the reflux symptom questionnaire electronic diary in partial responders to proton pump inhibitor therapy. Clin Transl Gastroenterol 2012;3:e7. [PMID: 23238029 DOI: 10.1038/ctg.2012.1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
395 Liu Q, Feng CC, Wang EM, Yan XJ, Chen SL. Efficacy of mosapride plus proton pump inhibitors for treatment of gastroesophageal reflux disease: a systematic review. World J Gastroenterol. 2013;19:9111-9118. [PMID: 24379638 DOI: org/10.3748/wjg.v19.i47.9111] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
396 Ventrella D, Salaroli R, Elmi A, Carnevali G, Forni M, Baldi F, Bacci ML. A novel ex vivo porcine model of acid-induced esophageal damage for preliminary functional evaluations of anti-gastroesophageal reflux disease medical devices. Vet World 2020;13:2728-35. [PMID: 33487991 DOI: 10.14202/vetworld.2020.2728-2735] [Reference Citation Analysis]
397 Lee SB, Jeon KM, Kim BS, Kim KC, Jung HY, Choi YB. Early experiences of minimally invasive surgery to treat gastroesophageal reflux disease. J Korean Surg Soc 2013;84:330-7. [PMID: 23741690 DOI: 10.4174/jkss.2013.84.6.330] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
398 Rydén A, Leavy OC, Halling K, Stone AA. Comparison of Daily versus Weekly Recording of Gastroesophageal Reflux Disease Symptoms in Patients with a Partial Response to Proton Pump Inhibitor Therapy. Value Health 2016;19:829-33. [PMID: 27712711 DOI: 10.1016/j.jval.2016.05.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
399 Murase K, Tabara Y, Takahashi Y, Muro S, Yamada R, Setoh K, Kawaguchi T, Kadotani H, Kosugi S, Sekine A, Nakayama T, Mishima M, Chiba T, Chin K, Matsuda F. Gastroesophageal reflux disease symptoms and dietary behaviors are significant correlates of short sleep duration in the general population: the Nagahama Study. Sleep 2014;37:1809-15. [PMID: 25364076 DOI: 10.5665/sleep.4176] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
400 Rugge M, Fassan M, Zaninotto G, Pizzi M, Giacomelli L, Battaglia G, Rizzetto C, Parente P, Ancona E. Aurora kinase A in Barrett's carcinogenesis. Hum Pathol. 2010;41:1380-1386. [PMID: 20656315 DOI: 10.1016/j.humpath.2010.02.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
401 Genta RM, Spechler SJ, Kielhorn AF. The Los Angeles and Savary-Miller systems for grading esophagitis: utilization and correlation with histology: Poor correlation between endoscopic and histologic grading of esophagitis. Diseases of the Esophagus 2011;24:10-7. [DOI: 10.1111/j.1442-2050.2010.01092.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
402 Lechien JR, Bobin F, Muls V, Mouawad F, Dequanter D, Horoi M, Thill MP, Rodriguez Ruiz A, Saussez S. The efficacy of a personalised treatment depending on the characteristics of reflux at multichannel intraluminal impedance-pH monitoring in patients with acid, non-acid and mixed laryngopharyngeal reflux. Clin Otolaryngol 2021;46:602-13. [PMID: 33503317 DOI: 10.1111/coa.13722] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
403 Chiou E, Rosen R, Jiang H, Nurko S. Diagnosis of supra-esophageal gastric reflux: correlation of oropharyngeal pH with esophageal impedance monitoring for gastro-esophageal reflux. Neurogastroenterol Motil 2011;23:717-e326. [PMID: 21592256 DOI: 10.1111/j.1365-2982.2011.01726.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
404 Lottrup C, Krarup AL, Gregersen H, Ejstrud P, Drewes AM. Patients with Barrett's esophagus are hypersensitive to acid but hyposensitive to other stimuli compared with healthy controls. Neurogastroenterol Motil 2017;29:e12992. [DOI: 10.1111/nmo.12992] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
405 Pace F, Pallotta S, Tonini M, Vakil N, Bianchi Porro G. Systematic review: gastro-oesophageal reflux disease and dental lesions: SYSTEMATIC REVIEW: DENTAL EROSIONS AND GERD. Alimentary Pharmacology & Therapeutics 2008;27:1179-86. [DOI: 10.1111/j.1365-2036.2008.03694.x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 68] [Article Influence: 7.3] [Reference Citation Analysis]
406 Bredenoord AJ, Smout AJ. Refractory gastrooesophageal reflux disease: . European Journal of Gastroenterology & Hepatology 2008;20:217-23. [DOI: 10.1097/meg.0b013e3282f1cc39] [Cited by in Crossref: 25] [Cited by in F6Publishing: 4] [Article Influence: 1.9] [Reference Citation Analysis]
407 Miyatani H, Mashima H, Sekine M, Matsumoto S. Clinical course of biliary-type sphincter of Oddi dysfunction: endoscopic sphincterotomy and functional dyspepsia as affecting factors. Ther Adv Gastrointest Endosc 2019;12:2631774519867184. [PMID: 31448369 DOI: 10.1177/2631774519867184] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
408 Lei WY, Vaezi MF, Naik RD, Chen CL. Mucosal impedance testing: A new diagnostic testing in gastroesophageal reflux disease. J Formos Med Assoc 2020;119:1575-80. [PMID: 31542333 DOI: 10.1016/j.jfma.2019.08.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
409 Shrivastava MS, Hussain Z, Giricz O, Shenoy N, Polineni R, Maitra A, Verma A. Targeting chemokine pathways in esophageal adenocarcinoma. Cell Cycle 2014;13:3320-7. [PMID: 25485576 DOI: 10.4161/15384101.2014.968426] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
410 Zerbib F, Simon M. Novel therapeutics for gastro-esophageal reflux symptoms. Expert Rev Clin Pharmacol. 2012;5:533-541. [PMID: 23121276 DOI: 10.1586/ecp.12.38] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
411 Kinoshita Y, Kato M, Fujishiro M, Masuyama H, Nakata R, Abe H, Kumagai S, Fukushima Y, Okubo Y, Hojo S, Kusano M. Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study. J Gastroenterol 2018;53:834-44. [PMID: 29188387 DOI: 10.1007/s00535-017-1417-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
412 Higo T, Mukaisho K, Ling ZQ, Oue K, Chen KH, Araki Y, Sugihara H, Yamamoto G, Hattori T. An animal model of intrinsic dental erosion caused by gastro-oesophageal reflux disease. Oral Dis 2009;15:360-5. [PMID: 19371399 DOI: 10.1111/j.1601-0825.2009.01561.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
413 Fakhre Yaseri H. Gender is a risk factor in patients with gastroesophageal reflux disease. Med J Islam Repub Iran 2017;31:58. [PMID: 29445687 DOI: 10.14196/mjiri.31.58] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
414 Andersson O, Rydén A, Ruth M, Möller RY, Finizia C. Development and validation of a laryngopharyngeal reflux questionnaire, the Pharyngeal Reflux Symptom Questionnaire. Scandinavian Journal of Gastroenterology 2010;45:147-59. [DOI: 10.3109/00365520903453166] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
415 Koshino K, Adachi K, Furuta K, Ohara S, Morita T, Nakata S, Tanimura T, Miki M, Kinoshita Y. Effects of mosapride on esophageal functions and gastroesophageal reflux. J Gastroenterol Hepatol. 2010;25:1066-1071. [PMID: 20594220 DOI: 10.1111/j.1440-1746.2010.06280.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
416 Song JY, Kim HH, Cho EJ, Kim TY. The relationship between gastroesophageal reflux disease and chronic periodontitis. Gut Liver 2014;8:35-40. [PMID: 24516699 DOI: 10.5009/gnl.2014.8.1.35] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
417 Cho JH, Kim HM, Ko GJ, Woo ML, Moon CM, Kim YJ, Han KJ, Song SY, Cho HG. Old age and male sex are associated with increased risk of asymptomatic erosive esophagitis: analysis of data from local health examinations by the Korean National Health Insurance Corporation. J Gastroenterol Hepatol. 2011;26:1034-1038. [PMID: 21299618 DOI: 10.1111/j.1440-1746.2011.06686.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
418 Armstrong D. Symptom Assessment: Methods and Content. Journal of Clinical Gastroenterology 2007;41:S184-92. [DOI: 10.1097/mcg.0b013e318042d636] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
419 Namasivayam V, Arora AS, Murray JA. Weakly acidic reflux. Dis Esophagus 2011;24:56-62. [PMID: 20659138 DOI: 10.1111/j.1442-2050.2010.01100.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
420 Park JM, Kim BJ, Kim JG, Chi KC. Factors predicting outcomes of laparoscopic Nissen fundoplication for gastroesophageal reflux disease: experience at a single institution in Korea. Ann Surg Treat Res 2017;92:184-90. [PMID: 28382290 DOI: 10.4174/astr.2017.92.4.184] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
421 Kim SY, Park B, Lim H, Kim M, Kong IG, Choi HG. Increased risk of larynx cancer in patients with gastroesophageal reflux disease from a national sample cohort. Clin Otolaryngol 2019;44:534-40. [DOI: 10.1111/coa.13328] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
422 Zikos TA, Triadafilopoulos G, Kamal A, Podboy A, Sonu IS, Regalia KA, Nandwani MC, Nguyen LA, Fernandez-Becker NQ, Clarke JO. Baseline impedance via manometry and ambulatory reflux testing are not equivalent when utilized in the evaluation of potential extra-esophageal gastroesophageal reflux disease. J Thorac Dis 2020;12:5628-38. [PMID: 33209395 DOI: 10.21037/jtd-20-1623] [Reference Citation Analysis]
423 Jeong ID, Park MI, Kim SE, Kim BJ, Kim SW, Kim JH, Sung HY, Oh TH, Kim YS; Korean Society of Neurogastroenterology and Motility, GERD and Esophageal Function Research Committee. The Degree of Disease Knowledge in Patients with Gastroesophageal Reflux Disease: A Multi-center Prospective Study in Korea. J Neurogastroenterol Motil 2017;23:385-91. [PMID: 28478662 DOI: 10.5056/jnm16123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
424 Frandsen LT, Westmark S, Melgaard D, Krarup AL. Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis-Results from the population-based DanEoE cohort shows a low complication rate. United European Gastroenterol J 2021;9:910-8. [PMID: 34477326 DOI: 10.1002/ueg2.12146] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
425 Romano L, Granata L, Fusco F, Napolitano L, Cerbone R, Priadko K, Sciorio C, Mirone V, Romano M. Sexual Dysfunction in Patients With Chronic Gastrointestinal and Liver Diseases: A neglected Issue. Sex Med Rev 2021:S2050-0521(21)00039-1. [PMID: 34353738 DOI: 10.1016/j.sxmr.2021.02.002] [Reference Citation Analysis]
426 Ashida K, Kinoshita Y, Hongo M; The Japan Rabeprazole Study Group for NERD. Acid-Suppressive Effect of Rabeprazole 5 mg and 10 mg Once Daily by 24-Hour Esophageal pH Monitoring in Patients with Non-erosive Reflux Disease in Japan: A Multicenter, Randomized, Parallel-Group, Double-Blind Pharmacodynamic Study. Dig Dis Sci 2011;56:2333-42. [DOI: 10.1007/s10620-011-1583-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
427 Labenz J, Feußner H. Therapieresistente Refluxkrankheit: Wie und wie lange medikamentös therapieren? Wann operieren? Gastroenterologe 2009;4:393-402. [DOI: 10.1007/s11377-009-0290-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
428 Tripathi M, Streutker CJ, Marginean EC. Relevance of histology in the diagnosis of reflux esophagitis. Ann N Y Acad Sci 2018;1434:94-101. [PMID: 29766511 DOI: 10.1111/nyas.13742] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
429 Matsumoto K, Suenaga M, Mizutani Y, Matsui K, Yoshida A, Nakamoto T, Kato S. Role of transient receptor potential vanilloid subtype 2 in lower oesophageal sphincter in rat acid reflux oesophagitis. J Pharmacol Sci 2021;146:125-35. [PMID: 34030795 DOI: 10.1016/j.jphs.2021.03.010] [Reference Citation Analysis]
430 Frazzoni M, Conigliaro R, Melotti G. Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor-resistant reflux oesophagitis. Aliment Pharmacol Ther. 2011;33:601-606. [PMID: 21198705 DOI: 10.1111/j.1365-2036.2010.04550.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
431 Ahmed S, Jamil S, Shaikh H, Abbasi M. Effects of Life style factors on the symptoms of gastro esophageal reflux disease: A cross sectional study in a Pakistani population. Pak J Med Sci 2020;36:115-20. [PMID: 32063943 DOI: 10.12669/pjms.36.2.1371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
432 Danjo A, Yamaguchi K, Fujimoto K, Saitoh T, Inamori M, Ando T, Shimatani T, Adachi K, Kinjo F, Kuribayashi S. Comparison of endoscopic findings with symptom assessment systems (FSSG and QUEST) for gastroesophageal reflux disease in Japanese centres. J Gastroenterol Hepatol. 2009;24:633-638. [PMID: 19220681 DOI: 10.1111/j.1440-1746.2008.05747.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
433 Stanghellini V, Tosetti C, Benedetto E, Condoluci M, De Bastiani R, Cogliandro R, Mastronuzzi T, De Polo M, Di Mita F, Napoli L, Ubaldi E, Nebiacolombo C, Cottone C, Grattagliano I, Zamparella M, Baldi E, Sanna G. Nickel sensitization in patients with gastro-esophageal reflux disease. United European Gastroenterol J 2016;4:184-90. [PMID: 27087945 DOI: 10.1177/2050640615595917] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
434 Wang AJ, Liang MJ, Jiang AY, Lin JK, Xiao YL, Peng S, Chen J, Wen WP, Chen MH. Predictors of acid suppression success in patients with chronic laryngitis. Neurogastroenterol Motil. 2012;24:432-437, e210. [PMID: 22276941 DOI: 10.1111/j.1365-2982.2011.01873.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
435 Cheng FK, Albert DM, Maydonovitch CL, Wong RK, Moawad FJ. Categorization of patients with reflux symptoms referred for pH and impedance testing while off therapy. Clin Gastroenterol Hepatol 2015;13:867-73. [PMID: 25445765 DOI: 10.1016/j.cgh.2014.10.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
436 Zhang H, Gao W, Wang L, Suzhen, Gao Y, Liu B, Zhou H, Fang D. A population-based study on prevalence and risk factors of gastroesophageal reflux disease in the Tibet Autonomous Region, China. PeerJ 2019;7:e6491. [PMID: 30842901 DOI: 10.7717/peerj.6491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
437 Fan WJ, Hou YT, Sun XH, Li XQ, Wang ZF, Guo M, Zhu LM, Wang N, Yu K, Li JN, Ke MY, Fang XC. Effect of high-fat, standard, and functional food meals on esophageal and gastric pH in patients with gastroesophageal reflux disease and healthy subjects. J Dig Dis 2018;19:664-73. [PMID: 30270576 DOI: 10.1111/1751-2980.12676] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
438 Dent J, Becher A, Sung J, Zou D, Agréus L, Bazzoli F. Systematic review: patterns of reflux-induced symptoms and esophageal endoscopic findings in large-scale surveys. Clin Gastroenterol Hepatol 2012;10:863-873.e3. [PMID: 22401904 DOI: 10.1016/j.cgh.2012.02.028] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
439 Chassany O, Holtmann G, Malagelada J, Gebauer U, Doerfler H, Devault K. Systematic review: health-related quality of life (HRQOL) questionnaires in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2008;27:1053-70. [PMID: 18363898 DOI: 10.1111/j.1365-2036.2008.03683.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
440 Jones R, Charlton J, Latinovic R, Gulliford MC. Alarm symptoms and identification of non-cancer diagnoses in primary care: cohort study. BMJ 2009;339:b3094. [PMID: 19679615 DOI: 10.1136/bmj.b3094] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
441 Lee SW, Lee TY, Lien HC, Yang SS, Yeh HZ, Chang CS. Characteristics of symptom presentation and risk factors in patients with erosive esophagitis and nonerosive reflux disease. Med Princ Pract 2014;23:460-4. [PMID: 25012767 DOI: 10.1159/000363661] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
442 Zamani M, Alizadeh-Tabari S, Hasanpour AH, Eusebi LH, Ford AC. Systematic review with meta-analysis: association of Helicobacter pylori infection with gastro-oesophageal reflux and its complications. Aliment Pharmacol Ther 2021;54:988-98. [PMID: 34437710 DOI: 10.1111/apt.16585] [Reference Citation Analysis]
443 Kirti YK. Reflux Finding Score (RFS) a Quantitative Guide for Diagnosis and Treatment of Laryngopharyngeal Reflux. Indian J Otolaryngol Head Neck Surg. 2018;70:362-365. [PMID: 30211090 DOI: 10.1007/s12070-018-1350-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
444 Selleslagh M, van Oudenhove L, Pauwels A, Tack J, Rommel N. The complexity of globus: a multidisciplinary perspective. Nat Rev Gastroenterol Hepatol 2014;11:220-33. [PMID: 24296583 DOI: 10.1038/nrgastro.2013.221] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
445 Patel DA, Sharda R, Choksi YA, Slaughter JC, Higginbotham T, Garrett CG, Francis DO, Ravi K, Hasak S, Katzka D, Gyawali CP, Vaezi MF. Model to Select On-Therapy vs Off-Therapy Tests for Patients With Refractory Esophageal or Extraesophageal Symptoms. Gastroenterology 2018;155:1729-1740.e1. [PMID: 30170117 DOI: 10.1053/j.gastro.2018.08.038] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
446 Frazzoni M, de Bortoli N, Frazzoni L, Tolone S, Savarino V, Savarino E. Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives. Dig Dis Sci. 2017;62:1881-1889. [PMID: 28550489 DOI: 10.1007/s10620-017-4625-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 8.5] [Reference Citation Analysis]
447 Gibson PG, Chang AB, Glasgow NJ, Holmes PW, Katelaris P, Kemp AS, Landau LI, Mazzone S, Newcombe P, Van Asperen P, Vertigan AE; CICADA. CICADA: Cough in Children and Adults: Diagnosis and Assessment. Australian cough guidelines summary statement. Med J Aust 2010;192:265-71. [PMID: 20201760 DOI: 10.5694/j.1326-5377.2010.tb03504.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 76] [Article Influence: 7.9] [Reference Citation Analysis]
448 Heimgartner B, Herzig M, Borbély Y, Kröll D, Nett P, Tutuian R. Symptoms, endoscopic findings and reflux monitoring results in candidates for bariatric surgery. Digestive and Liver Disease 2017;49:750-6. [DOI: 10.1016/j.dld.2017.01.165] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
449 Greene CL, Mcfadden PM. The surgeon's perspective on oesophageal disease, and what it means to pathologists. J Clin Pathol 2014;67:913-8. [DOI: 10.1136/jclinpath-2014-202518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
450 Kahrilas PJ. Regurgitation matters. Gut 2021;70:445-6. [PMID: 32694175 DOI: 10.1136/gutjnl-2020-321786] [Reference Citation Analysis]
451 Lim HC, Kim JH, Youn YH, Lee EH, Lee BK, Park H. Effects of the Addition of Mosapride to Gastroesophageal Reflux Disease Patients on Proton Pump Inhibitor: A Prospective Randomized, Double-blind Study. J Neurogastroenterol Motil. 2013;19:495-502. [PMID: 24199010 DOI: 10.5056/jnm.2013.19.4.495] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
452 Mouly S, Charlemagne A, Lejeunne P, Fagnani F. Therapeutic management of uncomplicated gastroesophageal reflux disease in france in 2005: Potential cost savings of omeprazole substitution. Curr Ther Res Clin Exp 2009;70:282-98. [PMID: 24683238 DOI: 10.1016/j.curtheres.2009.07.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
453 Ďurč P, Dosedělová V, Foret F, Dolina J, Konečný Š, Himmelsbach M, Buchberger W, Kubáň P. Analysis of major bile acids in saliva samples of patients with Barrett's esophagus using high-performance liquid chromatography-electrospray ionization-mass spectrometry. J Chromatogr A 2020;1625:461278. [PMID: 32709330 DOI: 10.1016/j.chroma.2020.461278] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
454 Yang XJ, Gan T, Wang L, Liao Z, Tao XH, Shen W, Zhao XY. Wireless esophageal pH capsule for patients with gastroesophageal reflux disease: A multicenter clinical study. World J Gastroenterol 2014; 20(40): 14865-14874 [PMID: 25356046 DOI: 10.3748/wjg.v20.i40.14865] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
455 Dore MP, Pes GM, Bassotti G, Farina MA, Marras G, Graham DY. Risk factors for erosive and non-erosive gastroesophageal reflux disease and Barrett's esophagus in Nothern Sardinia. Scandinavian Journal of Gastroenterology 2016;51:1281-7. [DOI: 10.1080/00365521.2016.1200137] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
456 Wood RK. Esophageal Dysmotility, Gastro-esophageal Reflux Disease, and Lung Transplantation: What Is the Evidence? Curr Gastroenterol Rep 2015;17:48. [PMID: 26454656 DOI: 10.1007/s11894-015-0474-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
457 Lundin P, Karpefors M, Carlsson K, Hansen MB, Ruth M. Bioimpedance spectroscopy: a new tool to assess early esophageal changes linked to gastroesophageal reflux disease?: Bioimpedance evaluation in GERD. Diseases of the Esophagus 2011;24:462-9. [DOI: 10.1111/j.1442-2050.2011.01181.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
458 Bonavina L, Saino G, Lipham JC, Demeester TR. LINX(®) Reflux Management System in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux. Therap Adv Gastroenterol 2013;6:261-8. [PMID: 23814607 DOI: 10.1177/1756283X13486311] [Cited by in Crossref: 45] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
459 Beltsis A, Katsinelos P, Kountouras J, Kamarianis N, Zavos C, Pournaras A, Kapetanos D, Fasoulas K, Zamboulis C, Eugenidis N. Double probe pH-monitoring findings in patients with benign lesions of the true vocal folds: comparison with typical GERD and the effect of smoking. Eur Arch Otorhinolaryngol 2011;268:1169-74. [DOI: 10.1007/s00405-011-1572-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
460 Boeckxstaens GE, Smout A. Systematic review: role of acid, weakly acidic and weakly alkaline reflux in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2010;32:334-343. [PMID: 20491749 DOI: 10.1111/j.1365-2036.2010.04358.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 75] [Article Influence: 7.4] [Reference Citation Analysis]
461 Mcdonnell MJ, Rutherford RM. Other Predisposing Factors for Bronchiectasis. In: Chalmers J, Polverino E, Aliberti S, editors. Bronchiectasis. Cham: Springer International Publishing; 2018. pp. 129-45. [DOI: 10.1007/978-3-319-61452-6_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
462 Kahrilas PJ. Editorial: time to retire Rome IV and the Montreal definition? Aliment Pharmacol Ther 2021;54:1081-2. [PMID: 34564883 DOI: 10.1111/apt.16572] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
463 Dal-Paz K, Moraes-Filho JP, Navarro-Rodriguez T, Eisig JN, Barbuti R, Quigley EM. Low levels of adherence with proton pump inhibitor therapy contribute to therapeutic failure in gastroesophageal reflux disease. Dis Esophagus. 2012;25:107-113. [PMID: 21777341 DOI: 10.1111/j.1442-2050.2011.01227.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
464 Parekh PJ, Oldfield EC, Johnson DA. Treatment of gastroesophageal reflux disease: two new oral formulations dexlansoprazole MR and esomezol (esomeprazole strontium). Expert Opinion on Pharmacotherapy 2014;15:1215-22. [DOI: 10.1517/14656566.2014.911841] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
465 Maradey-Romero C, Fass R. New and future drug development for gastroesophageal reflux disease. J Neurogastroenterol Motil. 2014;20:6-16. [PMID: 24466441 DOI: 10.5056/jnm.2014.20.1.6] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 5.5] [Reference Citation Analysis]
466 Zheng Z, Margolis KL, Liu S, Tinker LF, Ye W, Women’s Health Initiative Investigators. Effects of estrogen with and without progestin and obesity on symptomatic gastroesophageal reflux. Gastroenterology. 2008;135:72-81. [PMID: 18502208 DOI: 10.1053/j.gastro.2008.03.039] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
467 Salem SB, Kushner Y, Marcus V, Mayrand S, Fallone CA, Barkun AN. The potential impact of contemporary developments in the management of patients with gastroesophageal reflux disease undergoing an initial gastroscopy. Can J Gastroenterol 2009;23:99-104. [PMID: 19214284 DOI: 10.1155/2009/859271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
468 Erriu M, Pili FM, Cadoni S, Garau V. Diagnosis of Lingual Atrophic Conditions: Associations with Local and Systemic Factors. A Descriptive Review. Open Dent J 2016;10:619-35. [PMID: 27990187 DOI: 10.2174/1874210601610010619] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
469 Iwakiri K, Kinoshita Y, Habu Y, Oshima T, Manabe N, Fujiwara Y, Nagahara A, Kawamura O, Iwakiri R, Ozawa S, Ashida K, Ohara S, Kashiwagi H, Adachi K, Higuchi K, Miwa H, Fujimoto K, Kusano M, Hoshihara Y, Kawano T, Haruma K, Hongo M, Sugano K, Watanabe M, Shimosegawa T. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015. J Gastroenterol. 2016;51:751-767. [PMID: 27325300 DOI: 10.1007/s00535-016-1227-8] [Cited by in Crossref: 142] [Cited by in F6Publishing: 115] [Article Influence: 28.4] [Reference Citation Analysis]
470 Savarino V, Pace F, Scarpignato C; Esoxx Study Group. Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation. Aliment Pharmacol Ther 2017;45:631-42. [PMID: 28116754 DOI: 10.1111/apt.13914] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
471 Kimang'a A, Revathi G, Kariuki S, Sayed S, Devani S, Vivienne M, Kuester D, Mönkemüller K, Malfertheiner P, Wex T. IL-17A and IL-17F gene expression is strongly induced in the mucosa of H. pylori-infected subjects from Kenya and Germany. Scand J Immunol. 2010;72:522-528. [PMID: 21044126 DOI: 10.1111/j.1365-3083.2010.02469.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
472 Fujiwara Y, Arakawa T, Fass R. Gastroesophageal Reflux Disease and Sleep. Gastroenterology Clinics of North America 2013;42:57-70. [DOI: 10.1016/j.gtc.2012.11.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
473 Maret-Ouda J, Wahlin K, Artama M, Brusselaers N, Färkkilä M, Lynge E, Mattsson F, Pukkala E, Romundstad P, Tryggvadóttir L, von Euler-Chelpin M, Lagergren J. Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries. JAMA Oncol 2018;4:1576-82. [PMID: 30422249 DOI: 10.1001/jamaoncol.2018.3054] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
474 Cho JH, Shin CM, Yoon H, Park YS, Kim N, Lee DH. Efficacy of a high-dose proton pump inhibitor in patients with gastroesophageal reflux disease: a single center, randomized, open-label trial. BMC Gastroenterol 2020;20:275. [PMID: 32811427 DOI: 10.1186/s12876-020-01410-z] [Reference Citation Analysis]
475 Noh YW, Jung HK, Kim SE, Jung SA. Overlap of Erosive and Non-erosive Reflux Diseases With Functional Gastrointestinal Disorders According to Rome III Criteria. J Neurogastroenterol Motil. 2010;16:148-156. [PMID: 20535345 DOI: 10.5056/jnm.2010.16.2.148] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 5.0] [Reference Citation Analysis]
476 Rubenstein JH, Chen JW. Epidemiology of gastroesophageal reflux disease. Gastroenterol Clin North Am. 2014;43:1-14. [PMID: 24503355 DOI: 10.1016/j.gtc.2013.11.006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 7.8] [Reference Citation Analysis]
477 Kim SY, Jung H, Lee HA. Normal acid exposure time in esophageal pH monitoring in Asian and Western populations: A systematic review and meta‐analysis. Neurogastroenterology & Motility 2021;33. [DOI: 10.1111/nmo.14029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
478 Sharma P, Wani S, Romero Y, Johnson D, Hamilton F. Racial and geographic issues in gastroesophageal reflux disease. Am J Gastroenterol. 2008;103:2669-2680. [PMID: 19032462 DOI: 10.1111/j.1572-0241.2008.02089.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
479 Hemmink GJ, Bredenoord AJ, Aanen MC, Weusten BL, Timmer R, Smout AJ. Computer analysis of 24-h esophageal impedance signals. Scand J Gastroenterol 2011;46:271-6. [PMID: 21073370 DOI: 10.3109/00365521.2010.531483] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
480 Ang D, Zheng Q, Shi L, Tack J. Diagnostic yield of ambulatory oesophageal studies on versus off proton pump inhibitors: a systematic review and meta-analysis. United European Gastroenterol J 2018;6:1294-306. [PMID: 30386602 DOI: 10.1177/2050640618772787] [Reference Citation Analysis]
481 Tantbirojn D, Pintado MR, Versluis A, Dunn C, Delong R. Quantitative analysis of tooth surface loss associated with gastroesophageal reflux disease. The Journal of the American Dental Association 2012;143:278-85. [DOI: 10.14219/jada.archive.2012.0153] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
482 Bonavina L, Fisichella PM, Gavini S, Lee YY, Tatum RP. Clinical course of gastroesophageal reflux disease and impact of treatment in symptomatic young patients. Ann N Y Acad Sci 2020;1481:117-26. [PMID: 32266986 DOI: 10.1111/nyas.14350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
483 Saruç M, Aksoy EA, Vardereli E, Karaaslan M, Ciçek B, Ince U, Oz F, Tözün N. Risk factors for laryngopharyngeal reflux. Eur Arch Otorhinolaryngol 2012;269:1189-94. [PMID: 22207531 DOI: 10.1007/s00405-011-1905-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
484 Becker V, Graf S, Schlag C, Schuster T, Feussner H, Schmid RM, Bajbouj M. First agreement analysis and day-to-day comparison of pharyngeal pH monitoring with pH/impedance monitoring in patients with suspected laryngopharyngeal reflux. J Gastrointest Surg. 2012;16:1096-1101. [PMID: 22450948 DOI: 10.1007/s11605-012-1866-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
485 Wahlqvist P, Karlsson M, Johnson D, Carlsson J, Bolge SC, Wallander MA. Relationship between symptom load of gastro-oesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort. Aliment Pharmacol Ther. 2008;27:960-970. [PMID: 18315585 DOI: 10.1111/j.1365-2036.2008.03671.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 4.5] [Reference Citation Analysis]
486 Rosen R, Vandenplas Y, Singendonk M, Cabana M, DiLorenzo C, Gottrand F, Gupta S, Langendam M, Staiano A, Thapar N, Tipnis N, Tabbers M. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2018;66:516-554. [PMID: 29470322 DOI: 10.1097/mpg.0000000000001889] [Cited by in Crossref: 258] [Cited by in F6Publishing: 74] [Article Influence: 129.0] [Reference Citation Analysis]
487 Zaninotto G, Attwood SEA. Surgical management of refractory gastro-oesophageal reflux. British Journal of Surgery 2010;97:139-40. [DOI: 10.1002/bjs.6863] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
488 Ham NS, Jang JY, Ryu SW, Kim JH, Park EJ, Lee WC, Shim KY, Jeong SW, Kim HG, Lee TH, Jeon SR, Cho JH, Cho JY, Jin SY, Lee JS. Magnifying endoscopy for the diagnosis of specialized intestinal metaplasia in short-segment Barrett’s esophagus. World J Gastroenterol 2013; 19(41): 7089-7096 [PMID: 24222952 DOI: 10.3748/wjg.v19.i41.7089] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
489 Miwa H, Haruma K, Sakamoto S, Sanada K, Hiroi S, Kinoshita Y. Demography and treatment response in patients with predominant non-erosive reflux disease or functional dyspepsia. J Gastroenterol Hepatol 2015;30:834-41. [PMID: 25559435 DOI: 10.1111/jgh.12877] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
490 汪晓奕, 朱凌云. 胃食管反流病中西医治疗的进展. 世界华人消化杂志 2014; 22(4): 488-493 [DOI: 10.11569/wcjd.v22.i4.488] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
491 Gyawali CP, Roman S, Bredenoord AJ, Fox M, Keller J, Pandolfino JE, Sifrim D, Tatum R, Yadlapati R, Savarino E; International GERD Consensus Working Group. Classification of esophageal motor findings in gastro-esophageal reflux disease: Conclusions from an international consensus group. Neurogastroenterol Motil 2017;29. [PMID: 28544357 DOI: 10.1111/nmo.13104] [Cited by in Crossref: 106] [Cited by in F6Publishing: 79] [Article Influence: 26.5] [Reference Citation Analysis]
492 Calabrese C, Treré D, Liguori G, Gabusi V, Vici M, Cenacchi G, Derenzini M, Febo GD. Esophageal cell proliferation in gastroesophageal reflux disease: Clinical-morphological data before and after pantoprazole. World J Gastroenterol 2009; 15(8): 936-941 [PMID: 19248192 DOI: 10.3748/wjg.15.936] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
493 Cammarota G, Masala G, Cianci R, Palli D, Bendinelli B, Galli J, Pandolfi F, Gasbarrini A, Landolfi R. Reflux symptoms in wind instrument players. Alimentary Pharmacology & Therapeutics 2010;31:593-600. [DOI: 10.1111/j.1365-2036.2009.04208.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
494 Martigne L, Delaage P, Thomas-delecourt F, Bonnelye G, Barthélémy P, Gottrand F. Prevalence and management of gastroesophageal reflux disease in children and adolescents: a nationwide cross-sectional observational study. Eur J Pediatr 2012;171:1767-73. [DOI: 10.1007/s00431-012-1807-4] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
495 Yadlapati R, Pandolfino JE. Personalized Approach in the Work-up and Management of Gastroesophageal Reflux Disease. Gastrointest Endosc Clin N Am 2020;30:227-38. [PMID: 32146943 DOI: 10.1016/j.giec.2019.12.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
496 Kahrilas PJ. Chronic cough and gastroesophageal reflux disease: new twists to the riddle. Gastroenterology. 2010;139:716-718. [PMID: 20659461 DOI: 10.1053/j.gastro.2010.07.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
497 Rippel SW, Acra S, Correa H, Vaezi M, Di Lorenzo C, Walker LS. Pediatric patients with dyspepsia have chronic symptoms, anxiety, and lower quality of life as adolescents and adults. Gastroenterology 2012;142:754-61. [PMID: 22226783 DOI: 10.1053/j.gastro.2011.12.043] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
498 Mönnikes H, Schwan T, van Rensburg C, Straszak A, Theek C, Sander P, Lühmann R. Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2012;35:1279-89. [PMID: 22486552 DOI: 10.1111/j.1365-2036.2012.05085.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
499 Lee KS, Song IS, Kim ES, Ahn KH. Determinants of Spontaneous Preterm Labor and Birth Including Gastroesophageal Reflux Disease and Periodontitis. J Korean Med Sci 2020;35:e105. [PMID: 32281316 DOI: 10.3346/jkms.2020.35.e105] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
500 Coronel MA, Bernardo WM, Moura DTHD, Moura ETHD, Ribeiro IB, Moura EGHD. THE EFFICACY OF THE DIFFERENT ENDOSCOPIC TREATMENTS VERSUS SHAM, PHARMACOLOGIC OR SURGICAL METHODS FOR CHRONIC GASTROESOPHAGEAL REFLUX DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. Arq Gastroenterol 2018;55:296-305. [DOI: 10.1590/s0004-2803.201800000-65] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
501 Wang SE, Kendall BJ, Hodge AM, Dixon-Suen SC, Dashti SG, Makalic E, Williamson EM, Thomas RJS, Giles GG, English DR. Demographic and lifestyle risk factors for gastroesophageal reflux disease and Barrett's esophagus in Australia. Dis Esophagus 2021:doab058. [PMID: 34409990 DOI: 10.1093/dote/doab058] [Reference Citation Analysis]
502 Ranaldo N, Losurdo G, Iannone A, Principi M, Barone M, De Carne M, Ierardi E, Di Leo A. Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease. Cell Death Dis 2017;8:e3040. [PMID: 28880273 DOI: 10.1038/cddis.2017.436] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
503 Yadlapati R, Masihi M, Gyawali CP, Carlson DA, Kahrilas PJ, Nix BD, Jain A, Triggs JR, Vaezi MF, Kia L, Kaizer A, Pandolfino JE. Ambulatory Reflux Monitoring Guides Proton Pump Inhibitor Discontinuation in Patients With Gastroesophageal Reflux Symptoms: A Clinical Trial. Gastroenterology 2021;160:174-182.e1. [PMID: 32949568 DOI: 10.1053/j.gastro.2020.09.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
504 Richter JE. Role of the gastric refluxate in gastroesophageal reflux disease: acid, weak acid and bile. Am J Med Sci. 2009;338:89-95. [PMID: 19590427 DOI: 10.1097/maj.0b013e3181ad584a] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
505 Kumar AR, Katz PO. Functional esophageal disorders: a review of diagnosis and management. Expert Rev Gastroenterol Hepatol 2013;7:453-61. [PMID: 23899284 DOI: 10.1586/17474124.2013.811028] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
506 Yang X, Lovell JF, Zhang Y. Ingestible Contrast Agents for Gastrointestinal Imaging. Chembiochem 2019;20:462-73. [PMID: 30421487 DOI: 10.1002/cbic.201800589] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
507 Kuo CJ, Lin CH, Liu NJ, Wu RC, Tang JH, Cheng CL. Frequency and risk factors for Barrett's esophagus in Taiwanese patients: a prospective study in a tertiary referral center. Dig Dis Sci. 2010;55:1337-1343. [PMID: 19557516 DOI: 10.1007/s10620-009-0872-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
508 Wu K, Rayner CK, Chuah S, Chiu Y, Chiu K, Hu T, Chiu C. Effect of liquid meals with different volumes on gastroesophageal reflux disease: Dietary volume on reflux disease. J Gastroenterol Hepatol 2014;29:469-73. [DOI: 10.1111/jgh.12457] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
509 Krarup AL, Drewes AM, Ejstrud P, Laurberg PT, Vyberg M. Implementation of a biopsy protocol to improve detection of esophageal eosinophilia: a Danish registry-based study. Endoscopy 2021;53:15-24. [PMID: 32757199 DOI: 10.1055/a-1206-0852] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
510 Bacci MR, Chehter EZ. Dyspepsia among patients with chronic kidney disease: a cross sectional study. Int Arch Med. 2013;6:43. [PMID: 24139477 DOI: 10.1186/1755-7682-6-43] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
511 Jansson C, Wallander MA, Johansson S, Johnsen R, Hveem K. Stressful psychosocial factors and symptoms of gastroesophageal reflux disease: a population-based study in Norway. Scand J Gastroenterol. 2010;45:21-29. [PMID: 19961344 DOI: 10.3109/00365520903401967] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
512 Sinn DH, Shin DH, Lim SW, Kim KM, Son HJ, Kim JJ, Rhee JC, Rhee PL. The speed of eating and functional dyspepsia in young women. Gut Liver 2010;4:173-8. [PMID: 20559518 DOI: 10.5009/gnl.2010.4.2.173] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
513 Ohara S, Kawano T, Kusano M, Kouzu T. Survey on the prevalence of GERD and FD based on the Montreal definition and the Rome III criteria among patients presenting with epigastric symptoms in Japan. J Gastroenterol. 2011;46:603-611. [PMID: 21359521 DOI: 10.1007/s00535-011-0382-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
514 Cardile S, Romano C. Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients. Adolesc Health Med Ther 2012;3:27-31. [PMID: 24600284 DOI: 10.2147/AHMT.S23193] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
515 Mello MD, Shriver AR, Li Y, Patel A, Gyawali CP. Ineffective esophageal motility phenotypes following fundoplication in gastroesophageal reflux disease. Neurogastroenterol Motil 2016;28:292-8. [PMID: 26575034 DOI: 10.1111/nmo.12728] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 7.5] [Reference Citation Analysis]
516 Rohof WO, Lei A, Hirsch DP, Ny L, Astrand M, Hansen MB, Boeckxstaens GE. The effects of a novel metabotropic glutamate receptor 5 antagonist (AZD2066) on transient lower oesophageal sphincter relaxations and reflux episodes in healthy volunteers. Aliment Pharmacol Ther. 2012;35:1231-1242. [PMID: 22469098 DOI: 10.1111/j.1365-2036.2012.05081.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
517 Oridate N, Tokashiki R, Watanabe Y, Taguchi A, Kawamura O, Fujimoto K. Endoscopic laryngeal findings in Japanese patients with laryngopharyngeal reflux symptoms. Int J Otolaryngol. 2012;2012:908154. [PMID: 22164174 DOI: 10.1155/2012/908154] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
518 Sun HB, Li Y, Liu XB, Zhang RX, Wang ZF, Zheng Y, Qin JJ, Li HM, Chen XK, Wu Z. Embedded Three-Layer Esophagogastric Anastomosis Reduces Morbidity and Improves Short-Term Outcomes After Esophagectomy for Cancer. Ann Thorac Surg. 2016;101:1131-1138. [PMID: 26687140 DOI: 10.1016/j.athoracsur.2015.09.094] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
519 Liang WT, Wang ZG, Wang F, Yang Y, Hu ZW, Liu JJ, Zhu GC, Zhang C, Wu JM. Long-term outcomes of patients with refractory gastroesophageal reflux disease following a minimally invasive endoscopic procedure: a prospective observational study. BMC Gastroenterol 2014;14:178. [PMID: 25304252 DOI: 10.1186/1471-230X-14-178] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
520 Ang D, Xu Y, Ang TL, Law NM, Poh CH, Teo EK, Fock KM. Wireless oesophageal pH monitoring: Establishing values in a multiracial cohort of asymptomatic Asian subjects. Digestive and Liver Disease 2013;45:371-6. [DOI: 10.1016/j.dld.2012.11.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
521 Pilone V, Vitiello A, Hasani A, Di Micco R, Monda A, Izzo G, Forestieri P. Laparoscopic adjustable gastric banding outcomes in patients with gastroesophageal reflux disease or hiatal hernia. Obes Surg. 2015;25:290-294. [PMID: 25030091 DOI: 10.1007/s11695-014-1366-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
522 Darbà J, Kaskens L, Plans P, Elizalde JI, Coma M, Cuomo R, Santoiemma L, Geldmacher J. Epidemiology and societal costs of gastroesophageal reflux disease and Barrett's syndrome in Germany, Italy and Spain. Expert Rev Pharmacoecon Outcomes Res 2011;11:225-32. [PMID: 21476824 DOI: 10.1586/erp.11.5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
523 Moraes-Filho JP, Navarro-Rodriguez T, Eisig JN, Barbuti RC, Chinzon D, Quigley EM. Comorbidities are frequent in patients with gastroesophageal reflux disease in a tertiary health care hospital. Clinics (Sao Paulo). 2009;64:785-790. [PMID: 19690664 DOI: 10.1590/s1807-59322009000800013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
524 Tamura Y, Funaki Y, Izawa S, Iida A, Yamaguchi Y, Adachi K, Ogasawara N, Sasaki M, Kaneko H, Kasugai K. Pathophysiology of functional heartburn based on Rome III criteria in Japanese patients. World J Gastroenterol 2015; 21(16): 5009-5016 [PMID: 25945016 DOI: 10.3748/wjg.v21.i16.5009] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
525 Thompson W, Black C, Welch V, Farrell B, Bjerre LM, Tugwell P. Patient Values and Preferences Surrounding Proton Pump Inhibitor Use: A Scoping Review. Patient 2018;11:17-28. [DOI: 10.1007/s40271-017-0258-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
526 Lin Y, Yngve A, Lagergren J, Lu Y. A dietary pattern rich in lignans, quercetin and resveratrol decreases the risk of oesophageal cancer. Br J Nutr 2014;112:2002-9. [PMID: 25345471 DOI: 10.1017/S0007114514003055] [Cited by in Crossref: 34] [Cited by in F6Publishing: 15] [Article Influence: 4.9] [Reference Citation Analysis]
527 Perry KA, Pham TH, Spechler SJ, Hunter JG, Melvin WS, Velanovich V. 2014 SSAT State-of-the-Art Conference: Advances in Diagnosis and Management of Gastroesophageal Reflux Disease. J Gastrointest Surg 2015;19:458-66. [DOI: 10.1007/s11605-014-2724-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
528 Ahmadi M, Amiri M, Rezaeian T, Abdollahi I, Rezadoost AM, Sohrabi M, Bakhshi E. Different Effects of Aerobic Exercise and Diaphragmatic Breathing on Lower Esophageal Sphincter Pressure and Quality of Life in Patients with Reflux: A Comparative Study. Middle East J Dig Dis 2021;13:61-6. [PMID: 34712440 DOI: 10.34172/mejdd.2021.205] [Reference Citation Analysis]
529 Weijenborg PW, Cremonini F, Smout AJ, Bredenoord AJ. PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis. Neurogastroenterol Motil. 2012;24:747-757, e350. [PMID: 22309489 DOI: 10.1111/j.1365-2982.2012.01888.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 76] [Article Influence: 9.8] [Reference Citation Analysis]
530 Wang PC, Hsu CS, Tseng TC, Hsieh TC, Chen CH, Su WC, Lin HH, Wang CC. Male sex, hiatus hernia, and Helicobacter pylori infection associated with asymptomatic erosive esophagitis. J Gastroenterol Hepatol. 2012;27:586-591. [PMID: 21871022 DOI: 10.1111/j.1440-1746.2011.06881.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
531 Mastracci L, Fiocca R, Engström C, Attwood S, Ell C, Galmiche JP, Hatlebakk JG, Långström G, Eklund S, Lind T, Lundell L. The dynamics of the oesophageal squamous epithelium ‘normalisation’ process in patients with gastro-oesophageal reflux disease treated with long-term acid suppression or anti-reflux surgery. Aliment Pharmacol Ther 2017;45:1339-49. [DOI: 10.1111/apt.14038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
532 Bansal A, Kahrilas PJ. Treatment of GERD complications (Barrett's, peptic stricture) and extra-oesophageal syndromes. Best Pract Res Clin Gastroenterol 2010;24:961-8. [PMID: 21126707 DOI: 10.1016/j.bpg.2010.09.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
533 Scarpellini E, Pauwels A, Vos R, Rommel N, Tack J. Effect of methylnaltrexone and naloxone on esophageal motor function in man. Neurogastroenterol Motil 2017;29:e12938. [DOI: 10.1111/nmo.12938] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
534 Mochizuki N, Fujita T, Kobayashi M, Yamazaki Y, Terao S, Sanuki T, Okada A, Adachi M, Murakami M, Arisaka Y, Uno K, Masuda A, Yoshida M, Umegaki E, Kutsumi H, Azuma T. Factors associated with the presentation of erosive esophagitis symptoms in health checkup subjects: A prospective, multicenter cohort study. PLoS One 2018;13:e0196848. [PMID: 29723303 DOI: 10.1371/journal.pone.0196848] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
535 Chiu J, Wu J, Ni Y. Correlation Between Gastroesophageal Reflux Disease Questionnaire and Erosive Esophagitis in School-aged Children Receiving Endoscopy. Pediatrics & Neonatology 2014;55:439-43. [DOI: 10.1016/j.pedneo.2014.01.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
536 Sun J, Yang C, Zhao H, Zheng P, Wilkinson J, Ng B, Yuan Y. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China. Aliment Pharmacol Ther 2015;42:845-54. [PMID: 26228097 DOI: 10.1111/apt.13334] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
537 Crispino P, Alò PL, Rivera M, Barillà D, Nardi F, Mariotti M, Giancarlo Z, Botti C, Pica R, Cassieri C, Unim H, Paoluzi P. Evaluation of fatty acid synthase expression in oesophageal mucosa of patients with oesophagitis, Barrett's oesophagus and adenocarcinoma. J Cancer Res Clin Oncol 2009;135:1533-41. [PMID: 19471962 DOI: 10.1007/s00432-009-0600-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
538 Zhang H, Yang Z, Ni Z, Shi Y. A Meta-Analysis and Systematic Review of the Efficacy of Twice Daily PPIs versus Once Daily for Treatment of Gastroesophageal Reflux Disease. Gastroenterol Res Pract 2017;2017:9865963. [PMID: 28912807 DOI: 10.1155/2017/9865963] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
539 Ludvigsson JF, Aro P, Walker MM, Vieth M, Agréus L, Talley NJ, Murray JA, Ronkainen J. Celiac disease, eosinophilic esophagitis and gastroesophageal reflux disease, an adult population-based study. Scand J Gastroenterol 2013;48:808-14. [PMID: 23672638 DOI: 10.3109/00365521.2013.792389] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
540 Gweon TG, Park JH, Kim BW, Choi YK, Kim JS, Park SM, Kim CW, Kim HG, Chung JW; Incheon and Western Kyonggi Gastrointestinal Study. Additive Effects of Rebamipide Plus Proton Pump Inhibitors on the Expression of Tight Junction Proteins in a Rat Model of Gastro-Esophageal Reflux Disease. Gut Liver 2018;12:46-50. [PMID: 29069891 DOI: 10.5009/gnl17078] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
541 Kahrilas PJ, Keefer L, Pandolfino JE. Patients with refractory reflux symptoms: What do they have and how should they be managed? Neurogastroenterol Motil. 2015;27:1195-1201. [PMID: 26303047 DOI: 10.1111/nmo.12644] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
542 Carabotti M, Severi C, Leonetti F, De Angelis F, Iorio O, Corazziari E, Silecchia G. Upper gastrointestinal symptoms in obese patients and their outcomes after bariatric surgery. Expert Rev Gastroenterol Hepatol 2013;7:115-26. [PMID: 23363261 DOI: 10.1586/egh.12.81] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
543 Zullo A, Hassan C, Repici A, Bruzzese V. Helicobacter pylori eradication and reflux disease onset: Did gastric acid get "crazy"? World J Gastroenterol 2013; 19(6): 786-789 [PMID: 23429673 DOI: 10.3748/wjg.v19.i6.786] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
544 Lagergren J, Ye W, Lagergren P, Lu Y. The risk of esophageal adenocarcinoma after antireflux surgery. Gastroenterology. 2010;138:1297-1301. [PMID: 20080091 DOI: 10.1053/j.gastro.2010.01.004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
545 Bang KB, Park JH. Weight Loss as a Nonpharmacologic Strategy for Erosive Esophagitis: A 5-Year Follow-up Study. Gut Liver 2018;12:633-40. [PMID: 30037170 DOI: 10.5009/gnl18148] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
546 Lim CH, Choi MG, Baeg MK, Moon SJ, Kim JS, Cho YK, Park JM, Lee IS, Kim SW, Choi KY. Symptom characteristics and psychosomatic profiles in different spectrum of gastroesophageal reflux disease. Gut Liver 2014;8:165-9. [PMID: 24672658 DOI: 10.5009/gnl.2014.8.2.165] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
547 Dent J. Editorial: Better Ammunition for Use of Weight Loss in Managing Gastroesophageal Reflux Disease. American Journal of Gastroenterology 2013;108:383-5. [DOI: 10.1038/ajg.2012.473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
548 Miwa H, Koseki J, Oshima T, Kondo T, Tomita T, Watari J, Matsumoto T, Hattori T, Kubota K, Iizuka S. Rikkunshito, a traditional Japanese medicine, may relieve abdominal symptoms in rats with experimental esophagitis by improving the barrier function of epithelial cells in esophageal mucosa. J Gastroenterol. 2010;45:478-487. [PMID: 20016992 DOI: 10.1007/s00535-009-0180-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
549 Rengarajan A, Pomarat M, Zerbib F, Gyawali CP. Overlap of functional heartburn and reflux hypersensitivity with proven gastroesophageal reflux disease. Neurogastroenterology & Motility 2021;33. [DOI: 10.1111/nmo.14056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
550 Koop H. Medical Therapy of Gastroesophageal Reflux Disease Beyond Proton Pump Inhibitors: Where Are We Heading? Visc Med 2018;34:110-5. [PMID: 29888239 DOI: 10.1159/000486692] [Reference Citation Analysis]
551 Al-Sabah S, Akrouf S, Alhaddad M, Vaz JD. Management of gastroesophageal reflux disease and hiatal hernia post-sleeve gastrectomy: cardiopexy with ligamentum teres. Surg Obes Relat Dis 2017;13:2032-6. [PMID: 28986002 DOI: 10.1016/j.soard.2017.08.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
552 Malfertheiner P, Nocon M, Vieth M, Stolte M, Jaspersen D, Koelz HR, Labenz J, Leodolter A, Lind T, Richter K. Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care-the ProGERD study. Aliment Pharmacol Ther. 2012;35:154-164. [PMID: 22070159 DOI: 10.1111/j.1365-2036.2011.04901.x] [Cited by in Crossref: 100] [Cited by in F6Publishing: 55] [Article Influence: 10.0] [Reference Citation Analysis]
553 Yu Y, Gao F, Chen X, Zheng S, Zhang J. Changes in the distal esophageal microbiota in Chinese patients with reflux esophagitis. J Dig Dis. 2019;20:18-24. [PMID: 30520232 DOI: 10.1111/1751-2980.12692] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
554 Luo J, Lin H, Lu C, Chen T, Lin H, Li C, Liao W, Chang F, Lee S. Growth factors expression in patients with erosive esophagitis. Translational Research 2008;152:81-7. [DOI: 10.1016/j.trsl.2008.05.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
555 Dent J. Review article: from 1906 to 2006--a century of major evolution of understanding of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2006;24:1269-1281. [PMID: 17059509 DOI: 10.1111/j.1365-2036.2006.03122.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
556 Danilova DA, Bazaev AV, Gorbunova LI. [Current aspects of surgical treatment of gastro-esophageal reflux disease]. Khirurgiia (Mosk) 2020;:89-94. [PMID: 32105262 DOI: 10.17116/hirurgia202002189] [Reference Citation Analysis]
557 Zheng Z, Margolis KL, Liu S, Tinker LF, Ye W. Effects of estrogen with and without progestin and obesity on symptomatic gastroesophageal reflux. Gastroenterology. 2008;135:72-81. [PMID: 18502208 DOI: 10.1053/j.gastro.2008.03.039.effects] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
558 Bagheri Lankarani K, Sivandzadeh GR, Zare M, Nejati M, Niknam R, Taghavi AR, Ejtehadi F, Naini MA, Moini M, Anbardar MH, Peymani P. A preliminary report on the use of Midodrine in treating refractory gastroesophageal disease: Randomized Double-Blind Controlled Trial. Acta Biomed 2020;91:70-8. [PMID: 32191657 DOI: 10.23750/abm.v91i1.8486] [Reference Citation Analysis]
559 Chen BL, Xing XB, Wang JH, Feng T, Xiong LS, Wang JP, Cui Y. Improved biopsy accuracy in Barrett’s esophagus with a transparent cap. World J Gastroenterol 2014; 20(16): 4718-4722 [PMID: 24782624 DOI: 10.3748/wjg.v20.i16.4718] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
560 Kushner PR, Snoddy AM, Gilderman L, Peura DA. Lansoprazole 15 mg once daily for 14 days is effective for treatment of frequent heartburn: results of 2 randomized, placebo-controlled, double-blind studies. Postgrad Med 2009;121:67-75. [PMID: 19641272 DOI: 10.3810/pgm.2009.07.2019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
561 Yuan LZ, Yi P, Wang GS, Tan SY, Huang GM, Qi LZ, Jia Y, Wang F. Lifestyle intervention for gastroesophageal reflux disease: a national multicenter survey of lifestyle factor effects on gastroesophageal reflux disease in China. Therap Adv Gastroenterol 2019;12:1756284819877788. [PMID: 31598134 DOI: 10.1177/1756284819877788] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
562 Wang AJ, Wang H, Xu L, Lv NH, He XX, Hong JB, You Y, Zhu X. Predictors of clinical response of acid suppression in Chinese patients with gastroesophageal reflux disease. Dig Liver Dis 2013;45:296-300. [PMID: 23333666 DOI: 10.1016/j.dld.2012.11.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
563 Khoma O, Burton L, Falk MG, Van der Wall H, Falk GL. Predictors of reflux aspiration and laryngo-pharyngeal reflux. Esophagus 2020;17:355-62. [DOI: 10.1007/s10388-020-00726-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
564 Kim SE, Kim N, Oh S, Kim HM, Park MI, Lee DH, Jung HC. Predictive factors of response to proton pump inhibitors in korean patients with gastroesophageal reflux disease. J Neurogastroenterol Motil 2015;21:69-77. [PMID: 25537676 DOI: 10.5056/jnm14078] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
565 Hu HQ, Li HK, Xiong Y, Zhang XB, Zhi JL, Wang XX, Ling-Hu EQ. Peroral endoscopic cardial constriction in gastroesophageal reflux disease.Medicine (Baltimore). 2018;97:e0169. [PMID: 29642142 DOI: 10.1097/MD.0000000000010169] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
566 Madanick RD. Extraesophageal presentations of GERD: where is the science? Gastroenterol Clin North Am 2014;43:105-20. [PMID: 24503362 DOI: 10.1016/j.gtc.2013.11.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
567 Kinoshita Y, Miwa H, Sanada K, Miyata K, Haruma K. Clinical characteristics and effectiveness of lansoprazole in Japanese patients with gastroesophageal reflux disease and dyspepsia. J Gastroenterol 2014;49:628-37. [DOI: 10.1007/s00535-013-0812-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
568 Neumann H, Monkemuller K, Kandulski A, Malfertheiner P. Dyspepsia and IBS symptoms in patients with NERD, ERD and Barrett's esophagus. Dig Dis. 2008;26:243-247. [PMID: 18463443 DOI: 10.1159/000121354] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
569 Kulich KR, Madisch A, Pacini F, Piqué JM, Regula J, Van Rensburg CJ, Ujszászy L, Carlsson J, Halling K, Wiklund IK. Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study. Health Qual Life Outcomes. 2008;6:12. [PMID: 18237386 DOI: 10.1186/1477-7525-6-12] [Cited by in Crossref: 127] [Cited by in F6Publishing: 117] [Article Influence: 9.8] [Reference Citation Analysis]
570 Matsumura T, Arai M, Ishigami H, Fujie M, Ishikawa K, Akizue N, Taida T, Ohta Y, Hamanaka S, Okimoto K, Saito K, Maruoka D, Nakagawa T, Kato N. Evaluation of Esophageal Mucosal Integrity in Patients with Gastroesophageal Reflux Disease. Digestion 2018;97:31-7. [PMID: 29393167 DOI: 10.1159/000484106] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
571 Nakada K, Matsuhashi N, Iwakiri K, Oshio A, Joh T, Higuchi K, Haruma K. Development and validation of a simple and multifaceted instrument, GERD-TEST, for the clinical evaluation of gastroesophageal reflux and dyspeptic symptoms. World J Gastroenterol 2017; 23(28): 5216-5228 [PMID: 28811716 DOI: 10.3748/wjg.v23.i28.5216] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
572 Michel F, Dannesberger R, Stroh T, Fritsche R, Ahrens P. [Pharyngeal acid load and different functional endoscopy findings]. HNO 2019;67:940-7. [PMID: 31407018 DOI: 10.1007/s00106-019-0723-6] [Reference Citation Analysis]
573 Mazzoleni G, Vailati C, Lisma DG, Testoni PA, Passaretti S. Correlation between oropharyngeal pH-monitoring and esophageal pH-impedance monitoring in patients with suspected GERD-related extra-esophageal symptoms. Neurogastroenterol Motil. 2014;26:1557-1564. [PMID: 25208949 DOI: 10.1111/nmo.12422] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
574 Lee SP, Kae SH, Jang HJ, Koh DH, Jung ES. Inter-observer variability of experts and trainees for the diagnosis of reflux esophagitis: Comparison of linked color imaging, blue laser imaging, and white light imaging. J Dig Dis 2021;22:425-32. [PMID: 34036751 DOI: 10.1111/1751-2980.13023] [Reference Citation Analysis]
575 Breckan RK, Paulssen EJ, Asfeldt AM, Mortensen L, Straume B, Florholmen J. The impact of body mass index and Helicobacter pylori infection on gastro-oesophageal reflux symptoms: a population-based study in Northern Norway. Scand J Gastroenterol 2009;44:1060-6. [PMID: 19593688 DOI: 10.1080/00365520903093728] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
576 Arora G, Mannalithara A, Mithal A, Triadafilopoulos G, Singh G. Concurrent conditions in patients with chronic constipation: a population-based study. PLoS One. 2012;7:e42910. [PMID: 23071488 DOI: 10.1371/journal.pone.0042910] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
577 Kethman W, Hawn M. New Approaches to Gastroesophageal Reflux Disease. J Gastrointest Surg 2017;21:1544-52. [PMID: 28623447 DOI: 10.1007/s11605-017-3439-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 4.8] [Reference Citation Analysis]
578 Castilloux J, Bouron-Dal Soglio D, Faure C. Endoscopic assessment of children with esophageal atresia: Lack of relationship of esophagitis and esophageal metaplasia to symptomatology. Can J Gastroenterol 2010;24:312-6. [PMID: 20485706 DOI: 10.1155/2010/902847] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
579 Harding C, Faiman A, Wright J. Evaluation of an intensive desensitisation, oral tolerance therapy and hunger provocation program for children who have had prolonged periods of tube feeds. International Journal of Evidence-Based Healthcare 2010;8:268-76. [DOI: 10.1111/j.1744-1609.2010.00184.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
580 Katz PO. Editorial: refractory GERD-good drug, wrong patients? Aliment Pharmacol Ther 2017;46:203-4. [DOI: 10.1111/apt.14120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
581 Scarpignato C, Hongo M, Wu JCY, Lottrup C, Lazarescu A, Stein E, Hunt RH. Pharmacologic treatment of GERD: Where we are now, and where are we going? Ann N Y Acad Sci 2020;1482:193-212. [PMID: 32935346 DOI: 10.1111/nyas.14473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
582 Legros L, Ropert A, Brochard C, Bouguen G, Pagenault M, Siproudhis L, Bretagne JF. Long-term results of pneumatic dilatation for relapsing symptoms of achalasia after Heller myotomy. Neurogastroenterol Motil 2014;26:1248-55. [PMID: 24916630 DOI: 10.1111/nmo.12380] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
583 Seo PJ, Kim N, Oh JC, Lee BH, Shin CM, Suh S, Park H, Nam RH, Cha JA, Park YS, Lee DH. Comparison of Direct Medical Care Costs Between Erosive Reflux Disease and Non-erosive Reflux Disease in Korean Tertiary Medical Center. J Neurogastroenterol Motil 2010;16:291-8. [PMID: 20680168 DOI: 10.5056/jnm.2010.16.3.291] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
584 Ponce J, Mearin F, Ponce M, Balboa A, Zapardiel J. [Symptom profile in gastroesophageal reflux disease in untreated patients and those with persistent symptoms despite treatment]. Gastroenterol Hepatol 2010;33:271-9. [PMID: 20133018 DOI: 10.1016/j.gastrohep.2009.11.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
585 Shih Y, Tsai C, Li T, Yu C, Chou J, Feng C, Wang K, Lai H, Hsieh C. Effect of wu chu yu tang on gastroesophageal reflux disease: Randomized, double-blind, placebo-controlled trial. Phytomedicine 2019;56:118-25. [DOI: 10.1016/j.phymed.2018.09.185] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
586 Marelli S, Pace F. Rabeprazole for the treatment of acid-related disorders. Expert Rev Gastroenterol Hepatol. 2012;6:423-435. [PMID: 22928894 DOI: 10.1586/egh.12.18] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
587 Wang F, Li P, Ji GZ, Miao L, Fan Z, You S, Pan X, Chen X. An analysis of 342 patients with refractory gastroesophageal reflux disease symptoms using questionnaires, high-resolution manometry, and impedance-pH monitoring. Medicine (Baltimore) 2017;96:e5906. [PMID: 28151867 DOI: 10.1097/MD.0000000000005906] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
588 Amano Y, Yamashita H, Koshino K, Ohshima T, Miwa H, Iwakiri R, Fujimoto K, Manabe N, Haruma K, Kinoshita Y. Does magnifying endoscopy improve the diagnosis of erosive esophagitis? J Gastroenterol Hepatol 2008;23:1063-8. [PMID: 18554240 DOI: 10.1111/j.1440-1746.2008.05453.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
589 El-Serag H, Becher A, Jones R. Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies. Aliment Pharmacol Ther. 2010;32:720-737. [PMID: 20662774 DOI: 10.1111/j.1365-2036.2010.04406.x] [Cited by in Crossref: 153] [Cited by in F6Publishing: 129] [Article Influence: 15.3] [Reference Citation Analysis]
590 Nasseri-Moghaddam S, Nokhbeh-Zaeem H, Saniee P, Pedramnia S, Sotoudeh M, Malekzadeh R. Oral nitrate reductase activity and erosive gastro-esophageal reflux disease: a nitrate hypothesis for GERD pathogenesis. Dig Dis Sci. 2012;57:413-418. [PMID: 21881975 DOI: 10.1007/s10620-011-1865-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
591 Huerta-Iga FM, Tamayo-de la Cuesta JL, Noble-Lugo A, Remes-Troche JM, Valdovinos-Díaz MA, Carmona-Sánchez RI; el Grupo Mexicano para el Estudio de la Enfermedad por Reflujo Gastroesofágico 2011. [The Mexican consensus on gastroesophageal reflux disease. Part I]. Rev Gastroenterol Mex 2012;77:193-213. [PMID: 23153413 DOI: 10.1016/j.rgmx.2012.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
592 Vassiliou MC, von Renteln D, Rothstein RI. Recent advances in endoscopic antireflux techniques. Gastrointest Endosc Clin N Am. 2010;20:89-101, vii. [PMID: 19951796 DOI: 10.1016/j.giec.2009.08.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
593 Yadlapati R, Kaizer AM, Sikavi DR, Greytak M, Cai JX, Carroll TL, Gupta S, Wani S, Menard-Katcher P, Wu TC, Weissbrod P, Vahabzadeh-Hagh AM, Pandolfino JE, Chan WW. Distinct Clinical Physiologic Phenotypes of Patients With Laryngeal Symptoms Referred for Reflux Evaluation. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00563-2. [PMID: 34022451 DOI: 10.1016/j.cgh.2021.05.025] [Reference Citation Analysis]
594 Hori K, Kim Y, Sakurai J, Watari J, Tomita T, Oshima T, Kondo C, Matsumoto T, Miwa H. Non-erosive reflux disease rather than cervical inlet patch involves globus. J Gastroenterol. 2010;45:1138-1145. [PMID: 20582442 DOI: 10.1007/s00535-010-0275-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
595 Coyle C, Crawford G, Wilkinson J, Thomas SJ, Bytzer P. Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms. Aliment Pharmacol Ther 2017;45:1524-33. [DOI: 10.1111/apt.14064] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
596 Rajendra S, Sharma P. Management of Barrett's oesophagus and intramucosal oesophageal cancer: a review of recent development. Therap Adv Gastroenterol. 2012;5:285-299. [PMID: 22973415 DOI: 10.1177/1756283x12446668] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
597 Savarino E, de Bortoli N, De Cassan C, Della Coletta M, Bartolo O, Furnari M, Ottonello A, Marabotto E, Bodini G, Savarino V. The natural history of gastro-esophageal reflux disease: a comprehensive review. Dis Esophagus. 2017;30:1-9. [PMID: 27862680 DOI: 10.1111/dote.12511] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
598 Surdea-Blaga T, Negrutiu DE, Palage M, Dumitrascu DL. Food and Gastroesophageal Reflux Disease. Curr Med Chem. 2019;26:3497-3511. [PMID: 28521699 DOI: 10.2174/0929867324666170515123807] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 10.5] [Reference Citation Analysis]
599 Kimura Y, Kamiya T, Senoo K, Tsuchida K, Hirano A, Kojima H, Yamashita H, Yamakawa Y, Nishigaki N, Ozeki T, Endo M, Nakanishi K, Sando M, Inagaki Y, Shikano M, Mizoshita T, Kubota E, Tanida S, Kataoka H, Katsumi K, Joh T. Persistent reflux symptoms cause anxiety, depression, and mental health and sleep disorders in gastroesophageal reflux disease patients. J Clin Biochem Nutr. 2016;59:71-77. [PMID: 27499583 DOI: 10.3164/jcbn.16-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
600 Nwokediuko S. Gastroesophageal Reflux Disease: A Population Based Study. Gastroenterology Res 2009;2:152-6. [PMID: 27933125 DOI: 10.4021/gr2009.05.1291] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
601 Jensen ET, Kappelman MD, Kim HP, Ringel-Kulka T, Dellon ES. Early life exposures as risk factors for pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2013;57:67-71. [PMID: 23518485 DOI: 10.1097/MPG.0b013e318290d15a] [Cited by in Crossref: 99] [Cited by in F6Publishing: 53] [Article Influence: 14.1] [Reference Citation Analysis]
602 Tominaga K, Kato M, Takeda H, Shimoyama Y, Umegaki E, Iwakiri R, Furuta K, Sakurai K, Odaka T, Kusunoki H, Nagahara A, Iwakiri K, Furuta T, Murakami K, Miwa H, Kinoshita Y, Haruma K, Takahashi S, Watanabe S, Higuchi K, Kusano M, Fujimoto K, Arakawa T; G-PRIDE Study Group. A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study. J Gastroenterol 2014;49:1392-405. [DOI: 10.1007/s00535-013-0896-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 4.9] [Reference Citation Analysis]
603 Illueca M, Wernersson B, Henderson C, Lundborg P. Maintenance Treatment With Proton Pump Inhibitors for Reflux Esophagitis in Pediatric Patients: A Systematic Literature Analysis. Journal of Pediatric Gastroenterology & Nutrition 2010;51:733-40. [DOI: 10.1097/mpg.0b013e3181e2acfd] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
604 Dumic I, Nordin T, Jecmenica M, Stojkovic Lalosevic M, Milosavljevic T, Milovanovic T. Gastrointestinal Tract Disorders in Older Age. Can J Gastroenterol Hepatol 2019;2019:6757524. [PMID: 30792972 DOI: 10.1155/2019/6757524] [Cited by in Crossref: 51] [Cited by in F6Publishing: 28] [Article Influence: 25.5] [Reference Citation Analysis]
605 Bruley des Varannes S, Cestari R, Usova L, Triantafyllou K, Alvarez Sanchez A, Keim S, Bergmans P, Marelli S, Grahl E, Ducrotté P. Classification of adults suffering from typical gastroesophageal reflux disease symptoms: contribution of latent class analysis in a European observational study. BMC Gastroenterol 2014;14:112. [PMID: 24969728 DOI: 10.1186/1471-230X-14-112] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
606 Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-dodaran M, Bazzoli F, Ford AC. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut 2018;67:430-40. [DOI: 10.1136/gutjnl-2016-313589] [Cited by in Crossref: 129] [Cited by in F6Publishing: 98] [Article Influence: 32.3] [Reference Citation Analysis]
607 Scarpellini E, Vos R, Blondeau K, Boecxstaens V, Farré R, Gasbarrini A, Tack J. The effects of itopride on oesophageal motility and lower oesophageal sphincter function in man. Aliment Pharmacol Ther. 2011;33:99-105. [PMID: 21083582 DOI: 10.1111/j.1365-2036.2010.04487.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
608 Kawar N, Park SG, Schwartz JL, Callahan N, Obrez A, Yang B, Chen Z, Adami GR. Salivary microbiome with gastroesophageal reflux disease and treatment. Sci Rep 2021;11:188. [PMID: 33420219 DOI: 10.1038/s41598-020-80170-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
609 Alecci U, Bonina F, Bonina A, Rizza L, Inferrera S, Mannucci C, Calapai G. Efficacy and Safety of a Natural Remedy for the Treatment of Gastroesophageal Reflux: A Double-Blinded Randomized-Controlled Study. Evid Based Complement Alternat Med 2016;2016:2581461. [PMID: 27818697 DOI: 10.1155/2016/2581461] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
610 Chen J, Brady P. Gastroesophageal Reflux Disease: Pathophysiology, Diagnosis, and Treatment. Gastroenterol Nurs. 2019;42:20-28. [PMID: 30688703 DOI: 10.1097/sga.0000000000000359] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
611 Shields HM, Nardone G, Zhao J, Wang W, Xing Z, Fang D, Jacobson BC, Romero Y, Dvorak K, Goldman A, Pellegrini CA, Wiley EL, Peura DA, Tatum RP, Schnell TG. Barrett's esophagus: prevalence and incidence of adenocarcinomas: Barrett's esophagus: prevalence and incidence of adenocarcinomas. Annals of the New York Academy of Sciences 2011;1232:230-47. [DOI: 10.1111/j.1749-6632.2011.06054.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
612 Kandulski A, Peitz U, Mönkemüller K, Neumann H, Weigt J, Malfertheiner P. GERD assessment including pH metry predicts a high response rate to PPI standard therapy. BMC Gastroenterol 2013;13:12. [PMID: 23324360 DOI: 10.1186/1471-230X-13-12] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
613 Choi CW, Kim GH, Song CS, Wang SG, Lee BJ, I H, Kang DH, Song GA. Is obesity associated with gastropharyngeal reflux disease? World J Gastroenterol 2008; 14(2): 265-271 [PMID: 18186566 DOI: 10.3748/wjg.14.265] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
614 Chen CC, Hsu YC, Lee CT, Hsu CC, Tai CM, Wang WL, Tseng CH, Hsu CT, Lin JT, Chang CY. Central Obesity and H. pylori Infection Influence Risk of Barrett's Esophagus in an Asian Population. PLoS One 2016;11:e0167815. [PMID: 27936223 DOI: 10.1371/journal.pone.0167815] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
615 Kang HR, Lee YJ, Lee HY, Park TY, Lee JK, Heo EY, Chung HS, Choi SH, Kim DK. The Impact of Erosive Reflux Esophagitis on the Decline of Lung Function in the General Population. J Korean Med Sci 2021;36:e29. [PMID: 33527781 DOI: 10.3346/jkms.2021.36.e29] [Reference Citation Analysis]
616 Chang AB, Lasserson TJ, Gaffney J, Connor FL, Garske LA. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database Syst Rev 2006;:CD004823. [PMID: 17054216 DOI: 10.1002/14651858.CD004823.pub3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
617 Rameau A, Mudry A. When did gastro-esophageal reflux become a disease? A historical perspective on GER(D) nomenclature. International Journal of Pediatric Otorhinolaryngology 2020;137:110214. [DOI: 10.1016/j.ijporl.2020.110214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
618 Farjam M, Sharafi M, Bahramali E, Rezaei S, Hassanzadeh J, Rezaeian S. Socioeconomic Inequalities in Gastroesophageal Reflux Disorder: Results from an Iranian Cohort Study. Middle East J Dig Dis 2018;10:180-7. [PMID: 30186582 DOI: 10.15171/mejdd.2018.108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
619 Bortoli N, Gyawali CP, Frazzoni M, Tolone S, Frazzoni L, Vichi E, Visaggi P, Bellini M, Marabotto E, Penagini R, Savarino V, Marchi S, Savarino EV. Bile reflux in patients with nerd is associated with more severe heartburn and lower values of mean nocturnal baseline impedance and chemical clearance. Neurogastroenterology & Motility 2020;32. [DOI: 10.1111/nmo.13919] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
620 Sugimoto M, Nishino M, Kodaira C, Yamade M, Uotani T, Ikuma M, Umemura K, Furuta T. Characteristics of non-erosive gastroesophageal reflux disease refractory to proton pump inhibitor therapy. World J Gastroenterol 2011; 17(14): 1858-1865 [PMID: 21528060 DOI: 10.3748/wjg.v17.i14.1858] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
621 Zschau NB, Andrews JM, Holloway RH, Schoeman MN, Lange K, Tam WC, Holtmann GJ. Gastroesophageal reflux disease after diagnostic endoscopy in the clinical setting. World J Gastroenterol 2013; 19(16): 2514-2520 [PMID: 23674853 DOI: 10.3748/wjg.v19.i16.2514] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
622 Yadlapati R, Tye M, Keefer L, Kahrilas PJ, Pandolfino JE. Psychosocial Distress and Quality of Life Impairment Are Associated With Symptom Severity in PPI Non-Responders With Normal Impedance-pH Profiles. Am J Gastroenterol 2018;113:31-8. [PMID: 28895583 DOI: 10.1038/ajg.2017.263] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
623 Futagami S, Yamawaki H, Izumi N, Shimpuku M, Kodaka Y, Wakabayashi T, Nagoya H, Shindo T, Kawagoe T, Gudis K, Itoh T, Sakamoto C. Impact of sleep disorders in Japanese patients with functional dyspepsia (FD): Nizatidine improves clinical symptoms, gastric emptying and sleep disorders in FD patients: Sleep disorders in functional dyspepsia. J Gastroenterol Hepatol 2013;28:1314-20. [DOI: 10.1111/jgh.12236] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
624 Jones R, Latinovic R, Charlton J, Gulliford MC. Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database. BMJ 2007;334:1040. [PMID: 17493982 DOI: 10.1136/bmj.39171.637106.AE] [Cited by in Crossref: 150] [Cited by in F6Publishing: 98] [Article Influence: 10.7] [Reference Citation Analysis]
625 Sweis R, Kaufman E, Anggiansah A, Wong T, Dettmar P, Fried M, Schwizer W, Avvari RK, Pal A, Fox M. Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients. Aliment Pharmacol Ther. 2013;37:1093-1102. [PMID: 23600790 DOI: 10.1111/apt.12318] [Cited by in Crossref: 47] [Cited by in F6Publishing: 29] [Article Influence: 5.9] [Reference Citation Analysis]
626 Hu ZW, Wang ZG, Zhang Y, Wu JM, Liu JJ, Lu FF, Zhu GC, Liang WT. Gastroesophageal reflux in bronchiectasis and the effect of anti-reflux treatment. BMC Pulm Med 2013;13:34. [PMID: 23731838 DOI: 10.1186/1471-2466-13-34] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
627 Suzuki M, Saigusa H, Kurogi R, Yamamoto T, Ishiguro T, Yohsizawa T, Kuyama Y, Furukawa T. Arousals in obstructive sleep apnea patients with laryngopharyngeal and gastroesophageal reflux. Sleep Medicine 2010;11:356-60. [DOI: 10.1016/j.sleep.2009.09.008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
628 Zerbib F, Dulery C. Facts and Fantasies on Extraesophageal Reflux: A Gastroenterologist Perspective. J Clin Gastroenterol 2017;51:769-76. [PMID: 28858946 DOI: 10.1097/MCG.0000000000000918] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
629 Chang AB, Berkowitz RG. Cough in the Pediatric Population. Otolaryngologic Clinics of North America 2010;43:181-98. [DOI: 10.1016/j.otc.2009.11.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
630 Jeurnink SM, van Herwaarden-lindeboom MY, Siersema PD, Fischer K, Houwen RH, van der Zee DC. Barrett's esophagus in children: Does it need more attention? Digestive and Liver Disease 2011;43:682-7. [DOI: 10.1016/j.dld.2011.02.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
631 Sebastianelli L, Benois M, Vanbiervliet G, Bailly L, Robert M, Turrin N, Gizard E, Foletto M, Bisello M, Albanese A, Santonicola A, Iovino P, Piche T, Angrisani L, Turchi L, Schiavo L, Iannelli A. Systematic Endoscopy 5 Years After Sleeve Gastrectomy Results in a High Rate of Barrett's Esophagus: Results of a Multicenter Study. Obes Surg. 2019;29:1462-1469. [PMID: 30666544 DOI: 10.1007/s11695-019-03704-y] [Cited by in Crossref: 105] [Cited by in F6Publishing: 85] [Article Influence: 105.0] [Reference Citation Analysis]
632 Leodolter A, Nocon M, Vieth M, Lind T, Jaspersen D, Richter K, Willich S, Stolte M, Malfertheiner P, Labenz J. Progression of specialized intestinal metaplasia at the cardia to macroscopically evident Barrett's esophagus: an entity of concern in the ProGERD study. Scand J Gastroenterol 2012;47:1429-35. [PMID: 23110405 DOI: 10.3109/00365521.2012.733952] [Cited by in Crossref: 36] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
633 Lazarescu A, Sifrim D. Ambulatory monitoring of GERD: current technology. Gastroenterol Clin North Am. 2008;37:793-805, viii. [PMID: 19028318 DOI: 10.1016/j.gtc.2008.09.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
634 Foocharoen C, Chunlertrith K, Mairiang P, Mahakkanukrauh A, Suwannaroj S, Namvijit S, Wantha O, Nanagara R. Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: randomized placebo-controlled trial. Rheumatology (Oxford). 2017;56:214-222. [PMID: 27179107 DOI: 10.1093/rheumatology/kew216] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
635 Mizyed I, Fass SS, Fass R. Review article: gastro-oesophageal reflux disease and psychological comorbidity. Aliment Pharmacol Ther. 2009;29:351-358. [PMID: 19035971 DOI: 10.1111/j.1365-2036.2008.03883.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
636 Geeraerts A, Van Houtte B, Clevers E, Geysen H, Vanuytsel T, Tack J, Pauwels A. Gastroesophageal Reflux Disease—Functional Dyspepsia Overlap: Do Birds of a Feather Flock Together? Am J Gastroenterol 2020;115:1167-82. [DOI: 10.14309/ajg.0000000000000619] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
637 Fornari F, Sifrim D. Diagnostic options for patients with refractory GERD. Curr Gastroenterol Rep. 2008;10:283-288. [PMID: 18625140 DOI: 10.1007/s11894-008-0057-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
638 Kahrilas PJ, Howden CW, Hughes N. Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease. Am J Gastroenterol. 2011;106:1419-1425; quiz 1426. [PMID: 21537361 DOI: 10.1038/ajg.2011.146] [Cited by in Crossref: 103] [Cited by in F6Publishing: 88] [Article Influence: 10.3] [Reference Citation Analysis]
639 Rada RE. Dental erosion due to GERD in patients with developmental disabilities: case theory: DENTAL EROSION DUE TO GERD. Special Care in Dentistry 2014;34:7-11. [DOI: 10.1111/scd.12055] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
640 Hungin APS, Hill C, Molloy–bland M, Raghunath A. Systematic Review: Patterns of Proton Pump Inhibitor Use and Adherence in Gastroesophageal Reflux Disease. Clinical Gastroenterology and Hepatology 2012;10:109-16. [DOI: 10.1016/j.cgh.2011.07.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
641 Rodríguez de Santiago E, Albéniz E, Estremera-Arevalo F, Teruel Sanchez-Vegazo C, Lorenzo-Zúñiga V. Endoscopic anti-reflux therapy for gastroesophageal reflux disease. World J Gastroenterol 2021; 27(39): 6601-6614 [DOI: 10.3748/wjg.v27.i39.6601] [Reference Citation Analysis]
642 Wex T, Mönkemüller K, Kuester D, Weise S, Kropf S, Fry LC, Stahr A, Völkel S, Roessner A, Malfertheiner P. Gastroesophageal reflux disease does not lead to changes in the secretory leukocyte protease inhibitor expression in esophageal mucosa: . European Journal of Gastroenterology & Hepatology 2009;21:150-8. [DOI: 10.1097/meg.0b013e32830e4905] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
643 Chiu S, Birch DW, Shi X, Sharma AM, Karmali S. Effect of sleeve gastrectomy on gastroesophageal reflux disease: a systematic review. Surg Obes Relat Dis. 2011;7:510-515. [PMID: 21130052 DOI: 10.1016/j.soard.2010.09.011] [Cited by in Crossref: 192] [Cited by in F6Publishing: 153] [Article Influence: 17.5] [Reference Citation Analysis]
644 Wu P, Zhou L, Li YJ, Luo B, Yi LS, Chen SF, Sun HH, Chen Y, Cao ZJ, Xu SC. Protective effects of quercetin against chronic mixed reflux esophagitis in rats by inhibiting the nuclear factor-κB p65 and interleukin-8 signaling pathways: Quercetin and reflux esophagitis. Journal of Digestive Diseases 2015;16:319-26. [DOI: 10.1111/1751-2980.12249] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
645 Chih PC, Yang YC, Wu JS, Chang YF, Lu FH, Chang CJ. Overweight associated with increased risk of erosive esophagitis in a non-obese Taiwanese population. PLoS One 2013;8:e77932. [PMID: 24223746 DOI: 10.1371/journal.pone.0077932] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
646 Wang VL, Jalilvand AD, Gupta A, Chen J, Vadlamudi C, Perry KA. Tobacco use is not associated with increased risk of recurrent reflux 5 years after laparoscopic anti-reflux surgery. Surg Endosc 2021;35:4771-8. [PMID: 32914359 DOI: 10.1007/s00464-020-07956-z] [Reference Citation Analysis]
647 Toros AB, Toros SZ, Ozel L, Ersoz F, Saglam M, Sametoglu F. Comparative outcomes of antireflux treatment for laryngopharyngeal reflux symptoms and upper abdominal symptoms in patients with endoscopic esophagitis. Eur Arch Otorhinolaryngol 2011;268:703-8. [PMID: 21170720 DOI: 10.1007/s00405-010-1459-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
648 Chandrasoma PT. Histologic definition of gastro-esophageal reflux disease: . Current Opinion in Gastroenterology 2013;29:460-7. [DOI: 10.1097/mog.0b013e32836228fa] [Cited by in Crossref: 37] [Cited by in F6Publishing: 6] [Article Influence: 4.6] [Reference Citation Analysis]
649 Liu L, Gao H, Wang H, Yu W, Zhu K, Zhang Y, Guo J. Comparison of Esophageal Function Tests to Investigate the Effect of Helicobacter Pylori Infection on Gastroesophageal Reflux Disease (GERD). Med Sci Monit. 2018;24:4791-4797. [PMID: 29992917 DOI: 10.12659/msm.908051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
650 Wang C, Yuan Y, Hunt RH. Helicobacter pylori Infection and Barrett's Esophagus: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2009;104:492-500. [DOI: 10.1038/ajg.2008.37] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
651 Gisbert JP, Cooper A, Karagiannis D, Hatlebakk J, Agréus L, Jablonowski H, Zapardiel J. Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting. Health Qual Life Outcomes 2009;7:60. [PMID: 19573227 DOI: 10.1186/1477-7525-7-60] [Cited by in Crossref: 34] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
652 Hanschmidt F, Treml J, Kreuser N, Gockel I, Kersting A. Anxiety and depression in patients with Barrett's esophagus: estimates of disorder rates and associations with symptom load and treatment-seeking. Eur J Gastroenterol Hepatol 2021;33:825-31. [PMID: 33136727 DOI: 10.1097/MEG.0000000000001960] [Reference Citation Analysis]
653 Seleem WM, Hanafy AS, Mohamed SI. Endoscopic management of refractory gastroesophageal reflux disease. Scandinavian Journal of Gastroenterology 2018;53:390-7. [DOI: 10.1080/00365521.2018.1445775] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
654 Rauber BF, Milani DC, Callegari-Jacques SM, Fornari L, Bonadeo NM, Fornari F. Predictors of dental erosions in patients evaluated with upper digestive endoscopy: a cross-sectional study. Odontology 2020;108:723-9. [PMID: 32152820 DOI: 10.1007/s10266-020-00505-z] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
655 Blackshaw LA, Bordin DS, Brock C, Brokjaer A, Drewes AM, Farmer AD, Krarup AL, Lottrup C, Masharova AA, Moawad FJ, Olesen AE. Pharmacologic treatments for esophageal disorders: Pharmacologic treatments for esophageal disorders. Ann N Y Acad Sci 2014;1325:23-39. [DOI: 10.1111/nyas.12520] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
656 Georgia D, Stamatina T, Maria N, Konstantinos A, Konstantinos F, Emmanouil L, Georgios Z, Dimitrios T. 24-h Multichannel Intraluminal Impedance PH-metry 1 Year After Laparocopic Sleeve Gastrectomy: An Objective Assessment of Gastroesophageal Reflux Disease. Obes Surg. 2017;27:749-753. [PMID: 27592124 DOI: 10.1007/s11695-016-2359-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
657 Scaramucci T, Carvalho JC, Hara AT, Zero DT. Causes of Dental Erosion: Intrinsic Factors. In: Amaechi BT, editor. Dental Erosion and Its Clinical Management. Cham: Springer International Publishing; 2015. pp. 35-67. [DOI: 10.1007/978-3-319-13993-7_3] [Cited by in Crossref: 9] [Article Influence: 1.5] [Reference Citation Analysis]
658 Kumar S, Sharma S, Norboo T, Dolma D, Norboo A, Stobdan T, Rohatgi S, Munot K, Ahuja V, Saraya A. Population based study to assess prevalence and risk factors of gastroesophageal reflux disease in a high altitude area. Indian J Gastroenterol 2011;30:135-43. [DOI: 10.1007/s12664-010-0066-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
659 Jiang L, Ye B, Wang Y, Wang M, Lin L. Esophageal Body Motility for Clinical Assessment in Patients with Refractory Gastroesophageal Reflux Symptoms. J Neurogastroenterol Motil 2017;23:64-71. [PMID: 27599539 DOI: 10.5056/jnm16047] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
660 Scarpignato C. Poor effectiveness of proton pump inhibitors in non-erosive reflux disease: the truth in the end! Neurogastroenterol Motil. 2012;24:697-704. [PMID: 22783985 DOI: 10.1111/j.1365-2982.2012.01977.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
661 Lee SY, Ryu HS, Choi SC, Jang SH. Psychological Factors Influence the Overlap Syndrome in Functional Gastrointestinal Disorder and Quality of Life among Psychiatric Patients in South Korea. Psychiatry Investig 2020;17:262-7. [PMID: 32151127 DOI: 10.30773/pi.2019.0278] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
662 Madalosso CAS, Fornari F, Callegari-jacques SM, Madalosso CA, Gurski RR. Performance of the Montreal Consensus in the Diagnosis of Gastroesophageal Reflux Disease in Morbidly Obese Patients. OBES SURG 2008;18:668-74. [DOI: 10.1007/s11695-008-9462-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
663 Lechien JR, Calvo-henriquez C, Chiesa-estomba CM, Barillari MR, Trozzi M, Meucci D, Peer S, Ben Abdelouahed F, Schindler A, Saussez S. Reflux and dental disorders in the pediatric population: A systematic review. International Journal of Pediatric Otorhinolaryngology 2020;136:110166. [DOI: 10.1016/j.ijporl.2020.110166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
664 Vakil N, Halling K, Ohlsson L, Wernersson B. Symptom overlap between postprandial distress and epigastric pain syndromes of the Rome III dyspepsia classification. Am J Gastroenterol. 2013;108:767-774. [PMID: 23567354 DOI: 10.1038/ajg.2013.89] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 6.1] [Reference Citation Analysis]
665 Chen MJ, Lee YC, Chiu HM, Wu MS, Wang HP, Lin JT. Time trends of endoscopic and pathological diagnoses related to gastroesophageal reflux disease in a Chinese population: eight years single institution experience. Dis Esophagus. 2010;23:201-207. [PMID: 19788438 DOI: 10.1111/j.1442-2050.2009.01012.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
666 Ribolsi M, Giordano A, Guarino MPL, Tullio A, Cicala M. New classifications of gastroesophageal reflux disease: an improvement for patient management? Expert Review of Gastroenterology & Hepatology 2019;13:761-9. [DOI: 10.1080/17474124.2019.1645596] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
667 Stenard F, Iannelli A. Laparoscopic sleeve gastrectomy and gastroesophageal reflux. World J Gastroenterol 2015; 21(36): 10348-10357 [PMID: 26420961 DOI: 10.3748/wjg.v21.i36.10348] [Cited by in CrossRef: 123] [Cited by in F6Publishing: 84] [Article Influence: 20.5] [Reference Citation Analysis]
668 Martinucci I, de Bortoli N, Russo S, Bertani L, Furnari M, Mokrowiecka A, Malecka-Panas E, Savarino V, Savarino E, Marchi S. Barrett’s esophagus in 2016: From pathophysiology to treatment. World J Gastrointest Pharmacol Ther 2016; 7(2): 190-206 [PMID: 27158534 DOI: 10.4292/wjgpt.v7.i2.190] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
669 Haag S, Holtmann G. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily. Clin Ther. 2010;32:678-690. [PMID: 20435237 DOI: 10.1016/j.clinthera.2010.03.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
670 Emilsson OI, Gíslason T, Olin AC, Janson C, Olafsson I. Biomarkers for gastroesophageal reflux in respiratory diseases. Gastroenterol Res Pract 2013;2013:148086. [PMID: 23653634 DOI: 10.1155/2013/148086] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
671 Boeckxstaens GE. Review article: the pathophysiology of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2007;26:149-60. [PMID: 17593062 DOI: 10.1111/j.1365-2036.2007.03372.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
672 Langella C, Naviglio D, Marino M, Calogero A, Gallo M. New food approaches to reduce and/or eliminate increased gastric acidity related to gastroesophageal pathologies. Nutrition 2018;54:26-32. [PMID: 29729504 DOI: 10.1016/j.nut.2018.03.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
673 Nakahara K, Fujiwara Y, Tsukahara T, Yamagami H, Tanigawa T, Shiba M, Tominaga K, Watanabe T, Urade Y, Arakawa T. Acid reflux directly causes sleep disturbances in rat with chronic esophagitis. PLoS One 2014;9:e106969. [PMID: 25215524 DOI: 10.1371/journal.pone.0106969] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
674 Mohammad S, Chandio B, Soomro AA, Lakho S, Ali Z, Ali Soomro Z, Shaukat F. Depression and Anxiety in Patients with Gastroesophageal Reflux Disorder With and Without Chest Pain. Cureus 2019;11:e6103. [PMID: 31763106 DOI: 10.7759/cureus.6103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
675 Tschoner A. [Update on Endoscopic Therapies for the Treatment of GERD: GERDX, MUSE, EsophyX]. Zentralbl Chir 2021;146:188-93. [PMID: 33851381 DOI: 10.1055/a-1333-3751] [Reference Citation Analysis]
676 Emilsson ÖI, Benediktsdóttir B, Ólafsson Í, Cook E, Júlíusson S, Berg S, Nordang L, Björnsson ES, Guðlaugsdóttir S, Guðmundsdóttir AS, Janson C, Gislason T. Definition of nocturnal gastroesophageal reflux for studies on respiratory diseases. Scand J Gastroenterol 2016;51:524-30. [PMID: 26825677 DOI: 10.3109/00365521.2015.1124284] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
677 Soygun K, Soygun A, Dogan MC. The effect of gastric acid on chitosan modified glass ionomer cement: SEM-EDS. Microsc Res Tech 2020;83:3-9. [PMID: 31603592 DOI: 10.1002/jemt.23382] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
678 Mejia LM. Oral Manifestations of Gastrointestinal Disorders. Atlas Oral Maxillofac Surg Clin North Am 2017;25:93-104. [PMID: 28778312 DOI: 10.1016/j.cxom.2017.04.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
679 Chen YH, Yu HC, Lin KH, Lin HS, Hsu PI. Prevalence and risk factors for Barrett’s esophagus in Taiwan. World J Gastroenterol 2019; 25(25): 3231-3241 [PMID: 31333314 DOI: 10.3748/wjg.v25.i25.3231] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
680 Pomari C, Mauroner L, Paiano S, Assante LR, Bertolaccini L, Ruffo G, Mainardi P, Bocus P, Geccherle A, Albanese SI, Ciaffoni S. Bronchial reacutization and gastroesophageal reflux: is there a potential clinical correlation? Ann Transl Med 2016;4:304. [PMID: 27668224 DOI: 10.21037/atm.2016.08.40] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
681 Kandulski A, Wex T, Mönkemüller K, Kuester D, Fry LC, Roessner A, Malfertheiner P. Proteinase-activated receptor-2 in the pathogenesis of gastroesophageal reflux disease. Am J Gastroenterol 2010;105:1934-43. [PMID: 20588261 DOI: 10.1038/ajg.2010.265] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
682 Tsiouris A, Hammoud Z, Velanovich V. Barrett’s Esophagus After Resection of the Gastroesophageal Junction: Effects of Concomitant Fundoplication. World J Surg 2011;35:1867-72. [DOI: 10.1007/s00268-011-1142-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
683 Nahata M, Muto S, Oridate N, Ohnishi S, Nakagawa K, Sadakane C, Saegusa Y, Hattori T, Asaka M, Takeda H. Impaired ghrelin signaling is associated with gastrointestinal dysmotility in rats with gastroesophageal reflux disease. Am J Physiol Gastrointest Liver Physiol. 2012;303:G42-G53. [PMID: 22517773 DOI: 10.1152/ajpgi.00462.2011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
684 Sharma VK. Role of Endoscopy in GERD. Gastroenterology Clinics of North America 2014;43:39-46. [DOI: 10.1016/j.gtc.2013.12.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
685 Savarino E, Zentilin P, Marabotto E, Bodini G, Della Coletta M, Frazzoni M, de Bortoli N, Martinucci I, Tolone S, Pellegatta G, Savarino V. A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD). Expert Opin Pharmacother. 2017;18:1333-1343. [PMID: 28754071 DOI: 10.1080/14656566.2017.1361407] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
686 Gisbert JP, Cooper A, Karagiannis D, Hatlebakk J, Agréus L, Jablonowski H, Nuevo J. Impact of gastroesophageal reflux dis